Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,35728,94,2.57 [0.79-8.35],0.1163074508600929
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AAMDC,Mth938 domain-containing protein,34729,89,0.97 [0.66-1.43],0.8884228241952598
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,40826,102,1.69 [1.27-2.26],0.0003835415771779
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ABCA2,ATP-binding cassette sub-family A member 2,34555,92,1.05 [0.60-1.83],0.8754741727359585
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ABHD14B,Protein ABHD14B,40584,102,1.01 [0.74-1.37],0.9653731645065956
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ABL1,Tyrosine-protein kinase ABL1,40826,102,1.30 [1.02-1.66],0.0311007575185188
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ABO,Histo-blood group ABO system transferase,35700,95,1.08 [0.94-1.23],0.2641157634562749
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ABRAXAS2,BRISC complex subunit Abraxas 2,34555,92,0.95 [0.70-1.29],0.7405711359171665
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",40089,100,0.93 [0.75-1.17],0.5477649465404314
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",35020,92,0.74 [0.51-1.08],0.1179809438672263
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",35674,93,0.89 [0.71-1.12],0.32742850839336
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,40619,103,1.09 [0.58-2.06],0.7842612525404258
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACE,Angiotensin-converting enzyme,35700,95,0.95 [0.46-1.95],0.8915119783994464
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,40294,103,0.87 [0.61-1.24],0.4436093686648495
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,34914,93,1.44 [0.83-2.51],0.1991169607803648
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACOT13,Acyl-coenzyme A thioesterase 13,35523,94,0.95 [0.80-1.13],0.530887041306975
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,41020,104,1.05 [0.75-1.48],0.7788941813023122
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACP1,Low molecular weight phosphotyrosine protein phosphatase,34646,90,1.22 [0.81-1.83],0.3465000515929315
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,41207,106,1.04 [0.61-1.75],0.892208673599625
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,41331,103,1.38 [1.03-1.85],0.0327733737443164
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACRBP,Acrosin-binding protein,35512,93,0.77 [0.45-1.32],0.3434222134434085
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,34646,90,1.17 [0.95-1.44],0.1402219212948976
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACSL1,Long-chain-fatty-acid--CoA ligase 1,34555,92,0.98 [0.57-1.72],0.9573885184688063
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",40294,103,1.35 [0.97-1.89],0.0771154768135038
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACTN2,Alpha-actinin-2,34555,92,0.84 [0.59-1.21],0.3535072342063762
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACTN4,Alpha-actinin-4,40284,100,1.09 [0.65-1.83],0.7492428529135713
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,40651,102,2.56 [1.36-4.83],0.0036630897037186
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,41020,104,1.02 [0.77-1.36],0.8797541785974534
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,34555,92,1.46 [1.05-2.03],0.0230432650334352
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACYP1,Acylphosphatase-1,34781,91,1.03 [0.76-1.40],0.837293627001062
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,41488,104,1.19 [0.75-1.90],0.450283454794447
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,40780,102,1.71 [1.17-2.50],0.005613550923776
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,34646,90,1.67 [1.07-2.61],0.023845748683831
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40294,103,3.17 [1.83-5.49],4.013913708502907e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40720,102,1.88 [1.16-3.07],0.0110738920068359
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,41488,104,1.07 [0.65-1.77],0.7787829577798775
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,41312,103,2.90 [2.26-3.73],1.0498992263979856e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,35523,94,2.89 [1.75-4.79],3.481334765060595e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,34646,90,0.81 [0.41-1.60],0.5442632038335911
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,41521,106,0.90 [0.44-1.87],0.7834882559713682
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40826,102,0.87 [0.58-1.29],0.4877118730060044
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40294,103,0.78 [0.42-1.45],0.4263629156726529
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,34646,90,1.34 [0.79-2.27],0.2699768036251387
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,41133,105,1.11 [0.76-1.62],0.5898536440561855
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,35680,94,0.98 [0.53-1.78],0.936047570684204
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTSL4,ADAMTS-like protein 4,34729,89,1.12 [0.47-2.64],0.7972070526313773
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTSL5,ADAMTS-like protein 5,35674,93,0.78 [0.47-1.29],0.3297275328581314
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,40089,100,1.07 [0.67-1.72],0.7658331474501214
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADD1,Alpha-adducin,34914,93,1.06 [0.80-1.41],0.685726120921728
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,40651,102,0.86 [0.51-1.46],0.5694301616031601
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,34914,93,1.10 [0.66-1.83],0.7106723929260638
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,35523,94,1.91 [1.39-2.62],6.566350510625321e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,41181,102,4.49 [2.73-7.39],3.1093218876591683e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,41323,105,3.12 [2.39-4.05],2.6157649873248924e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRF5,Adhesion G protein-coupled receptor F5,35674,93,0.74 [0.36-1.52],0.4134336078800763
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,40826,102,1.06 [0.86-1.31],0.5996824058297276
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,41020,104,1.54 [0.81-2.94],0.1912819959319911
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRV1,Adhesion G-protein coupled receptor V1,34584,91,0.80 [0.57-1.13],0.2012734927296458
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADH1B,All-trans-retinol dehydrogenase,34914,93,1.06 [0.82-1.37],0.6689701355765252
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40294,103,0.91 [0.73-1.12],0.3681561065637369
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADIPOQ,Adiponectin,35728,94,1.09 [0.81-1.45],0.5753627160320518
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADM,Pro-adrenomedullin,41393,103,1.47 [0.75-2.91],0.2658565662466847
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADRA2A,Alpha-2A adrenergic receptor,34555,92,0.99 [0.75-1.32],0.9682368966965818
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AFAP1,Actin filament-associated protein 1,34914,93,0.94 [0.73-1.20],0.595959632198363
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AFM,Afamin,35728,94,0.60 [0.22-1.59],0.3043276306053961
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,40590,101,1.53 [1.19-1.98],0.0010349486801817
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AGBL2,Cytosolic carboxypeptidase 2,34584,91,1.15 [0.92-1.44],0.2223129341454279
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,40909,102,0.77 [0.50-1.19],0.2332921576039947
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AGR2,Anterior gradient protein 2 homolog,39736,101,1.02 [0.86-1.23],0.7880648273046147
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AGR3,Anterior gradient protein 3,40023,100,0.90 [0.66-1.22],0.5023965692501906
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,41181,102,1.01 [0.60-1.71],0.9592859677470758
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AGRP,Agouti-related protein,41488,104,0.97 [0.69-1.34],0.8396510749209924
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AGT,Angiotensinogen,35700,95,0.58 [0.37-0.90],0.0149231280738041
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,41020,104,1.03 [0.82-1.29],0.8033448541507173
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AHCY,Adenosylhomocysteinase,41020,104,1.14 [0.88-1.47],0.3149698954677176
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,34729,89,3.73 [2.70-5.17],1.7711089449509057e-15
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AHNAK2,Protein AHNAK2,34729,89,1.57 [0.88-2.81],0.1281642585714154
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,35512,93,0.78 [0.55-1.11],0.1700948158279646
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AHSG,Alpha-2-HS-glycoprotein,35700,95,2.11 [1.06-4.20],0.0328321314343254
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,40954,103,1.13 [0.92-1.39],0.22899776544219
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AIDA,"Axin interactor, dorsalization-associated protein",34720,90,0.86 [0.66-1.13],0.2817439303601227
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AIF1,Allograft inflammatory factor 1,40089,100,0.83 [0.59-1.17],0.2963902023649173
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AIF1L,Allograft inflammatory factor 1-like,34729,89,0.66 [0.41-1.07],0.09202867731168
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40758,102,1.02 [0.87-1.21],0.8047976787197378
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AK1,Adenylate kinase isoenzyme 1,41020,104,0.99 [0.75-1.30],0.9374723739716218
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AK2,"Adenylate kinase 2, mitochondrial",35608,95,0.98 [0.81-1.18],0.8259572618319257
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,34914,93,2.27 [1.33-3.86],0.0026691928059931
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKR1B1,Aldo-keto reductase family 1 member B1,40089,100,1.05 [0.83-1.33],0.7007901796406389
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,34720,90,1.01 [0.73-1.40],0.9413503794165242
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,40294,103,0.65 [0.43-0.99],0.0454072832559354
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,34646,90,0.96 [0.71-1.30],0.8045565285450516
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKT1S1,Proline-rich AKT1 substrate 1,40064,101,0.98 [0.75-1.29],0.9047343492243892
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKT2,RAC-beta serine/threonine-protein kinase,35624,95,0.98 [0.84-1.15],0.8073930369772333
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKT3,RAC-gamma serine/threonine-protein kinase,39895,100,0.84 [0.61-1.15],0.2648200916620948
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,41521,106,11.76 [5.50-25.16],2.1474793345032568e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,41027,103,1.25 [0.93-1.69],0.1450093769925683
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALDH2,"Aldehyde dehydrogenase, mitochondrial",35512,93,1.01 [0.68-1.48],0.9744950577031156
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40910,103,1.08 [0.85-1.38],0.5132718389470547
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",35624,95,1.64 [1.17-2.31],0.0045662036056804
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALMS1,Alstrom syndrome protein 1,35020,92,1.22 [0.83-1.80],0.3062878273497579
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALPI,Intestinal-type alkaline phosphatase,34646,90,0.85 [0.72-1.01],0.066128071413628
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",40826,102,0.94 [0.79-1.11],0.4571655371244215
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMBN,Ameloblastin,40284,100,1.54 [1.08-2.18],0.0156801884978735
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMBP,Protein AMBP,41334,103,1.17 [0.49-2.80],0.7240899469373343
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,35680,94,1.29 [0.60-2.79],0.5133959649257157
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMFR,E3 ubiquitin-protein ligase AMFR,40064,101,1.06 [0.81-1.39],0.6557422175939428
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMIGO1,Amphoterin-induced protein 1,34720,90,0.88 [0.56-1.36],0.5562123685386405
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMIGO2,Amphoterin-induced protein 2,40826,102,1.60 [0.76-3.40],0.2171310308407626
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMN,Protein amnionless,40284,100,1.18 [0.82-1.70],0.3798986658654423
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,34914,93,0.98 [0.58-1.65],0.9285041946067444
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMOTL2,Angiomotin-like protein 2,35388,93,0.96 [0.64-1.46],0.8647916471323639
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,35608,95,1.43 [1.10-1.86],0.0071678185862638
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,33411,88,0.73 [0.47-1.13],0.1549142366620031
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMY2A,Pancreatic alpha-amylase,39454,102,0.79 [0.54-1.14],0.2025219575897106
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMY2B,Alpha-amylase 2B,38244,98,0.73 [0.50-1.06],0.0976397162524162
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANG,Angiogenin,40911,102,0.67 [0.39-1.15],0.1476288625304293
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANGPT1,Angiopoietin-1,40863,102,0.79 [0.65-0.97],0.0240612854176023
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,41393,103,1.14 [0.72-1.80],0.5900249403226754
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,40437,103,0.88 [0.48-1.62],0.6823956412755985
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,41046,102,1.19 [0.77-1.85],0.4356564578394961
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,41038,102,1.04 [0.63-1.72],0.867657127332341
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,41121,102,1.11 [0.75-1.64],0.6064443077304709
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,41393,103,0.79 [0.49-1.29],0.3505256685658204
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANK2,Ankyrin-2,34555,92,0.78 [0.55-1.10],0.1585231148658128
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,34646,90,1.00 [0.77-1.28],0.9707637410243248
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANKRA2,Ankyrin repeat family A protein 2,34427,89,0.80 [0.54-1.18],0.2558502054949073
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANKRD54,Ankyrin repeat domain-containing protein 54,40089,100,1.03 [0.76-1.39],0.8670324184826899
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,34729,89,0.40 [0.19-0.86],0.0193761723578699
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,41104,103,0.92 [0.49-1.75],0.8040438944484629
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA1,Annexin A1,34708,91,1.15 [0.75-1.74],0.5209529490837715
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA10,Annexin A10,40064,101,1.00 [0.80-1.24],0.9666477686800689
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA11,Annexin A11,40906,102,0.88 [0.68-1.13],0.3061698780919951
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,34213,87,1.81 [1.53-2.13],4.47008056270812e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA3,Annexin A3,41312,103,0.80 [0.62-1.02],0.0743321935252392
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA4,Annexin A4,40825,104,0.93 [0.73-1.18],0.5436782456197593
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA5,Annexin A5,39941,101,0.96 [0.53-1.73],0.8944726732400382
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AOC1,Amiloride-sensitive amine oxidase [copper-containing],40284,100,0.63 [0.41-0.96],0.0323810330149827
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,41170,103,0.83 [0.46-1.47],0.5185878281013456
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AP1G2,AP-1 complex subunit gamma-like 2,35512,93,1.05 [0.82-1.34],0.6913265200918122
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AP2B1,AP-2 complex subunit beta,34720,90,1.15 [0.77-1.72],0.4945137207225181
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AP3B1,AP-3 complex subunit beta-1,35523,94,1.09 [0.85-1.41],0.4999813811914296
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AP3S2,AP-3 complex subunit sigma-2,35608,95,1.14 [0.76-1.69],0.5317474804121296
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40826,102,1.88 [1.46-2.40],7.219129286202282e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,35403,94,0.75 [0.42-1.34],0.3356632857912218
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,41269,103,2.78 [2.31-3.35],6.435226129797013e-27
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APLP1,Amyloid-like protein 1,41020,104,1.33 [0.96-1.85],0.0892406229165139
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,35728,94,1.20 [0.60-2.40],0.6106961025943567
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOA2,Apolipoprotein A-II,35700,95,1.40 [0.95-2.07],0.0911295686585524
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOA4,Apolipoprotein A-IV,35728,94,1.44 [0.89-2.33],0.1337488824593597
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOB,Apolipoprotein B-100,35700,95,1.21 [0.51-2.87],0.6630634544195629
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,34729,89,0.71 [0.45-1.12],0.1389161599227447
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,35659,94,1.10 [0.65-1.85],0.7257784949393573
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,34105,90,1.37 [0.96-1.96],0.0797694987589851
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOE,Apolipoprotein E,35728,94,1.19 [0.97-1.47],0.0954003559711234
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,35700,95,1.00 [0.48-2.09],0.9985456503424798
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOH,Beta-2-glycoprotein 1,41027,103,0.94 [0.58-1.52],0.8022539049020563
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOL1,Apolipoprotein L1,35700,95,0.84 [0.59-1.22],0.3662537676030372
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,41111,103,0.44 [0.24-0.79],0.0058372132225609
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APP,Amyloid-beta precursor protein,40969,103,0.71 [0.54-0.93],0.012594387381987
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APPL2,DCC-interacting protein 13-beta,34914,93,0.88 [0.74-1.05],0.1592388301398849
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,40658,100,1.79 [1.20-2.67],0.004274147716717
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARAF,Serine/threonine-protein kinase A-Raf,35020,92,0.87 [0.64-1.20],0.3996750420168056
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,40826,102,1.03 [0.67-1.58],0.902943570132434
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARF6,ADP-ribosylation factor 6,35523,94,1.00 [0.83-1.20],0.9684062365855172
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARFIP1,Arfaptin-1,35624,95,1.13 [0.85-1.49],0.4072819699773706
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARG1,Arginase-1,40821,101,1.41 [1.01-1.96],0.0449732043306751
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARG2,"Arginase-2, mitochondrial",35512,93,1.14 [0.74-1.75],0.5599871652265886
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGAP1,Rho GTPase-activating protein 1,40089,100,1.07 [0.73-1.58],0.7301776853155797
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,40089,100,1.78 [1.46-2.17],1.215775043083566e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGAP30,Rho GTPase-activating protein 30,35020,92,0.97 [0.58-1.60],0.8974478746608255
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGAP45,Rho GTPase-activating protein 45,34914,93,0.95 [0.75-1.22],0.7099584959319383
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGAP5,Rho GTPase-activating protein 5,34427,89,0.85 [0.63-1.14],0.2821997963793277
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGEF1,Rho guanine nucleotide exchange factor 1,35608,95,1.12 [0.90-1.40],0.3046117110883033
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGEF10,Rho guanine nucleotide exchange factor 10,35624,95,1.11 [0.90-1.36],0.3234581397374338
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGEF12,Rho guanine nucleotide exchange factor 12,40974,103,0.96 [0.81-1.14],0.6315627837724075
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGEF5,Rho guanine nucleotide exchange factor 5,34584,91,0.86 [0.64-1.16],0.3225250437747306
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARID3A,AT-rich interactive domain-containing protein 3A,34584,91,0.84 [0.49-1.42],0.5119860236098861
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,40064,101,1.89 [1.57-2.28],2.303485343378157e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARL13B,ADP-ribosylation factor-like protein 13B,34555,92,0.93 [0.69-1.25],0.6281502996949129
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,34555,92,1.22 [0.76-1.98],0.4076180477415119
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARMCX2,Armadillo repeat-containing X-linked protein 2,34584,91,0.90 [0.63-1.30],0.590594822446832
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARNT,Aryl hydrocarbon receptor nuclear translocator,40284,100,1.04 [0.64-1.67],0.8808657732067648
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,34555,92,0.87 [0.56-1.34],0.5304298260934136
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARSA,Arylsulfatase A,41027,103,0.83 [0.56-1.24],0.3641848137780041
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARSB,Arylsulfatase B,40826,102,0.88 [0.64-1.22],0.4416308052054191
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ART3,Ecto-ADP-ribosyltransferase 3,41170,103,1.62 [1.00-2.64],0.0514432863572474
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ART5,Ecto-ADP-ribosyltransferase 5,34584,91,0.94 [0.66-1.32],0.7100654021256251
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARTN,Artemin,40284,100,1.15 [0.81-1.62],0.4431913700980111
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ASAH1,Acid ceramidase,35354,92,1.14 [0.76-1.72],0.520216412633649
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,40720,102,0.88 [0.64-1.19],0.4048077581639747
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,40720,102,1.52 [0.86-2.67],0.1480259510220468
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,35700,95,1.32 [0.63-2.75],0.4601662680590112
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,35674,93,0.45 [0.21-0.98],0.0441234722822126
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ASPSCR1,Tether containing UBX domain for GLUT4,35624,95,1.12 [0.84-1.49],0.4541499212611677
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ASRGL1,Isoaspartyl peptidase/L-asparaginase,34729,89,0.95 [0.77-1.16],0.5927460267664351
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ASS1,Argininosuccinate synthase,34555,92,0.91 [0.70-1.19],0.4881824093043615
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATF2,Cyclic AMP-dependent transcription factor ATF-2,40064,101,1.03 [0.80-1.33],0.8007825986319651
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATF4,Cyclic AMP-dependent transcription factor ATF-4,34427,89,1.24 [0.71-2.17],0.4496992004019768
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATG16L1,Autophagy-related protein 16-1,35523,94,1.04 [0.82-1.31],0.7463752992256134
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,40089,100,1.21 [0.91-1.61],0.1927109694821909
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATOX1,Copper transport protein ATOX1,41133,105,1.22 [0.95-1.56],0.1160446173825053
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,34555,92,0.79 [0.48-1.29],0.3423436291381538
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,34555,92,0.84 [0.43-1.62],0.595950376785007
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,34555,92,0.70 [0.38-1.26],0.2323807143276012
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP1B4,Protein ATP1B4,34427,89,0.71 [0.41-1.23],0.2203151677964928
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP2B4,Plasma membrane calcium-transporting ATPase 4,34555,92,0.86 [0.60-1.24],0.4238158340404043
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP5F1D,"ATP synthase subunit delta, mitochondrial",34555,92,0.95 [0.63-1.43],0.8063182775008413
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP5IF1,"ATPase inhibitor, mitochondrial",41181,102,0.90 [0.77-1.06],0.2080888571781874
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP5PO,"ATP synthase subunit O, mitochondrial",40064,101,1.21 [0.87-1.69],0.2653079782516448
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP6AP2,Renin receptor,40089,100,1.32 [0.92-1.88],0.1302899403751286
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP6V1D,V-type proton ATPase subunit D,40826,102,1.15 [0.61-2.18],0.6590491598996155
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP6V1F,V-type proton ATPase subunit F,39988,101,0.90 [0.68-1.18],0.443692122729719
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP6V1G1,V-type proton ATPase subunit G 1,34729,89,1.04 [0.79-1.38],0.7709591762770016
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP6V1G2,V-type proton ATPase subunit G 2,34555,92,1.06 [0.86-1.29],0.5980425783785639
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,35523,94,1.76 [1.33-2.34],8.353336941946397e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATRN,"Attractin, Isoform 2",35728,94,2.95 [0.92-9.45],0.0685641103840435
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATXN10,Ataxin-10,40064,101,1.05 [0.82-1.35],0.6895763911243602
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATXN2,Ataxin-2,34584,91,0.84 [0.67-1.05],0.1296580276805007
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATXN2L,Ataxin-2-like protein,35624,95,1.31 [0.92-1.85],0.1316672368071511
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATXN3,Ataxin-3,35608,95,1.33 [0.98-1.79],0.0670289372970936
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AXIN1,Axin-1,40974,103,0.98 [0.81-1.17],0.7992940718213074
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,41170,103,1.86 [1.00-3.45],0.0481867570745719
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,35624,95,1.55 [1.13-2.12],0.0064309596629249
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AZU1,Azurocidin,39762,101,0.99 [0.79-1.25],0.9572564629659088
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,35728,94,1.63 [1.25-2.12],0.0002964310541442
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,34555,92,0.97 [0.37-2.58],0.9543584381781908
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",34729,89,1.01 [0.58-1.77],0.960151966830448
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",41181,102,9.82 [6.29-15.35],1.0361206945558857e-23
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",B4GAT1,"Beta-1,4-glucuronyltransferase 1",41027,103,1.21 [0.59-2.47],0.603121229285229
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BABAM1,BRISC and BRCA1-A complex member 1,34646,90,1.15 [0.60-2.20],0.680068228900546
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BACH1,Transcription regulator protein BACH1,40974,103,1.13 [0.89-1.43],0.3169519750019248
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAG3,BAG family molecular chaperone regulator 3,40651,102,0.79 [0.52-1.19],0.2523268383455225
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,34646,90,1.87 [1.39-2.51],3.460713185325802e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,40294,103,1.59 [1.00-2.53],0.0486798100139239
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,40089,100,1.12 [0.85-1.47],0.4130134621924026
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,40089,100,1.69 [0.97-2.95],0.0619708408955033
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BANK1,B-cell scaffold protein with ankyrin repeats,40974,103,1.17 [0.98-1.39],0.0757362653169257
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,35608,95,1.86 [1.66-2.10],4.51693299687156e-25
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BATF,Basic leucine zipper transcriptional factor ATF-like,34720,90,1.16 [0.96-1.40],0.1273979501033525
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAX,Apoptosis regulator BAX,40004,101,1.04 [0.86-1.27],0.6828146860008013
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,41027,103,2.04 [1.04-4.02],0.0393012223278876
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCAN,Brevican core protein,40720,102,1.04 [0.62-1.73],0.87812733598803
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",35674,93,0.89 [0.45-1.73],0.722155089471761
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",34584,91,0.77 [0.49-1.21],0.2619798262001268
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCHE,Cholinesterase,35031,93,0.84 [0.41-1.71],0.6249615648078202
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,35523,94,2.35 [2.05-2.70],5.957424009963496e-35
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCL2L1,Bcl-2-like protein 1,35608,95,0.97 [0.80-1.19],0.7886441688705974
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40974,103,1.16 [0.76-1.78],0.4892775329459142
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCL2L15,Bcl-2-like protein 15,34646,90,0.79 [0.53-1.16],0.227340355161037
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCL7A,B-cell CLL/lymphoma 7 protein family member A,34427,89,0.76 [0.52-1.10],0.1436805812108031
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCL7B,B-cell CLL/lymphoma 7 protein family member B,35512,93,1.24 [0.87-1.77],0.2265450804477177
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCR,Breakpoint cluster region protein,40974,103,0.97 [0.80-1.18],0.778282690979485
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,35680,94,0.68 [0.55-0.85],0.000571014680933
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BECN1,Beclin-1,34729,89,1.38 [1.01-1.90],0.0449860886522589
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BEX3,Protein BEX3,34427,89,0.91 [0.56-1.46],0.6881569835520779
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BGLAP,Osteocalcin,35680,94,0.90 [0.72-1.12],0.3479873381055182
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,40024,100,1.21 [1.05-1.40],0.0094442567538019
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BHLHE40,Class E basic helix-loop-helix protein 40,34584,91,0.89 [0.65-1.20],0.4382507495185677
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,34555,92,0.75 [0.35-1.62],0.4634469749740966
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BID,BH3-interacting domain death agonist,40974,103,0.93 [0.71-1.21],0.579797358185236
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BIN2,Bridging integrator 2,41027,103,0.92 [0.75-1.11],0.3779030616463412
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BIRC2,Baculoviral IAP repeat-containing protein 2,40089,100,0.86 [0.64-1.15],0.2996849709603575
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BLMH,Bleomycin hydrolase,41521,106,0.95 [0.55-1.66],0.8666425771196048
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,34646,90,2.66 [2.27-3.12],3.0916769753716205e-33
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,34584,91,0.81 [0.59-1.11],0.1953223633263334
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,35608,95,1.29 [0.82-2.04],0.271825774903248
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,41027,103,1.27 [1.00-1.62],0.0492507997834599
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,34914,93,1.18 [0.59-2.38],0.6414962554400616
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BMP4,Bone morphogenetic protein 4,40651,102,0.81 [0.54-1.20],0.2851051590907925
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BMP6,Bone morphogenetic protein 6,40228,103,0.76 [0.50-1.16],0.197278156985821
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,34914,93,2.25 [1.05-4.80],0.0364817613539239
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,35674,93,1.08 [0.61-1.92],0.7964893436099558
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,34646,90,2.89 [2.19-3.80],3.826419514348986e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BOC,Brother of CDO,40294,103,1.23 [0.58-2.60],0.5959254624598235
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BOLA1,BolA-like protein 1,34584,91,1.34 [0.98-1.82],0.0663742758716396
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BOLA2_BOLA2B,BolA-like protein 2,34729,89,1.27 [0.87-1.85],0.2153555300536793
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BPIFA2,BPI fold-containing family A member 2,33506,86,1.03 [0.85-1.24],0.7866536743618231
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BPIFB1,BPI fold-containing family B member 1,40933,102,0.76 [0.58-0.99],0.0431328655241995
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,35612,93,0.79 [0.57-1.09],0.1539124263836259
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BRAP,BRCA1-associated protein,35191,94,1.10 [0.92-1.33],0.2928609774516735
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BRD1,Bromodomain-containing protein 1,35020,92,1.11 [0.59-2.10],0.7411434617685277
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BRD2,Bromodomain-containing protein 2,34584,91,1.57 [1.06-2.33],0.0255000627538019
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BRD3,Bromodomain-containing protein 3,34555,92,0.96 [0.62-1.47],0.837758073896325
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BRDT,Bromodomain testis-specific protein,34555,92,1.14 [0.67-1.95],0.6350357144260421
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,40064,101,0.97 [0.65-1.45],0.8887802031633191
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BRME1,Break repair meiotic recombinase recruitment factor 1,34584,91,1.16 [0.76-1.79],0.4934861665122557
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BRSK2,Serine/threonine-protein kinase BRSK2,35624,95,1.01 [0.60-1.68],0.9834568833714592
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BSG,Basigin,41415,104,3.80 [1.70-8.50],0.0011744140410546
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BSND,Barttin,34427,89,0.63 [0.31-1.27],0.1935420989922894
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,41382,103,1.12 [0.75-1.68],0.5767463273417952
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,41382,103,1.46 [1.10-1.94],0.0079516725234081
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTC,Probetacellulin,40089,100,0.72 [0.55-0.94],0.0142696438559938
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTD,Biotinidase,35728,94,0.86 [0.33-2.20],0.7471175021898082
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTLA,B- and T-lymphocyte attenuator,34427,89,0.83 [0.62-1.11],0.2155505221199188
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTN1A1,Butyrophilin subfamily 1 member A1,35444,93,0.99 [0.60-1.64],0.969261302147944
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,41181,102,3.62 [2.11-6.23],3.270549546081949e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,40974,103,1.87 [1.27-2.75],0.001485063539558
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTNL10,Butyrophilin-like protein 10,34427,89,0.96 [0.57-1.62],0.8873064212906822
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,40064,101,1.16 [0.91-1.48],0.2200713966339658
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1GALT1C1,C1GALT1-specific chaperone 1,34555,92,0.81 [0.42-1.57],0.5352123816371341
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,41280,104,3.34 [1.69-6.60],0.000541962762694
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",35624,95,1.00 [0.76-1.33],0.9747142606181144
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1QL2,Complement C1q-like protein 2,34646,90,0.64 [0.39-1.06],0.0852575079471191
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,41170,103,1.11 [0.75-1.66],0.5964961556558137
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,34914,93,0.91 [0.53-1.57],0.735927889350773
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,35624,95,1.64 [1.03-2.62],0.0359493262078738
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,34848,93,1.13 [0.74-1.72],0.579553566113512
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1R,Complement C1r subcomponent,35728,94,1.32 [0.52-3.40],0.5600698532693029
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,35661,94,4.61 [1.65-12.86],0.0035327656236897
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,35728,94,1.13 [0.44-2.88],0.7950245804917083
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C2,Complement C2,41111,103,0.57 [0.40-0.83],0.0029997174634973
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,39988,101,0.97 [0.64-1.47],0.8781788995078048
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C2orf69,UPF0565 protein C2orf69,34720,90,1.03 [0.73-1.45],0.8616900752073235
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C3,Complement C3,33910,88,1.03 [0.65-1.62],0.9079068521180962
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,41133,105,0.93 [0.60-1.44],0.7401017782377661
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C5,Complement C5,35728,94,1.76 [0.51-6.03],0.3715507714656914
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,34874,94,1.95 [1.05-3.63],0.0340741453648339
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,35608,95,3.21 [2.67-3.85],9.098076453998217e-36
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C8B,Complement component C8 beta chain,35728,94,0.68 [0.36-1.30],0.2454882009703785
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,35700,95,1.50 [1.03-2.17],0.0333744275477211
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,35523,94,1.30 [1.03-1.64],0.0255952370747366
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA1,Carbonic anhydrase 1,40126,101,1.32 [0.99-1.77],0.061839455792023
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA11,Carbonic anhydrase-related protein 11,40089,100,1.10 [0.65-1.86],0.7132012264440414
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,40826,102,1.35 [0.80-2.28],0.2582643788396583
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA13,Carbonic anhydrase 13,40559,103,0.90 [0.76-1.06],0.1885331191333087
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,41393,103,1.39 [0.85-2.25],0.1880675822895159
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA2,Carbonic anhydrase 2,40891,101,1.20 [0.94-1.54],0.1390131605642726
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA3,Carbonic anhydrase 3,41457,106,1.26 [0.96-1.64],0.0969182553566304
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA4,Carbonic anhydrase 4,41521,106,1.14 [0.56-2.33],0.7199921270473926
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",40294,103,1.03 [0.85-1.25],0.7616107665743688
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,40896,102,0.89 [0.68-1.18],0.4302319453479357
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA7,Carbonic anhydrase 7,35020,92,0.81 [0.43-1.52],0.5060004080605442
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA8,Carbonic anhydrase-related protein,34646,90,1.07 [0.51-2.23],0.8560000879185847
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,41393,103,0.86 [0.59-1.26],0.4315897061841987
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CABP2,Calcium-binding protein 2,34720,90,0.94 [0.68-1.29],0.6972137403000773
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,34584,91,0.97 [0.51-1.82],0.9134037373070676
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,34555,92,0.90 [0.61-1.33],0.597635551893622
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,34584,91,1.12 [0.82-1.54],0.4737970178540021
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,35624,95,1.02 [0.81-1.29],0.8736230102487761
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CACYBP,Calcyclin-binding protein,34844,93,0.97 [0.80-1.18],0.7420901761971129
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CADPS,Calcium-dependent secretion activator 1,34720,90,0.64 [0.35-1.18],0.1550957790709352
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CALB1,Calbindin,40826,102,1.42 [0.95-2.12],0.0844944453345035
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CALB2,Calretinin,40064,101,0.69 [0.36-1.32],0.265126423283608
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,40644,102,0.90 [0.68-1.20],0.4764372056127507
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CALCB,Calcitonin gene-related peptide 2,35608,95,1.18 [0.75-1.84],0.4793857132785641
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,41266,103,1.01 [0.85-1.20],0.9036436398536098
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,34729,89,1.41 [1.09-1.81],0.0090551212655401
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CALY,Neuron-specific vesicular protein calcyon,34555,92,0.69 [0.37-1.30],0.2515892486542964
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,40089,100,1.33 [0.92-1.92],0.1326583636404431
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,34720,90,0.95 [0.65-1.40],0.8068402439043406
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,35624,95,1.08 [0.90-1.29],0.4111305379027322
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,40891,104,15.02 [6.72-33.61],4.186316975696203e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,40751,100,1.68 [1.30-2.17],7.648372965197758e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CAPN3,Calpain-3,35512,93,0.73 [0.40-1.33],0.3036633607575893
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CAPS,Calcyphosin,35608,95,0.84 [0.65-1.10],0.2165877902299665
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,40064,101,1.07 [0.77-1.50],0.6900123968781116
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASC3,Protein CASC3,34720,90,1.52 [0.99-2.34],0.0562759622907869
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,40064,101,1.09 [0.85-1.38],0.5080723240125458
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP10,Caspase-10,40064,101,0.84 [0.65-1.07],0.1604219017918733
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP2,Caspase-2,40974,103,0.93 [0.72-1.21],0.5836484427583759
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP3,Caspase-3,41521,106,0.95 [0.78-1.15],0.5804735513734145
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,35020,92,0.79 [0.67-0.92],0.0025474070332483
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP7,Caspase-7,35608,95,1.07 [0.85-1.35],0.5606743273483457
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP8,Caspase-8,41272,103,1.18 [0.90-1.53],0.2300760282656521
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP9,Caspase-9,34646,90,1.09 [0.79-1.49],0.6064788631660889
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASQ2,Calsequestrin-2,34555,92,0.35 [0.18-0.67],0.0013490070731914
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CAT,Catalase,35164,93,1.26 [0.89-1.78],0.183919607598564
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CBLIF,Cobalamin binding intrinsic factor,40966,104,0.80 [0.65-0.98],0.031628130256582
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CBLN1,Cerebellin-1,34584,91,0.77 [0.58-1.03],0.0799487496379992
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CBLN4,Cerebellin-4,41393,103,0.69 [0.40-1.19],0.1772144107089196
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,34729,89,1.17 [0.80-1.69],0.4239387465158297
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CBX2,Chromobox protein homolog 2,34555,92,0.87 [0.50-1.52],0.6351059014855758
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,40720,102,1.07 [0.84-1.35],0.5909311343034866
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCAR2,Cell cycle and apoptosis regulator protein 2,35608,95,1.39 [1.13-1.72],0.002013665653411
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCDC134,Coiled-coil domain-containing protein 134,35512,93,0.76 [0.50-1.17],0.217907053845203
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCDC28A,Coiled-coil domain-containing protein 28A,34720,90,1.43 [0.72-2.86],0.3072422492061354
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,35624,95,1.60 [1.38-1.84],1.3889171870338618e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCDC80,Coiled-coil domain-containing protein 80,41020,104,1.03 [0.63-1.68],0.9135426594884004
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,34729,89,1.21 [0.88-1.66],0.2364517648234884
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL11,Eotaxin,41488,104,0.64 [0.41-0.99],0.0432475507329954
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL13,C-C motif chemokine 13,41421,104,0.76 [0.59-0.98],0.0353814157625269
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,40911,102,1.10 [0.72-1.70],0.6513859660850677
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,41521,106,1.06 [0.72-1.56],0.7786600255352272
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL16,C-C motif chemokine 16,41521,106,1.19 [0.84-1.66],0.3258916512121511
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,40928,102,0.78 [0.64-0.94],0.0113592195746712
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,40447,101,1.14 [0.91-1.43],0.2534043782995214
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL19,C-C motif chemokine 19,41382,103,1.04 [0.91-1.18],0.6027993592948211
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL2,C-C motif chemokine 2,40651,102,1.36 [0.99-1.86],0.0591996261690186
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL20,C-C motif chemokine 20,41488,104,0.87 [0.70-1.08],0.2009628894356401
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,41181,102,0.96 [0.61-1.50],0.8524048865949412
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,40578,102,1.04 [0.74-1.47],0.7995622337562674
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL23,C-C motif chemokine 23,41181,102,1.03 [0.67-1.56],0.9047317924379686
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,41121,102,0.99 [0.80-1.22],0.9206917823411483
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL25,C-C motif chemokine 25,41488,104,0.86 [0.60-1.24],0.4232136895578309
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL26,C-C motif chemokine 26,40974,103,0.80 [0.65-0.99],0.04288363162861
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL27,C-C motif chemokine 27,41020,104,0.81 [0.61-1.08],0.1520815822386098
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL28,C-C motif chemokine 28,40836,103,0.75 [0.55-1.04],0.0851034939086616
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,40974,103,1.56 [1.38-1.77],1.416194859259647e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,41055,102,1.35 [1.13-1.62],0.0009771133415698
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,41170,103,0.74 [0.63-0.88],0.0006493974055888
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,40974,103,0.81 [0.58-1.13],0.2112847451460717
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL8,C-C motif chemokine 8,41334,103,0.78 [0.60-1.03],0.0793298014371242
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,40760,102,0.70 [0.56-0.88],0.002179427166302
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,40993,100,0.52 [0.38-0.72],7.972017212624929e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,41451,106,1.46 [0.89-2.39],0.1343840597091593
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCN4,CCN family member 4,41393,103,0.84 [0.53-1.32],0.4380911085482623
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCN5,CCN family member 5,41027,103,1.55 [1.00-2.40],0.0504369849935581
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,35020,92,2.44 [1.39-4.29],0.0019307963659352
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCNE1,G1/S-specific cyclin-E1,34646,90,1.17 [0.99-1.38],0.0632708604370666
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCS,Copper chaperone for superoxide dismutase,40720,102,1.25 [0.87-1.79],0.2285973033627227
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCT5,T-complex protein 1 subunit epsilon,40089,100,1.08 [0.74-1.59],0.691159698954102
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD101,Immunoglobulin superfamily member 2,35523,94,1.21 [0.76-1.91],0.4263783392565182
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,41027,103,0.76 [0.45-1.26],0.2842288715456361
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,40182,101,1.68 [1.13-2.51],0.0107408340736827
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,41488,104,1.05 [0.73-1.52],0.7875374351102717
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,41170,103,2.00 [1.38-2.89],0.0002471552859734
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD164,Sialomucin core protein 24,41027,103,1.33 [0.80-2.22],0.2740906808073067
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD164L2,CD164 sialomucin-like 2 protein,34720,90,0.94 [0.53-1.64],0.8165641019125431
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,40966,103,1.40 [1.19-1.64],3.224862126949349e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,41133,105,4.13 [2.02-8.45],0.0001049752992691
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD2,T-cell surface antigen CD2,34555,92,1.07 [0.66-1.74],0.7731621890856344
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,40974,103,6.38 [5.30-7.69],1.1689164064449995e-84
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,40840,103,1.60 [1.00-2.55],0.0514667240913058
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD207,C-type lectin domain family 4 member K,40094,101,0.79 [0.50-1.25],0.3171731710681134
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD209,CD209 antigen,41115,104,1.07 [0.68-1.66],0.7784593968007889
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,41488,104,5.75 [4.84-6.83],1.663908868920165e-88
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD226,CD226 antigen,34646,90,0.58 [0.35-0.95],0.0306330202185108
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,41488,104,1.09 [0.58-2.06],0.7800082217514639
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD248,Endosialin,35680,94,1.18 [0.72-1.92],0.5078505165869325
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,41133,105,6.65 [5.18-8.54],9.199271675119507e-50
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,40720,102,1.73 [1.09-2.73],0.0189836935013362
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,40982,102,1.07 [0.66-1.76],0.7766730419316804
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,40089,100,2.39 [1.91-3.00],2.820766783203985e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD2AP,CD2-associated protein,41020,104,1.32 [1.02-1.72],0.0361980646959824
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,34914,93,2.83 [1.55-5.16],0.0006840669383051
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,41382,103,1.92 [1.19-3.08],0.0070438607319425
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,41259,102,1.79 [1.20-2.65],0.0040978581676977
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,41393,103,1.59 [1.14-2.20],0.0056674465520313
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD300LG,CMRF35-like molecule 9,41027,103,1.45 [0.91-2.30],0.1141078083291565
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,40826,102,1.73 [1.01-2.96],0.0459706792399635
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD33,Myeloid cell surface antigen CD33,41133,105,0.93 [0.75-1.15],0.4847265034842738
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD34,Hematopoietic progenitor cell antigen CD34,41240,103,2.14 [1.06-4.32],0.0349301642713184
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD36,Platelet glycoprotein 4,34646,90,0.85 [0.54-1.35],0.4998634190588186
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40826,102,1.00 [0.58-1.74],0.9911006236673552
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD3D,T-cell surface glycoprotein CD3 delta chain,34584,91,1.04 [0.58-1.87],0.890592367242359
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,35020,92,0.96 [0.55-1.70],0.9017126954478704
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD3G,T-cell surface glycoprotein CD3 gamma chain,34646,90,0.94 [0.73-1.20],0.6107328358719897
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,40900,103,1.42 [0.86-2.32],0.1669115431285386
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD40,Tumor necrosis factor receptor superfamily member 5,40995,102,1.18 [0.84-1.66],0.3382471467131922
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD40LG,CD40 ligand,41488,104,0.76 [0.61-0.94],0.0115646458421927
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,40776,102,2.98 [1.97-4.51],2.254425944937464e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,41121,102,19.51 [13.88-27.42],1.207744631130887e-65
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,41334,103,6.12 [5.28-7.11],1.7885985121335347e-125
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD55,Complement decay-accelerating factor,39589,99,1.78 [0.99-3.18],0.0527582678806429
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,40914,102,1.56 [0.57-4.23],0.3832003814497732
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,39542,98,2.90 [1.62-5.19],0.0003284682345441
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,35541,92,0.54 [0.35-0.83],0.0048731156850026
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,41415,104,4.93 [3.67-6.62],3.623987692803068e-26
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD63,CD63 antigen,40651,102,0.63 [0.45-0.89],0.0084309721878479
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD69,Early activation antigen CD69,40830,103,0.95 [0.78-1.15],0.5920020750661348
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,34580,90,1.71 [1.17-2.51],0.0058654070372385
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,40974,103,5.91 [4.89-7.15],5.698706735458608e-75
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,34914,93,8.18 [6.54-10.24],4.2881096614627723e-75
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,41382,103,9.38 [6.89-12.76],5.29567611968461e-46
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,41488,104,6.65 [5.62-7.86],9.89298699537768e-109
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,35674,93,8.64 [6.53-11.42],9.877414647228816e-52
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD82,CD82 antigen,35020,92,0.56 [0.30-1.06],0.0768774448902151
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,40974,103,6.60 [4.51-9.66],2.775900055367103e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD84,SLAM family member 5,40974,103,0.68 [0.40-1.18],0.1751713819161954
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,35523,94,4.81 [2.95-7.87],3.4824693655618637e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,41382,103,1.74 [1.29-2.34],0.0002534326423455
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,39464,99,1.48 [0.84-2.60],0.1728980950442896
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD99,CD99 antigen,41027,103,1.47 [0.61-3.55],0.3916976270909023
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD99L2,CD99 antigen-like protein 2,41027,103,1.07 [0.52-2.20],0.857156965831358
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDA,Cytidine deaminase,35610,91,0.71 [0.46-1.10],0.1286266402767899
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDAN1,Codanin-1,35608,95,1.18 [0.54-2.59],0.6825356523394258
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDC123,Cell division cycle protein 123 homolog,34427,89,0.93 [0.66-1.31],0.6728844777263681
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDC25A,M-phase inducer phosphatase 1,34427,89,0.69 [0.39-1.24],0.214236549120563
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDC26,Anaphase-promoting complex subunit CDC26,35457,94,1.11 [0.84-1.47],0.4497035511321813
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,40089,100,1.47 [1.14-1.88],0.0027947454977342
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDC37,Hsp90 co-chaperone Cdc37,41133,105,1.02 [0.83-1.25],0.8676600009449271
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDC42BPB,Serine/threonine-protein kinase MRCK beta,35523,94,0.95 [0.78-1.15],0.582159845855966
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,40720,102,1.58 [1.18-2.11],0.0018520024761643
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,39639,101,0.79 [0.49-1.29],0.350206928602217
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,41306,103,0.64 [0.47-0.88],0.0059634429262722
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,41020,104,0.68 [0.52-0.90],0.0069023620976748
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,41020,104,1.31 [0.81-2.13],0.272406531261045
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH22,Cadherin-22,35020,92,0.58 [0.27-1.27],0.1713343726194506
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH23,Cadherin-23,35608,95,1.06 [0.51-2.19],0.8775662721243593
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,41382,103,2.78 [1.88-4.09],2.499734655209907e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH4,Cadherin-4,34584,91,0.80 [0.50-1.28],0.3442091326696147
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,41521,106,1.52 [0.88-2.63],0.1301254096877435
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,41020,104,1.44 [0.93-2.25],0.1052404080783892
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDHR1,Cadherin-related family member 1,40064,101,0.82 [0.52-1.29],0.3862019952320192
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,40826,102,1.10 [0.85-1.42],0.4697136072591925
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,41020,104,1.19 [0.76-1.88],0.4482233704795783
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,34427,89,1.91 [1.13-3.22],0.0159761864339141
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,35624,95,0.74 [0.51-1.07],0.1126325582851945
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDKL5,Cyclin-dependent kinase-like 5,34584,91,0.90 [0.59-1.35],0.6033222315910742
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDKN1A,Cyclin-dependent kinase inhibitor 1,40826,102,0.90 [0.76-1.06],0.1941988240713349
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40826,102,0.85 [0.72-1.02],0.0818524289774936
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDNF,Cerebral dopamine neurotrophic factor,40826,102,1.04 [0.61-1.78],0.88755402965684
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,41054,102,0.49 [0.26-0.92],0.0253655691630243
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDSN,Corneodesmosin,41356,103,1.14 [0.76-1.70],0.5214940439192417
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,41068,105,2.03 [0.91-4.51],0.0820384635232119
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,35523,94,1.13 [0.89-1.45],0.3164605774471005
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,35020,92,0.67 [0.44-1.01],0.0567320056801163
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,35523,94,0.92 [0.56-1.51],0.7469611782662123
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,35020,92,0.94 [0.59-1.51],0.8085237131949479
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40974,103,1.35 [1.11-1.62],0.0020028381970777
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,40089,100,0.87 [0.58-1.28],0.4750387008228126
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39552,100,1.05 [0.79-1.40],0.7280958463864203
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,35680,94,0.51 [0.30-0.88],0.0160493405373266
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40294,103,1.21 [0.86-1.70],0.2685811335037698
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEBPA,CCAAT/enhancer-binding protein alpha,34646,90,0.87 [0.47-1.61],0.6517447109464571
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEBPB,CCAAT/enhancer-binding protein beta,40294,103,0.89 [0.55-1.43],0.6275837903984103
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CELA2A,Chymotrypsin-like elastase family member 2A,35680,94,0.93 [0.68-1.28],0.6621870456793644
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CELA3A,Chymotrypsin-like elastase family member 3A,41452,106,1.01 [0.76-1.36],0.9242709302408012
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,34914,93,0.74 [0.37-1.50],0.4066184001783933
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEMIP2,Cell surface hyaluronidase,34646,90,1.56 [1.03-2.37],0.0357211895858621
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEND1,Cell cycle exit and neuronal differentiation protein 1,34584,91,0.76 [0.49-1.17],0.2092297294067934
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CENPF,Centromere protein F,35020,92,1.27 [0.92-1.77],0.1503821994506192
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CENPJ,Centromere protein J,35020,92,1.03 [0.78-1.36],0.8451640305278609
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP112,Centrosomal protein of 112 kDa,34555,92,0.43 [0.22-0.87],0.0187801705472669
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP152,Centrosomal protein of 152 kDa,34427,89,0.96 [0.59-1.57],0.8825544178869342
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,40284,100,1.19 [0.96-1.48],0.1172175492244804
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP170,Centrosomal protein of 170 kDa,34729,89,1.00 [0.76-1.31],0.9941343210955448
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP20,Centrosomal protein 20,40089,100,0.97 [0.76-1.24],0.8168411638536993
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP290,Centrosomal protein of 290 kDa,35020,92,0.86 [0.57-1.30],0.4764052607778171
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP350,Centrosome-associated protein 350,34427,89,1.15 [0.68-1.94],0.6096367145566848
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,39978,103,1.34 [1.05-1.71],0.0182543635673101
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,40089,100,1.38 [1.08-1.77],0.0097072078817318
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CERT,Ceramide transfer protein,40064,101,0.93 [0.69-1.24],0.6150734726140801
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,41110,105,0.93 [0.75-1.15],0.4914306756282761
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CES2,Cocaine esterase,40826,102,0.72 [0.51-1.01],0.0543452534957167
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,40826,102,0.72 [0.54-0.96],0.0234929434895921
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CETN2,Centrin-2,40064,101,1.19 [0.93-1.53],0.1645596372084872
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CETN3,Centrin-3,35523,94,1.05 [0.82-1.36],0.6810724877137473
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,35079,90,1.70 [0.91-3.18],0.0964815746896702
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,40089,100,0.90 [0.60-1.34],0.5970030179694472
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFD,Complement factor D,35728,94,1.22 [0.47-3.13],0.6835891351083676
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,33661,88,1.42 [0.59-3.43],0.4366835212141087
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFHR2,Complement factor H-related protein 2,35472,94,0.97 [0.69-1.37],0.8685416512778457
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,35663,94,1.05 [0.80-1.38],0.7272087220554009
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,35234,93,0.69 [0.45-1.06],0.0909742900347226
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,35728,94,1.19 [0.44-3.24],0.7275523247588846
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFP,Properdin,35728,94,1.64 [0.96-2.82],0.0727727317054468
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,41027,103,1.11 [0.86-1.44],0.4061713285097069
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,35700,95,0.91 [0.54-1.52],0.7105410738006694
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,34720,90,0.95 [0.56-1.62],0.8614900450466495
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CGREF1,Cell growth regulator with EF hand domain protein 1,41020,104,1.40 [0.94-2.08],0.1014043388864466
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,40089,100,1.03 [0.76-1.38],0.8665130754137276
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,34914,93,0.52 [0.35-0.76],0.000797159978899
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",35608,95,2.75 [2.20-3.44],1.0840890034839605e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,35512,93,1.93 [1.22-3.07],0.0053644791792184
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHEK2,Serine/threonine-protein kinase Chk2,40294,103,0.94 [0.55-1.61],0.8340313040514065
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,35680,94,1.02 [0.82-1.27],0.8768879635702213
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHGB,Secretogranin-1,41241,103,1.43 [0.94-2.17],0.0904766898406868
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,40117,100,1.04 [0.83-1.29],0.7406964144272119
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHIT1,Chitotriosidase-1,41199,105,1.00 [0.89-1.11],0.9462944612844396
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHL1,Neural cell adhesion molecule L1-like protein,41106,103,1.20 [0.68-2.10],0.5278166407526867
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHM,Rab proteins geranylgeranyltransferase component A 1,34720,90,1.02 [0.73-1.42],0.9243226019074724
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHMP1A,Charged multivesicular body protein 1a,40720,102,0.85 [0.68-1.05],0.135780088554807
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHMP6,Charged multivesicular body protein 6,35674,93,0.83 [0.58-1.18],0.3030424676706874
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHP1,Calcineurin B homologous protein 1,34584,91,0.81 [0.60-1.11],0.1993859694793405
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,41121,102,1.28 [0.73-2.22],0.3879040335295695
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,41020,104,1.04 [0.74-1.48],0.8111779997344534
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHRM1,Muscarinic acetylcholine receptor M1,34720,90,0.78 [0.42-1.44],0.4231850848622526
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CIAPIN1,Anamorsin,41133,105,1.01 [0.76-1.33],0.95855653421352
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CILP,Cartilage intermediate layer protein 1,35680,94,0.92 [0.64-1.31],0.6287216265674789
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CINP,Cyclin-dependent kinase 2-interacting protein,35020,92,0.96 [0.60-1.53],0.8639328052074997
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CIRBP,Cold-inducible RNA-binding protein,35523,94,1.07 [0.87-1.32],0.5182794593298186
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,34720,90,1.60 [1.15-2.23],0.0051114263414458
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,41289,104,2.42 [1.77-3.31],3.637799635408008e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,35680,94,1.51 [1.08-2.11],0.0156229190437989
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40855,102,0.95 [0.74-1.24],0.7208617180602316
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLASP1,CLIP-associating protein 1,34427,89,0.98 [0.75-1.30],0.9080608505706612
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLC,Galectin-10,40956,104,0.69 [0.52-0.92],0.0116465681337392
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC10A,C-type lectin domain family 10 member A,40720,102,1.00 [0.62-1.63],0.9908296270978008
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,40951,103,0.70 [0.49-0.99],0.0465062664138176
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,34646,90,4.04 [2.80-5.84],9.706738267344397e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,41027,103,1.59 [0.94-2.69],0.0857736048409551
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,40294,103,1.95 [1.19-3.19],0.008247991274881
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC1B,C-type lectin domain family 1 member B,41382,103,0.85 [0.71-1.02],0.0770254129079581
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC2L,C-type lectin domain family 2 member L,34720,90,0.95 [0.63-1.43],0.8160137888432528
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,34893,90,1.15 [0.47-2.82],0.7677120276224678
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC4A,C-type lectin domain family 4 member A,40974,103,1.37 [0.82-2.27],0.2248672835458071
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,40974,103,2.39 [1.74-3.28],6.25339083722569e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC4D,C-type lectin domain family 4 member D,40974,103,1.22 [0.93-1.62],0.1559440878781912
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,40974,103,1.31 [0.78-2.21],0.304059357344436
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC4M,C-type lectin domain family 4 member M,35618,93,0.98 [0.65-1.47],0.914566600994246
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC5A,C-type lectin domain family 5 member A,40893,104,1.62 [0.92-2.83],0.0931575811740906
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,40089,100,1.36 [0.95-1.95],0.094001591683826
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC7A,C-type lectin domain family 7 member A,41488,104,1.29 [0.91-1.83],0.1583349101218934
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,34720,90,0.86 [0.53-1.38],0.5244061116663248
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLIC5,Chloride intracellular channel protein 5,34720,90,0.89 [0.46-1.74],0.7368616540790773
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLINT1,Clathrin interactor 1,34427,89,1.14 [0.79-1.66],0.4823854795520916
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLIP2,CAP-Gly domain-containing linker protein 2,40974,103,0.95 [0.81-1.11],0.4967691629371832
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,41393,103,1.71 [0.77-3.82],0.1874561843859992
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLNS1A,Methylosome subunit pICln,34720,90,1.16 [0.66-2.03],0.610867800064566
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40644,102,0.97 [0.81-1.17],0.7684171150352075
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLPS,Colipase,40954,103,1.06 [0.83-1.35],0.6579304786583258
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLSPN,Claspin,39988,101,0.79 [0.44-1.41],0.4238477512248697
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLSTN1,Calsyntenin-1,40064,101,0.96 [0.68-1.36],0.8087124708152791
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,41488,104,1.19 [0.78-1.81],0.4251887801326545
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,35608,95,3.81 [2.79-5.20],3.134923811255488e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLTA,Clathrin light chain A,40294,103,1.00 [0.69-1.46],0.9842792448219106
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,35728,94,1.37 [0.88-2.15],0.1659292719761181
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLUL1,Clusterin-like protein 1,40955,104,0.95 [0.65-1.41],0.8122878707713598
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CMC1,COX assembly mitochondrial protein homolog,35674,93,0.90 [0.72-1.12],0.3384027984639069
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CMIP,C-Maf-inducing protein,35512,93,0.90 [0.71-1.15],0.3929285277147275
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,41170,103,0.79 [0.55-1.13],0.1980426133635896
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNGB3,Cyclic nucleotide-gated cation channel beta-3,34584,91,0.78 [0.49-1.23],0.2861017027527189
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",34664,89,1.05 [0.81-1.37],0.6907864578348804
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNPY2,Protein canopy homolog 2,40294,103,0.85 [0.61-1.19],0.3540431132821822
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNPY4,Protein canopy homolog 4,40826,102,0.82 [0.65-1.03],0.0918115729440278
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNST,Consortin,41020,104,0.98 [0.83-1.15],0.7694883710371984
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTF,Ciliary neurotrophic factor,34584,91,1.12 [0.63-2.00],0.7048100322604975
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,41521,106,2.04 [1.08-3.85],0.0288366397169252
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTN2,Contactin-2,41393,103,0.87 [0.58-1.28],0.4713401167082734
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,41027,103,0.86 [0.49-1.51],0.5946598564028863
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,41027,103,0.81 [0.39-1.69],0.5829321995105103
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTN5,Contactin-5,41119,103,1.14 [0.71-1.83],0.5894292715406317
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,40974,103,2.02 [1.40-2.91],0.0001621230242434
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTNAP4,Contactin-associated protein-like 4,34720,90,1.07 [0.90-1.27],0.4692949462848523
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,35674,93,3.17 [2.29-4.40],3.955849369786362e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL15A1,Collagen alpha-1(XV) chain,35680,94,1.15 [0.54-2.42],0.720084072138476
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,41188,104,2.36 [1.14-4.90],0.0207054758837005
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,41521,106,0.53 [0.26-1.08],0.080109709606585
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,35523,94,0.79 [0.58-1.09],0.1497797942618733
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL28A1,Collagen alpha-1(XXVIII) chain,34720,90,1.12 [0.87-1.44],0.3699941283849319
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,34729,89,0.75 [0.57-0.98],0.036433814984151
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL3A1,Collagen alpha-1(III) chain,35680,94,1.10 [0.47-2.55],0.8320465694343862
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,41020,104,2.10 [1.42-3.12],0.0002290038269396
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL4A4,Collagen alpha-4(IV) chain,34960,92,1.15 [0.78-1.70],0.4826389070199695
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,34914,93,0.91 [0.54-1.52],0.7152153323740784
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,41521,106,1.56 [0.98-2.49],0.0599974016298258
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL9A1,Collagen alpha-1(IX) chain,40974,103,0.77 [0.52-1.14],0.1926280805642651
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,35020,92,1.64 [1.30-2.07],3.2927353405703334e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,40982,102,2.02 [1.07-3.83],0.0299131200845893
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COMMD1,COMM domain-containing protein 1,34729,89,1.19 [0.86-1.65],0.2989459881945165
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COMMD9,COMM domain-containing protein 9,35512,93,1.30 [0.85-1.98],0.22095304481664
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COMP,Cartilage oligomeric matrix protein,40581,101,0.93 [0.55-1.59],0.8027087164050162
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COMT,Catechol O-methyltransferase,39860,101,1.02 [0.83-1.27],0.8341269379465955
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COPB2,Coatomer subunit beta',34555,92,1.14 [0.74-1.77],0.548964265185588
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COPE,Coatomer subunit epsilon,40064,101,0.59 [0.36-0.96],0.0342093795152167
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",34729,89,1.35 [0.92-1.99],0.1203008931210346
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CORO1A,Coronin-1A,40171,101,1.13 [0.94-1.36],0.1950458658056245
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CORO6,Coronin-6,34584,91,0.78 [0.44-1.40],0.4088348315970004
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40826,102,0.93 [0.72-1.21],0.6063937752528952
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COX6B1,Cytochrome c oxidase subunit 6B1,35674,93,1.10 [0.61-2.01],0.7439979065116267
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPA1,Carboxypeptidase A1,41521,106,0.96 [0.73-1.26],0.7519398338661302
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPA2,Carboxypeptidase A2,41243,103,0.83 [0.64-1.09],0.182929472954065
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPA4,Carboxypeptidase A4,34221,90,1.10 [0.68-1.77],0.6951873016542485
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPB1,Carboxypeptidase B,41521,106,0.95 [0.71-1.26],0.7087737913778281
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,35659,94,0.78 [0.33-1.88],0.5840992811190386
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPE,Carboxypeptidase E,41069,101,1.26 [0.78-2.04],0.3352867947955151
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPLX2,Complexin-2,34427,89,0.86 [0.44-1.70],0.6644461688386245
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPM,Carboxypeptidase M,41189,103,1.18 [0.72-1.94],0.5115901061961792
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",34646,90,1.57 [0.87-2.83],0.1352423160332162
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPPED1,Serine/threonine-protein phosphatase CPPED1,41382,103,1.07 [0.82-1.38],0.6234770763902723
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPQ,Carboxypeptidase Q,35611,94,0.64 [0.40-1.04],0.0728515988211502
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPTP,Ceramide-1-phosphate transfer protein,34555,92,0.60 [0.33-1.09],0.0953077660652127
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,41330,103,1.84 [1.18-2.88],0.0075373230879434
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,41133,105,0.70 [0.54-0.91],0.006717970270434
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,35674,93,1.68 [0.84-3.38],0.1434233559757859
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,35561,93,3.41 [2.06-5.64],1.6821380317744506e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,41170,103,2.71 [1.93-3.81],7.942774399551565e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,40089,100,1.07 [0.87-1.31],0.5346086194107385
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRADD,Death domain-containing protein CRADD,40644,102,0.93 [0.73-1.17],0.5282370811280888
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CREB3,Cyclic AMP-responsive element-binding protein 3,34427,89,0.77 [0.50-1.17],0.2235041467433081
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CREBZF,CREB/ATF bZIP transcription factor,34427,89,1.38 [0.67-2.87],0.3820592738506648
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,40480,104,1.09 [0.70-1.68],0.7146601181377239
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,34914,93,1.12 [0.65-1.92],0.6906941266318463
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRELD2,Protein disulfide isomerase CRELD2,41121,102,1.10 [0.79-1.53],0.5758519584847777
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,40021,99,1.99 [1.66-2.38],1.3829673093203206e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRHBP,Corticotropin-releasing factor-binding protein,40982,102,1.83 [0.97-3.45],0.0626492416495389
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRHR1,Corticotropin-releasing factor receptor 1,40294,103,0.76 [0.55-1.06],0.101312856585865
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,41181,102,3.59 [1.63-7.95],0.0015762731702054
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRIP2,Cysteine-rich protein 2,40720,102,1.08 [0.68-1.72],0.7400219043524103
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRISP2,Cysteine-rich secretory protein 2,41393,103,1.10 [0.81-1.51],0.5339817463270236
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,35366,95,0.47 [0.23-0.96],0.0382289620856578
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRKL,Crk-like protein,41053,102,0.92 [0.78-1.08],0.3227409894791301
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,41181,102,5.40 [2.73-10.67],1.229116596148077e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRNN,Cornulin,39854,99,0.97 [0.75-1.26],0.8194651272685288
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRTAC1,Cartilage acidic protein 1,41521,106,0.84 [0.48-1.46],0.5369839768551967
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,40720,102,4.31 [3.21-5.77],1.6690571313703097e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRTAP,Cartilage-associated protein,34720,90,0.74 [0.45-1.20],0.2241826394470987
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRX,Cone-rod homeobox protein,40294,103,0.92 [0.77-1.11],0.3805078415114183
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRYBB1,Beta-crystallin B1,35674,93,1.03 [0.76-1.39],0.8635317377162043
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRYBB2,Beta-crystallin B2,35608,95,0.80 [0.56-1.15],0.2276068027518516
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRYGD,Gamma-crystallin D,35608,95,0.99 [0.81-1.21],0.8977638944153385
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRYM,Ketimine reductase mu-crystallin,34584,91,1.05 [0.81-1.37],0.7022265720511899
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRYZL1,Quinone oxidoreductase-like protein 1,34729,89,1.02 [0.82-1.29],0.8369808191798784
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSDE1,Cold shock domain-containing protein E1,34555,92,1.07 [0.91-1.25],0.4089514053404478
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,41181,102,5.06 [2.95-8.68],3.6013495679576366e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,35700,95,2.54 [1.88-3.44],1.2307985632469955e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,34555,92,1.30 [0.78-2.14],0.3116853787844783
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40720,102,0.94 [0.71-1.26],0.6874993682236037
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,34646,90,1.84 [1.14-2.96],0.01195141402956
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,40284,100,1.05 [0.73-1.51],0.7895494906193177
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF3R,Granulocyte colony-stimulating factor receptor,34646,90,1.26 [0.67-2.38],0.4677054595583012
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSH1,Chorionic somatomammotropin hormone 1,35700,95,1.22 [0.67-2.19],0.5158767989749254
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSNK1D,Casein kinase I isoform delta,34646,90,1.30 [0.98-1.72],0.0669685385990455
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSNK2A1,Casein kinase II subunit alpha,35624,95,1.57 [1.03-2.38],0.0359829203013921
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,35680,94,1.33 [0.73-2.42],0.3476461541854412
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSPG5,Chondroitin sulfate proteoglycan 5,34584,91,1.27 [0.90-1.79],0.1735729615886456
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,34555,92,0.89 [0.71-1.11],0.3032118068653212
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CST1,Cystatin-SN,30966,80,1.01 [0.81-1.26],0.9234625416958816
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,41102,103,1.27 [0.69-2.33],0.4452471128537493
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CST5,Cystatin-D,40258,101,0.94 [0.68-1.30],0.7053262813723675
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,39970,101,0.78 [0.54-1.13],0.18829123478051
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,41055,102,1.09 [0.92-1.29],0.3218370818232764
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,40457,103,2.10 [1.51-2.94],1.1845630809370624e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTAG1A_CTAG1B,Cancer/testis antigen 1,34950,92,1.24 [0.86-1.78],0.2453112561531414
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTBS,Di-N-acetylchitobiase,35180,90,1.13 [0.52-2.42],0.7628769306451623
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTF1,Cardiotrophin-1,40294,103,0.80 [0.64-0.99],0.0390186450231075
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,35680,94,1.31 [0.66-2.61],0.4418821626012424
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTLA4,Cytotoxic T-lymphocyte protein 4,35680,94,1.28 [0.74-2.21],0.3847344281599523
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTNNA1,Catenin alpha-1,34584,91,0.70 [0.34-1.42],0.3177074515704222
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTRB1,Chymotrypsinogen B,41027,103,0.90 [0.66-1.22],0.5024641208260212
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTRC,Chymotrypsin-C,40991,102,0.89 [0.68-1.16],0.3797437406534302
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTRL,Chymotrypsin-like protease CTRL-1,35608,95,1.10 [0.83-1.46],0.5271104259398349
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,41044,104,1.67 [1.24-2.25],0.0007009570430722
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSC,Dipeptidyl peptidase 1,40910,99,1.05 [0.71-1.57],0.793303222826049
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,38316,97,1.22 [0.80-1.85],0.3582234928570543
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSE,Cathepsin E,34914,93,1.20 [0.82-1.74],0.3525419381592362
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSF,Cathepsin F,41133,105,0.87 [0.56-1.34],0.5229162208606777
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,40168,101,1.30 [1.03-1.65],0.0266590172383524
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,41020,104,5.33 [2.98-9.53],1.6811258480917594e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,41488,104,1.58 [0.92-2.72],0.0985603872920261
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,32291,88,3.86 [1.76-8.46],0.0007372961009396
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,41264,102,0.49 [0.31-0.77],0.0019513397282146
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,41033,103,1.88 [1.10-3.21],0.0218294437167496
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CUZD1,CUB and zona pellucida-like domain-containing protein 1,34720,90,1.51 [1.08-2.11],0.0172583598064531
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,35313,93,1.98 [1.70-2.31],1.6796911417020815e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,40720,102,1.16 [0.69-1.96],0.5781802073802275
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,40974,103,1.04 [0.73-1.47],0.8479542239703504
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL1,Growth-regulated alpha protein,40926,100,0.90 [0.74-1.10],0.3003751813615245
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,41181,102,1.12 [0.87-1.44],0.3907838342333865
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,41382,103,1.01 [0.81-1.26],0.9077992836245063
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL12,Stromal cell-derived factor 1,40284,100,0.87 [0.55-1.37],0.5414394932571659
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,41382,103,1.51 [1.30-1.75],7.95907422784923e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL14,C-X-C motif chemokine 14,40284,100,0.96 [0.70-1.32],0.7990877744384829
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,41451,106,0.73 [0.34-1.53],0.4017087636746582
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,41488,104,1.02 [0.67-1.55],0.927628329434508
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,40995,102,0.70 [0.59-0.83],4.700433983323927e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,40885,104,0.74 [0.64-0.86],0.0001048425889
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL6,C-X-C motif chemokine 6,41488,104,1.03 [0.82-1.29],0.8237312908875687
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,40738,103,0.95 [0.73-1.23],0.6815933367122927
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,41181,102,1.44 [1.16-1.80],0.0010657296611276
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CYB5A,Cytochrome b5,34427,89,0.74 [0.52-1.04],0.0864118840924164
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,35116,93,2.89 [2.34-3.57],6.341046722932957e-23
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",34555,92,0.74 [0.54-1.01],0.0584281670083465
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CYTH3,Cytohesin-3,34427,89,0.84 [0.61-1.15],0.2700362944958059
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CYTL1,Cytokine-like protein 1,35680,94,1.02 [0.46-2.29],0.957533502704892
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DAAM1,Disheveled-associated activator of morphogenesis 1,34914,93,0.88 [0.69-1.12],0.3075218102441797
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DAB2,Disabled homolog 2,41393,103,0.90 [0.77-1.05],0.1854389379674039
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DAG1,Dystroglycan,41181,102,0.76 [0.52-1.11],0.1520093767424484
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DAND5,DAN domain family member 5,34646,90,0.88 [0.61-1.28],0.509031114818818
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DAPK2,Death-associated protein kinase 2,34646,90,1.10 [0.78-1.54],0.587307847516953
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40974,103,0.93 [0.81-1.07],0.3182690030561536
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DARS1,"Aspartate--tRNA ligase, cytoplasmic",40644,102,0.94 [0.73-1.19],0.5945667256285452
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DBH,Dopamine beta-hydroxylase,35636,93,1.00 [0.84-1.20],0.97649299579444
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,40840,102,1.28 [1.03-1.60],0.0267058741800744
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DBN1,Drebrin,34646,90,1.01 [0.67-1.51],0.965055121464276
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DBNL,Drebrin-like protein,41181,102,0.95 [0.78-1.15],0.5813468496524319
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",41133,105,1.39 [0.86-2.25],0.1843070993278899
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCC,Netrin receptor DCC,34720,90,1.16 [0.51-2.60],0.7274045768019552
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCDC2C,Doublecortin domain-containing protein 2C,34427,89,0.81 [0.57-1.17],0.2608055569083466
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCLRE1C,Protein artemis,34427,89,0.95 [0.49-1.84],0.8679275600477826
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCN,Decorin,40294,103,1.90 [0.91-3.95],0.0850837141357437
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCTD,Deoxycytidylate deaminase,34914,93,0.92 [0.75-1.14],0.4438462305710915
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCTN1,Dynactin subunit 1,41393,103,1.00 [0.76-1.30],0.9790944527706716
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCTN2,Dynactin subunit 2,40826,102,1.02 [0.85-1.23],0.8218419146098105
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCTN6,Dynactin subunit 6,40064,101,0.75 [0.57-1.00],0.0537511141192288
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,41020,104,4.78 [3.10-7.38],1.5124736187905569e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCUN1D1,DCN1-like protein 1,34584,91,1.04 [0.80-1.34],0.7865849128966872
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCUN1D2,DCN1-like protein 2,34427,89,0.80 [0.59-1.08],0.1441584429117084
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCXR,L-xylulose reductase,41133,105,1.03 [0.75-1.42],0.8482376057659016
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,34555,92,1.63 [1.16-2.30],0.0051265481760337
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40826,102,1.08 [0.73-1.60],0.6934547275636247
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDC,Aromatic-L-amino-acid decarboxylase,40966,104,1.22 [0.86-1.75],0.2694199951842129
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDHD2,Phospholipase DDHD2,35624,95,1.21 [0.90-1.63],0.1991675746226979
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDI2,Protein DDI1 homolog 2,34914,93,1.19 [0.93-1.52],0.1768511565989872
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,41382,103,5.99 [3.48-10.30],9.961821070273348e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,35680,94,1.71 [1.15-2.54],0.0077146521733152
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDX1,ATP-dependent RNA helicase DDX1,35523,94,0.97 [0.65-1.46],0.8974063491589008
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDX25,ATP-dependent RNA helicase DDX25,34720,90,0.78 [0.42-1.46],0.4395114470326016
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,34646,90,2.07 [1.29-3.32],0.0026787515583496
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDX4,Probable ATP-dependent RNA helicase DDX4,34646,90,0.85 [0.56-1.30],0.4570282223156262
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDX53,Probable ATP-dependent RNA helicase DDX53,34720,90,0.91 [0.52-1.61],0.7588123231801744
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,40089,100,1.48 [1.20-1.84],0.0003280467715603
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40974,103,1.00 [0.83-1.20],0.9683936273796472
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,40197,102,0.68 [0.47-0.99],0.043227591331475
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DEFB103A_DEFB103B,Beta-defensin 103,34385,88,0.81 [0.47-1.41],0.4658236499890678
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DEFB104A_DEFB104B,Beta-defensin 104,34584,91,1.01 [0.70-1.46],0.9453017372270032
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DEFB116,Beta-defensin 116,34584,91,0.88 [0.65-1.20],0.4161812647494157
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DEFB118,Beta-defensin 118,34584,91,0.63 [0.38-1.06],0.0809895952538237
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DEFB4A_DEFB4B,Beta-defensin 4A,40425,101,0.91 [0.81-1.03],0.1413199658253327
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DENND2B,DENN domain-containing protein 2B,34555,92,0.58 [0.33-1.03],0.0609309520196242
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DENR,Density-regulated protein,34646,90,1.09 [0.78-1.53],0.6159730067034191
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,41488,104,1.54 [1.22-1.95],0.0003432859119258
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,34584,91,1.91 [1.61-2.27],1.42163303870296e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DGKA,Diacylglycerol kinase alpha,34646,90,1.39 [0.98-1.98],0.0637198680654599
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DGKZ,Diacylglycerol kinase zeta,40284,100,0.66 [0.39-1.12],0.1219989817315177
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DHODH,Dihydroorotate dehydrogenase,34555,92,0.70 [0.42-1.15],0.1571284814210847
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,35512,93,2.05 [1.67-2.53],1.2468412202574258e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,35608,95,1.06 [0.70-1.59],0.7853413236770159
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DIABLO,"Diablo homolog, mitochondrial",40893,104,0.93 [0.79-1.09],0.3731785913063781
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DIPK1C,Divergent protein kinase domain 1C,34720,90,0.77 [0.45-1.32],0.3451183942634802
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,34914,93,0.96 [0.47-1.96],0.9028459189898383
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,41382,103,0.67 [0.50-0.89],0.0065957357337999
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,41521,106,1.23 [0.69-2.18],0.4893949914371733
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DKK4,Dickkopf-related protein 4,40656,102,0.93 [0.63-1.37],0.6987285815645342
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,40826,102,1.47 [1.15-1.89],0.0022325278408936
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DLG4,Disks large homolog 4,35608,95,0.92 [0.69-1.21],0.5425142298097833
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DLGAP5,Disks large-associated protein 5,35624,95,1.00 [0.68-1.46],0.9832071682285788
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DLK1,Protein delta homolog 1,41521,106,1.20 [0.89-1.62],0.2402543412322028
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,41133,105,2.70 [1.59-4.57],0.0002214442037079
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,34729,89,0.41 [0.24-0.69],0.0009335322568941
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,34729,89,1.56 [1.17-2.08],0.0023359799099679
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DMP1,Dentin matrix acidic phosphoprotein 1,34729,89,0.85 [0.61-1.18],0.326677078185103
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJA1,DnaJ homolog subfamily A member 1,34427,89,1.07 [0.70-1.64],0.7660136789646492
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJA2,DnaJ homolog subfamily A member 2,41362,104,0.92 [0.75-1.14],0.4652050825408409
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJA4,DnaJ homolog subfamily A member 4,35608,95,1.21 [0.93-1.58],0.1546898086972582
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJB1,DnaJ homolog subfamily B member 1,40826,102,0.93 [0.76-1.14],0.4774734557751194
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJB14,DnaJ homolog subfamily B member 14,35523,94,1.11 [0.82-1.49],0.5016799534842946
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJB2,DnaJ homolog subfamily B member 2,34914,93,1.04 [0.72-1.51],0.8199330075708086
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJB6,DnaJ homolog subfamily B member 6,34578,90,0.83 [0.65-1.06],0.1433898315257849
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJB8,DnaJ homolog subfamily B member 8,40294,103,0.83 [0.58-1.18],0.2936953201743031
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJC21,DnaJ homolog subfamily C member 21,35608,95,1.37 [0.87-2.14],0.1718992322347892
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJC6,Putative tyrosine-protein phosphatase auxilin,34729,89,1.08 [0.85-1.37],0.5452493822835662
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,35523,94,1.39 [1.09-1.79],0.0092232829086194
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNER,Delta and Notch-like epidermal growth factor-related receptor,40921,102,0.73 [0.37-1.44],0.3634448369631378
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNLZ,DNL-type zinc finger protein,34584,91,0.81 [0.60-1.08],0.1478168266746715
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNM1,Dynamin-1,35523,94,0.81 [0.69-0.96],0.0147324480689012
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNM3,Dynamin-3,35624,95,1.08 [0.76-1.53],0.6688410513800359
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,40720,102,1.99 [1.60-2.47],5.690441419583153e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNPEP,Aspartyl aminopeptidase,35608,95,1.37 [0.97-1.94],0.0745751641123682
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,41113,102,1.31 [0.94-1.82],0.1118897685871015
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DOC2B,Double C2-like domain-containing protein beta,34720,90,0.88 [0.47-1.62],0.6715836433026021
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DOCK9,Dedicator of cytokinesis protein 9,34584,91,0.83 [0.66-1.03],0.0903508263414535
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DOK1,Docking protein 1,35608,95,0.98 [0.85-1.13],0.8046658454880344
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DOK2,Docking protein 2,41020,104,0.96 [0.84-1.11],0.6196126753891322
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPEP1,Dipeptidase 1,40644,102,1.05 [0.73-1.52],0.779534824271592
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,40826,102,4.08 [2.57-6.48],2.6653513955285194e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,40974,103,1.15 [0.71-1.85],0.5676877045480766
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,40253,101,0.71 [0.38-1.33],0.2891514321810232
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPP6,Dipeptidyl aminopeptidase-like protein 6,40826,102,0.98 [0.59-1.65],0.9534035652372116
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPP7,Dipeptidyl peptidase 2,40692,103,0.88 [0.66-1.17],0.375817384012254
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,41521,106,1.50 [0.75-2.99],0.2553572500033728
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,41269,103,1.76 [1.43-2.16],6.937783302478147e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,40720,102,1.30 [0.86-1.95],0.2113211961684179
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DRG2,Developmentally-regulated GTP-binding protein 2,40826,102,0.94 [0.69-1.29],0.7025159692125451
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,40552,102,1.95 [1.21-3.12],0.005856817148771
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,35624,95,3.90 [2.40-6.36],4.550092933522703e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DSG2,Desmoglein-2,41027,103,0.92 [0.48-1.75],0.7997787140713581
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DSG3,Desmoglein-3,41266,103,1.01 [0.61-1.68],0.9690656386863018
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DSG4,Desmoglein-4,40681,102,0.97 [0.68-1.38],0.8589415032689236
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DTD1,D-aminoacyl-tRNA deacylase 1,34914,93,0.89 [0.71-1.12],0.3328908071504326
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,35446,93,1.72 [1.18-2.51],0.0044459171205995
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DTX2,Probable E3 ubiquitin-protein ligase DTX2,34720,90,0.71 [0.47-1.06],0.0934569401855323
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,40826,102,6.40 [4.36-9.41],3.3920152954594914e-21
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DTYMK,Thymidylate kinase,35674,93,0.98 [0.74-1.32],0.917472484832406
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DUOX2,Dual oxidase 2,40294,103,0.77 [0.57-1.05],0.095206780098111
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DUSP13,Dual specificity protein phosphatase 13 isoform A,35512,93,0.72 [0.44-1.19],0.2039994593571457
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DUSP29,Dual specificity phosphatase 29,34720,90,0.80 [0.56-1.14],0.2224332175837631
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DUSP3,Dual specificity protein phosphatase 3,40064,101,0.78 [0.61-1.00],0.0528162254503141
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",35523,94,0.92 [0.76-1.12],0.4242701169264822
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,35608,95,1.97 [1.34-2.90],0.0006074405862722
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,35512,93,0.99 [0.65-1.52],0.9717424274352366
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DYNLT1,Dynein light chain Tctex-type 1,34720,90,1.30 [1.04-1.62],0.019342633422992
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DYNLT3,Dynein light chain Tctex-type 3,35512,93,1.18 [0.76-1.83],0.4594401973444515
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,40720,102,1.06 [0.88-1.28],0.5169731874338996
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,41331,103,3.25 [2.03-5.19],8.604083473341687e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ECE1,Endothelin-converting enzyme 1,40064,101,0.84 [0.51-1.38],0.4868717267507184
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",35674,93,1.10 [0.85-1.42],0.4715657444029112
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",34729,89,1.19 [0.97-1.46],0.0994726607559082
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ECI2,Enoyl-CoA delta isomerase 2,34555,92,0.95 [0.68-1.33],0.7704041945625254
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ECM1,Extracellular matrix protein 1,34743,92,0.92 [0.54-1.56],0.7607365905915564
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ECSCR,Endothelial cell-specific chemotaxis regulator,34584,91,0.82 [0.52-1.30],0.3955459758050942
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,41393,103,1.82 [1.18-2.81],0.0068868525002703
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,40974,103,0.76 [0.63-0.93],0.0074471091007843
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDDM3B,Epididymal secretory protein E3-beta,35512,93,0.85 [0.59-1.25],0.4142102671835747
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,34555,92,0.31 [0.15-0.66],0.0024395385817045
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDF1,Endothelial differentiation-related factor 1,35624,95,1.12 [0.87-1.45],0.3855008865821639
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40294,103,0.96 [0.57-1.61],0.8820642907830143
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,34729,89,1.98 [1.01-3.89],0.0467454355225673
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,34646,90,0.74 [0.42-1.28],0.2790056682890994
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EEF1D,Elongation factor 1-delta,35674,93,1.13 [0.91-1.39],0.2723490828950634
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,35523,94,1.71 [1.10-2.66],0.0180698021959886
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFCAB2,Dynein regulatory complex protein 8,35020,92,0.70 [0.38-1.29],0.2546046038985826
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,41101,103,0.85 [0.48-1.49],0.5632521432581155
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,35624,95,1.60 [1.03-2.47],0.035765710740057
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,40961,102,2.67 [1.57-4.54],0.0002797458553919
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,40651,102,9.65 [7.44-12.53],4.529536381212732e-65
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFNB2,Ephrin-B2,34720,90,1.15 [0.84-1.57],0.3969785495517123
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EGF,Pro-epidermal growth factor,40931,101,0.84 [0.71-0.99],0.0388826161487575
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,40089,100,0.46 [0.29-0.75],0.001877974299866
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EGFLAM,Pikachurin,35523,94,1.46 [0.80-2.64],0.2176236014898653
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,41521,106,0.89 [0.31-2.55],0.8253395182668921
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,40974,103,1.82 [1.60-2.06],5.35441168213612e-20
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EHBP1,EH domain-binding protein 1,35674,93,0.97 [0.74-1.26],0.7955640410147986
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EHD3,EH domain-containing protein 3,34729,89,0.84 [0.71-1.00],0.0437396461778149
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",35608,95,1.04 [0.74-1.47],0.8008187468275041
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",35399,94,0.94 [0.78-1.13],0.5084190803476628
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,34555,92,1.12 [0.84-1.50],0.4510151614132298
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,34729,89,1.17 [0.75-1.84],0.4884554856352022
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF4B,Eukaryotic translation initiation factor 4B,40720,102,1.06 [0.78-1.46],0.6953578057151917
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF4E,Eukaryotic translation initiation factor 4E,34646,90,1.05 [0.83-1.31],0.7015024768258475
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,41020,104,1.21 [0.94-1.56],0.1394201193775875
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,41488,104,1.01 [0.85-1.21],0.8715884071643658
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,35624,95,0.90 [0.66-1.22],0.4902643648467903
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF5,Eukaryotic translation initiation factor 5,34555,92,0.77 [0.46-1.28],0.3180732535681401
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF5A,Eukaryotic translation initiation factor 5A-1,40284,100,0.77 [0.41-1.44],0.4121589039030306
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ELAC1,Zinc phosphodiesterase ELAC protein 1,35624,95,1.13 [0.90-1.42],0.3033622569988943
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ELAVL4,ELAV-like protein 4,34584,91,0.77 [0.59-1.01],0.0570181850045755
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ELN,Elastin,35674,93,1.12 [0.63-1.99],0.6925567688548198
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,40826,102,2.22 [2.00-2.47],1.3656836399163636e-48
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ELOB,Elongin-B,34555,92,0.73 [0.41-1.32],0.2995230162467932
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,40284,100,0.91 [0.62-1.34],0.6353129334737598
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,32934,87,0.85 [0.58-1.26],0.4268564233458251
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,41521,106,6.45 [2.91-14.33],4.648250806140604e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENO1,Alpha-enolase,40969,102,0.95 [0.76-1.18],0.621100740153552
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENO2,Gamma-enolase,41382,103,0.91 [0.70-1.19],0.4927862285558688
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENO3,Beta-enolase,34729,89,0.94 [0.66-1.33],0.7172280105825939
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENOPH1,Enolase-phosphatase E1,35512,93,0.98 [0.67-1.42],0.8968294671155351
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,34555,92,3.14 [2.25-4.39],1.6458103277204257e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENPEP,Glutamyl aminopeptidase,34555,92,0.85 [0.50-1.44],0.5365063732825079
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,41521,106,2.86 [1.57-5.20],0.0005841649819887
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,41181,102,1.12 [0.73-1.72],0.5912017912102876
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,34729,89,1.36 [0.77-2.39],0.2901971556620991
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39734,94,1.19 [0.96-1.48],0.116842351028461
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENSA,Alpha-endosulfine,35512,93,0.89 [0.60-1.32],0.5711492280949954
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,40089,100,0.88 [0.58-1.33],0.5443942312911461
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40294,103,0.73 [0.33-1.61],0.4305210833658648
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40294,103,3.96 [1.90-8.24],0.0002332857577214
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,34729,89,2.06 [1.65-2.58],2.8093682395759644e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,34646,90,1.47 [0.88-2.46],0.1445228693365359
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPB41L5,Band 4.1-like protein 5,34720,90,0.85 [0.59-1.22],0.3780643920305085
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPCAM,Epithelial cell adhesion molecule,40981,102,0.82 [0.68-0.99],0.0380793553906177
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPGN,Epigen,35512,93,0.89 [0.55-1.45],0.6411982555736313
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHA1,Ephrin type-A receptor 1,41113,102,1.01 [0.59-1.73],0.976386480768362
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHA10,Ephrin type-A receptor 10,40064,101,1.17 [0.94-1.47],0.1564412098957791
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,39571,100,2.95 [2.06-4.23],3.805532709837025e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,34914,93,5.25 [2.72-10.13],7.883504790222351e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,41521,106,2.75 [1.49-5.08],0.0012086591979239
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,40644,102,4.51 [2.79-7.29],7.18451895583441e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHX2,Bifunctional epoxide hydrolase 2,40294,103,0.92 [0.68-1.24],0.5784926714368084
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPN1,Epsin-1,35020,92,0.67 [0.38-1.18],0.1704168307883297
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,40974,103,1.44 [1.21-1.71],3.4966796747706246e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPPK1,Epiplakin,34729,89,1.05 [0.80-1.39],0.7078419398127269
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,41331,103,5.34 [3.80-7.50],5.628960155898647e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,41133,105,1.22 [0.60-2.48],0.5886258470678761
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,40860,102,1.34 [0.56-3.21],0.5162306282319997
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,41133,105,0.65 [0.32-1.32],0.232688234665567
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERBIN,Erbin,40826,102,0.89 [0.75-1.06],0.1869902063095657
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERC2,ERC protein 2,34720,90,1.05 [0.81-1.36],0.7017074070202914
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERCC1,DNA excision repair protein ERCC-1,34427,89,0.91 [0.48-1.74],0.7850434170710148
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,40644,102,0.65 [0.50-0.83],0.0006481584608928
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,35020,92,3.21 [2.47-4.16],1.9576492352841296e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERMAP,Erythroid membrane-associated protein,34646,90,1.12 [0.71-1.77],0.6125524654058329
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,35512,93,0.96 [0.56-1.65],0.8868263374163696
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERP29,Endoplasmic reticulum resident protein 29,34914,93,0.92 [0.78-1.09],0.3579420359563502
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERP44,Endoplasmic reticulum resident protein 44,40760,102,0.63 [0.32-1.24],0.1810942163608702
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,34555,92,0.64 [0.37-1.08],0.0940378924329302
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,41521,106,1.31 [0.77-2.21],0.3174049931063086
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,40982,102,1.34 [0.81-2.23],0.2567806488393416
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ESPL1,Separin,34427,89,1.11 [0.80-1.54],0.5291955958864564
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ESR1,Estrogen receptor,34646,90,1.08 [0.78-1.50],0.6356018958794522
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ESYT2,Extended synaptotagmin-2,35608,95,0.97 [0.77-1.24],0.825147552566491
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EVI2B,Protein EVI2B,34427,89,1.23 [0.81-1.86],0.3330682745685428
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EVI5,Ecotropic viral integration site 5 protein homolog,34646,90,1.12 [0.90-1.41],0.3026093613522868
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EVPL,Envoplakin,35020,92,0.93 [0.50-1.75],0.832245303622725
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EXOSC10,Exosome component 10,34555,92,1.26 [0.96-1.65],0.0956335616713127
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EXTL1,Exostosin-like 1,34555,92,0.72 [0.44-1.19],0.2010804283791096
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,41382,103,10.92 [8.23-14.49],1.3250571903018776e-61
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,35700,95,0.91 [0.45-1.83],0.7942066161011143
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,35214,92,1.26 [0.74-2.16],0.392538217209797
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F11R,Junctional adhesion molecule A,41027,103,0.98 [0.72-1.34],0.9147877885504718
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F12,Coagulation factor XII,35728,94,1.04 [0.64-1.67],0.8872810381393744
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,35541,92,0.85 [0.39-1.86],0.6923662150241314
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,35728,94,1.25 [0.34-4.61],0.7394058029119028
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F2R,Proteinase-activated receptor 1,41121,102,0.79 [0.58-1.08],0.1338115155473392
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,41138,103,1.12 [0.59-2.15],0.7245954040613065
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,41112,103,0.81 [0.46-1.41],0.446326012818548
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,41111,103,0.50 [0.20-1.25],0.137311020359503
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",40982,102,1.13 [0.95-1.36],0.1703315878970901
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FABP2,"Fatty acid-binding protein, intestinal",41020,104,1.13 [0.91-1.39],0.2740660691000576
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FABP3,"Fatty acid-binding protein, heart",35674,93,1.36 [0.96-1.92],0.0849163744441552
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",41521,106,1.27 [0.91-1.77],0.1675300545418714
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FABP5,Fatty acid-binding protein 5,41254,102,0.98 [0.75-1.27],0.8773375526040835
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FABP6,Gastrotropin,40231,103,0.87 [0.63-1.20],0.3965924639342828
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FABP9,Fatty acid-binding protein 9,40974,103,0.95 [0.69-1.30],0.7426467156235398
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FADD,FAS-associated death domain protein,41020,104,0.93 [0.74-1.17],0.519109371274399
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM13A,Protein FAM13A,35523,94,0.83 [0.61-1.13],0.2423263700397706
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM171A2,Protein FAM171A2,35624,95,0.93 [0.82-1.07],0.3154316899657708
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM171B,Protein FAM171B,35512,93,1.17 [0.60-2.26],0.6481581341895187
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM172A,Cotranscriptional regulator FAM172A,34729,89,1.02 [0.73-1.43],0.8958021276786559
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,35674,93,1.00 [0.49-2.03],0.9961234394936306
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM3B,Protein FAM3B,40826,102,1.35 [0.81-2.24],0.2539120160129369
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,40966,104,2.52 [1.47-4.34],0.0008285713072436
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM3D,Protein FAM3D,35523,94,1.07 [0.85-1.34],0.5638267476982244
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,41521,106,0.81 [0.43-1.52],0.5108041759011336
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FARSA,Phenylalanine--tRNA ligase alpha subunit,34720,90,0.98 [0.73-1.32],0.9135637176688846
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,41393,106,1.60 [1.17-2.20],0.0036235992412256
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FASLG,Tumor necrosis factor ligand superfamily member 6,41488,104,1.28 [0.80-2.06],0.3015390049192041
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,35680,94,2.03 [1.10-3.73],0.0227232488708256
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FBN2,Fibrillin-2,34720,90,1.18 [0.84-1.66],0.3323898728533542
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FBP1,"Fructose-1,6-bisphosphatase 1",41020,104,0.99 [0.78-1.25],0.9269874203223654
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,35674,93,2.15 [1.69-2.74],3.6551044887916143e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCAR,Immunoglobulin alpha Fc receptor,40974,103,0.73 [0.50-1.05],0.091094382828925
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,35624,95,2.34 [1.24-4.42],0.0086529880950736
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,41027,103,4.46 [4.04-4.92],1.2262589167271424e-194
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40848,102,0.93 [0.71-1.23],0.6259002020577045
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,40089,100,1.71 [1.39-2.10],4.788239739198654e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,41046,103,1.03 [0.72-1.46],0.8785059938980889
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCN1,Ficolin-1,35636,93,0.91 [0.65-1.27],0.5798707867424384
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,40832,102,0.73 [0.49-1.08],0.1111107279008843
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,41020,104,22.71 [10.98-46.98],3.69248866660999e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,41297,104,3.18 [2.80-3.60],6.855920158279601e-72
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,40284,100,5.70 [4.95-6.56],1.788824968355558e-129
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,41027,103,5.52 [4.39-6.93],6.7547993428323024e-49
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,40974,103,1.25 [0.97-1.62],0.0829624221150752
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,40089,100,1.62 [1.36-1.94],7.510758641616217e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FDX1,"Adrenodoxin, mitochondrial",34555,92,1.13 [0.85-1.50],0.412977444255326
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FDX2,"Ferredoxin-2, mitochondrial",34555,92,0.99 [0.70-1.42],0.9725575300611046
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,40089,100,1.54 [1.36-1.75],1.379989936847704e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FES,Tyrosine-protein kinase Fes/Fps,40089,100,1.01 [0.69-1.47],0.9694541854144044
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,41111,103,1.24 [0.71-2.16],0.4570437478169337
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGA,Fibrinogen alpha chain,34894,92,1.47 [0.77-2.79],0.2438180139867443
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",35624,95,1.08 [0.85-1.38],0.536513456548862
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF12,Fibroblast growth factor 12,34646,90,0.69 [0.37-1.31],0.2582178273307973
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF16,Fibroblast growth factor 16,34646,90,0.84 [0.52-1.34],0.4600573762470846
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF19,Fibroblast growth factor 19,41181,102,0.96 [0.77-1.20],0.7067341738507239
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,40974,103,1.85 [1.48-2.30],3.891386064570125e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF20,Fibroblast growth factor 20,34646,90,0.54 [0.29-1.02],0.0561203052914005
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF21,Fibroblast growth factor 21,41331,103,1.05 [0.91-1.22],0.5039727510331427
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,41331,103,1.41 [1.10-1.81],0.0065393043746669
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF3,Fibroblast growth factor 3,34646,90,0.90 [0.44-1.83],0.76439304011789
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF5,Fibroblast growth factor 5,40284,100,1.29 [0.77-2.16],0.3262227814594399
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF6,Fibroblast growth factor 6,34646,90,0.44 [0.22-0.89],0.0230817096179641
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF7,Fibroblast growth factor 7,34427,89,0.59 [0.40-0.87],0.0078857869313675
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF9,Fibroblast growth factor 9,34362,89,1.06 [0.64-1.76],0.8141247220724135
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,41133,105,0.74 [0.44-1.24],0.2472769399060962
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,35680,94,0.78 [0.53-1.16],0.2252199168849763
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGFBP3,Fibroblast growth factor-binding protein 3,35608,95,0.93 [0.55-1.59],0.7938049958427434
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,41133,105,2.13 [1.02-4.47],0.0446807614422923
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGFR4,Fibroblast growth factor receptor 4,34914,93,1.13 [0.77-1.65],0.5320405445844348
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,35700,95,1.10 [0.81-1.49],0.5561597063669194
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGR,Tyrosine-protein kinase Fgr,40064,101,1.00 [0.75-1.34],0.9936980810936396
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FH,"Fumarate hydratase, mitochondrial",34584,91,1.12 [0.91-1.38],0.2680379004787328
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FHIP2A,FHF complex subunit HOOK interacting protein 2A,34555,92,0.69 [0.43-1.12],0.1336807293295716
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FHIT,Bis(5'-adenosyl)-triphosphatase,40064,101,0.86 [0.67-1.10],0.2242258944206138
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FIS1,Mitochondrial fission 1 protein,40987,102,0.94 [0.74-1.18],0.5718344817533207
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,35624,95,0.90 [0.74-1.10],0.2980578530592525
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,41156,104,0.94 [0.80-1.09],0.405488871829186
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40720,102,1.51 [1.00-2.28],0.0475743227126695
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,40720,102,0.96 [0.80-1.16],0.6628409467227376
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39988,101,0.78 [0.51-1.20],0.2625861960518637
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FKBPL,FK506-binding protein-like,35523,94,0.98 [0.70-1.37],0.8989101437751641
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FLI1,Friend leukemia integration 1 transcription factor,40089,100,0.99 [0.84-1.16],0.8730132160306103
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40720,102,1.88 [1.05-3.38],0.0346061447372322
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FLT1,Vascular endothelial growth factor receptor 1,40749,102,1.34 [0.63-2.81],0.4469410577484792
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FLT3,Receptor-type tyrosine-protein kinase FLT3,40089,100,1.63 [1.07-2.49],0.022822252188855
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,41488,104,1.90 [1.15-3.13],0.0117610110525827
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,41133,105,0.86 [0.52-1.42],0.5550902832661472
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FMNL1,Formin-like protein 1,40064,101,1.29 [1.07-1.56],0.0066013646011559
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FMR1,Synaptic functional regulator FMR1,40089,100,1.21 [0.74-1.99],0.4446851914042962
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FN1,Fibronectin,35728,94,0.84 [0.40-1.76],0.6420372518754751
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,35608,95,0.89 [0.59-1.35],0.590943585054852
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,35512,93,1.40 [0.86-2.29],0.1720377023304866
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOLH1,Glutamate carboxypeptidase 2,34646,90,1.03 [0.85-1.23],0.7883891140061371
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,40944,105,1.61 [0.90-2.88],0.1074929562030698
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,41382,103,1.67 [0.93-3.00],0.0843290460439767
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOLR3,Folate receptor gamma,41004,105,1.01 [0.92-1.10],0.8923049827238273
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOS,Proto-oncogene c-Fos,34362,89,1.13 [0.64-1.99],0.6786897560091
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOSB,Protein fosB,40064,101,0.91 [0.56-1.49],0.7180148429045287
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,34646,90,1.94 [1.45-2.59],7.352357754731304e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,40974,103,1.50 [1.23-1.82],5.2519082843777794e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOXO3,Forkhead box protein O3,40089,100,0.93 [0.76-1.13],0.4473808575811747
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FRMD4B,FERM domain-containing protein 4B,34555,92,0.93 [0.69-1.25],0.6372682344663443
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FRMD7,FERM domain-containing protein 7,34720,90,0.88 [0.48-1.61],0.6714766223836544
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,40589,102,2.19 [1.04-4.59],0.0385986267677729
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,34729,89,1.20 [0.84-1.72],0.3172366558540429
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FST,Follistatin,41121,102,0.85 [0.59-1.22],0.3729658672100453
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,34729,89,2.28 [1.00-5.20],0.0496011676271969
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,40919,102,1.88 [1.12-3.15],0.0170574014526957
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FTCD,Formimidoyltransferase-cyclodeaminase,35542,95,1.02 [0.81-1.28],0.8662728300658683
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUCA1,Tissue alpha-L-fucosidase,41264,105,0.90 [0.74-1.10],0.3039110384317459
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,34914,93,1.38 [1.03-1.86],0.0326131572802716
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FURIN,Furin,41133,105,0.57 [0.34-0.96],0.0357449043307271
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,40028,100,3.72 [3.01-4.60],4.1026992763803605e-34
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",34950,92,1.10 [0.82-1.48],0.5147358933344377
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,41382,103,1.76 [1.23-2.53],0.0022191649059976
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUT8,"Alpha-(1,6)-fucosyltransferase",40720,102,0.88 [0.65-1.20],0.4196027347592507
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FXN,"Frataxin, mitochondrial",41393,103,0.90 [0.71-1.15],0.4066555116517573
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FXYD5,FXYD domain-containing ion transport regulator 5,40284,100,0.92 [0.69-1.22],0.5563488185254293
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FYB1,FYN-binding protein 1,40954,103,0.93 [0.77-1.12],0.4579251150544414
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FZD10,Frizzled-10,34720,90,0.66 [0.42-1.04],0.0747463482195242
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FZD8,Frizzled-8,34584,91,1.08 [0.69-1.68],0.7489701982031184
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GABARAP,Gamma-aminobutyric acid receptor-associated protein,35512,93,1.03 [0.69-1.55],0.8758742349025663
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,35020,92,0.91 [0.66-1.27],0.5898614296300774
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,34584,91,0.91 [0.65-1.28],0.6019834078045568
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAD1,Glutamate decarboxylase 1,34427,89,1.19 [0.54-2.61],0.660975330330249
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAD2,Glutamate decarboxylase 2,34646,90,1.06 [0.69-1.62],0.7889432150153308
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,35020,92,0.60 [0.33-1.09],0.0932039312205052
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,34729,89,1.15 [0.79-1.67],0.4769998192019919
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAGE2A,G antigen 2A,34427,89,0.96 [0.69-1.33],0.8168441043762832
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,41181,102,0.68 [0.52-0.89],0.005780354956712
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40826,102,1.34 [0.72-2.51],0.3620756617014022
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,41393,103,1.62 [0.84-3.11],0.1484436047673427
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40284,100,3.16 [2.41-4.14],9.054241418564907e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,35674,93,1.83 [0.99-3.39],0.0538568783066493
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,40826,102,7.73 [4.17-14.31],8.131416024149176e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAMT,Guanidinoacetate N-methyltransferase,34555,92,0.50 [0.24-1.06],0.0704623140948277
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,34147,89,0.69 [0.38-1.26],0.2275757950673847
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GART,Trifunctional purine biosynthetic protein adenosine-3,35624,95,1.08 [0.53-2.22],0.8328561915000011
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,35020,92,0.70 [0.44-1.13],0.1461505381775011
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,41253,104,2.27 [1.15-4.50],0.0185623197318636
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,34555,92,0.81 [0.50-1.29],0.3702549032426802
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAST,Gastrin,35608,95,1.00 [0.86-1.15],0.95261390783767
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,34427,89,1.09 [0.50-2.34],0.8351892228206763
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",34729,89,1.26 [0.98-1.62],0.0745679000738908
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GBA,Lysosomal acid glucosylceramidase,34720,90,1.11 [0.77-1.60],0.5774469352557421
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,35543,95,1.74 [1.37-2.21],5.734139500062591e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,40284,100,1.30 [0.99-1.69],0.0546419741622114
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GBP4,Guanylate-binding protein 4,40064,101,0.88 [0.60-1.28],0.499489181005505
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GBP6,Guanylate-binding protein 6,34555,92,0.65 [0.37-1.15],0.1412486562597646
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GC,Vitamin D-binding protein,35728,94,0.84 [0.39-1.81],0.6568886409136656
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GCC1,GRIP and coiled-coil domain-containing protein 1,35608,95,0.96 [0.80-1.15],0.6428898530589227
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GCG,Pro-glucagon,40089,100,0.92 [0.80-1.06],0.2728756494732163
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,34067,87,1.96 [1.57-2.45],2.626261404419575e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GCLM,Glutamate--cysteine ligase regulatory subunit,34555,92,1.05 [0.69-1.61],0.8121593445261747
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40826,102,1.78 [1.10-2.90],0.0199627868642243
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,41521,106,1.55 [1.12-2.15],0.0082678934208698
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,41020,104,0.51 [0.31-0.83],0.00693460031748
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,40064,101,1.29 [0.83-2.02],0.2568618646964877
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GET3,ATPase GET3,35674,93,1.03 [0.72-1.48],0.8787680169248885
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFAP,Glial fibrillary acidic protein,40023,100,1.25 [0.86-1.82],0.2367455600914863
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFER,FAD-linked sulfhydryl oxidase ALR,40089,100,1.35 [1.03-1.76],0.0277513060708967
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,40089,100,0.97 [0.84-1.13],0.7045302992574003
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,41331,103,3.38 [1.97-5.77],8.83630542256761e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFRA2,GDNF family receptor alpha-2,40826,102,2.06 [0.93-4.58],0.0755608947577814
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFRA3,GDNF family receptor alpha-3,40597,101,0.90 [0.48-1.70],0.7499109936768403
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFRAL,GDNF family receptor alpha-like,34559,95,1.12 [0.82-1.53],0.4678352452395115
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GGA1,ADP-ribosylation factor-binding protein GGA1,40064,101,0.58 [0.40-0.84],0.0037568268543127
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GGACT,Gamma-glutamylaminecyclotransferase,35674,93,1.06 [0.81-1.41],0.662101445419519
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GGCT,Gamma-glutamylcyclotransferase,35604,93,1.12 [0.75-1.68],0.5891545324311692
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,40324,100,1.48 [0.91-2.40],0.1159838938072347
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,40961,102,1.10 [0.78-1.55],0.5953045617319912
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,40720,102,2.21 [1.14-4.29],0.0189340261777446
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GH1,Somatotropin,40966,104,1.05 [0.95-1.15],0.3301946432224675
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,40089,100,0.68 [0.57-0.81],1.2372253651275198e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,34914,93,0.73 [0.36-1.48],0.381384375927457
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GHRHR,Growth hormone-releasing hormone receptor,40064,101,0.77 [0.52-1.14],0.1871286035044399
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GHRL,Appetite-regulating hormone,41020,104,0.97 [0.78-1.19],0.7432957431137085
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GID8,Glucose-induced degradation protein 8 homolog,35624,95,0.79 [0.40-1.55],0.4926311048841186
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIGYF2,GRB10-interacting GYF protein 2,35624,95,1.27 [1.00-1.62],0.0528217441229506
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIMAP7,GTPase IMAP family member 7,34914,93,1.34 [0.79-2.30],0.2805999008056185
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIMAP8,GTPase IMAP family member 8,34427,89,1.22 [0.86-1.74],0.2685369761255012
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIP,Gastric inhibitory polypeptide,34729,89,0.98 [0.67-1.43],0.9126086563704062
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,35608,95,2.46 [1.47-4.15],0.000675437159926
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIPC3,PDZ domain-containing protein GIPC3,35523,94,0.89 [0.73-1.08],0.2291908321432282
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIPR,Gastric inhibitory polypeptide receptor,34646,90,0.64 [0.37-1.09],0.1000533813097605
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIT1,ARF GTPase-activating protein GIT1,34646,90,1.12 [0.91-1.38],0.2962539756395979
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GJA8,Gap junction alpha-8 protein,34427,89,0.87 [0.61-1.25],0.4658139734014695
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GKN1,Gastrokine-1,39297,100,1.01 [0.53-1.92],0.9811144431539094
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLA,Alpha-galactosidase A,34844,93,0.76 [0.45-1.29],0.311842539993395
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLB1,Beta-galactosidase,40720,102,0.97 [0.64-1.47],0.8736035710352323
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,34646,90,1.13 [0.63-2.01],0.6878115404301794
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLO1,Lactoylglutathione lyase,40294,103,1.07 [0.79-1.44],0.6794078455085637
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLOD4,Glyoxalase domain-containing protein 4,40927,102,1.25 [0.76-2.07],0.3771163881012122
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLP1R,Glucagon-like peptide 1 receptor,34584,91,1.27 [0.80-2.02],0.3016806204118875
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,40749,103,1.16 [0.86-1.56],0.333977932037092
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",34914,93,1.05 [0.84-1.31],0.6918283858114638
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,40064,101,1.08 [0.76-1.53],0.6785067947033148
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,35512,93,1.79 [1.48-2.17],1.4431364138931512e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,34815,89,1.77 [1.32-2.38],0.0001225192509275
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GMFG,Glia maturation factor gamma,35674,93,0.94 [0.71-1.24],0.6666927312298097
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GMPR,GMP reductase 1,41488,104,1.24 [0.86-1.78],0.2467003263433732
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GMPR2,GMP reductase 2,34914,93,1.05 [0.78-1.41],0.7553490964020996
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GNAS,Neuroendocrine secretory protein 55,35624,95,0.64 [0.47-0.86],0.0035417429780543
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,40089,100,1.05 [0.80-1.37],0.7290352151069233
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,34720,90,1.03 [0.70-1.52],0.8899760456051555
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,41027,103,1.53 [1.12-2.09],0.0077709068337146
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GNPDA1,Glucosamine-6-phosphate isomerase 1,34729,89,1.26 [0.79-2.02],0.3262559900350136
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GNPDA2,Glucosamine-6-phosphate isomerase 2,34914,93,1.00 [0.58-1.73],0.9957063262883336
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,35624,95,1.38 [1.10-1.74],0.0062967260539741
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,41382,103,1.91 [1.12-3.26],0.0170856201663429
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40974,103,0.92 [0.78-1.09],0.3418386781861501
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GORASP2,Golgi reassembly-stacking protein 2,35523,94,0.97 [0.64-1.47],0.8873526028053795
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",35680,94,1.68 [1.17-2.41],0.0050872721197467
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GP1BA,Platelet glycoprotein Ib alpha chain,40840,102,0.76 [0.44-1.30],0.3186998697866558
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GP1BB,Platelet glycoprotein Ib beta chain,34555,92,0.83 [0.62-1.12],0.2250544310622788
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39785,99,0.97 [0.78-1.20],0.7677066612640497
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,34914,93,0.44 [0.27-0.73],0.0013327488958853
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GP6,Platelet glycoprotein VI,40954,103,0.86 [0.71-1.05],0.1352195181868798
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPA33,Cell surface A33 antigen,40826,102,0.92 [0.81-1.04],0.1889092170563499
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,41393,103,1.41 [0.78-2.56],0.2522577394130602
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPC5,Glypican-5,40720,102,0.91 [0.67-1.25],0.5696022986116205
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPD1,Glycerol-3-phosphate dehydrogenase,35512,93,1.29 [0.91-1.83],0.1586111383364323
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPHA2,Glycoprotein hormone alpha-2,35523,94,0.95 [0.61-1.50],0.8402950578093035
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPI,Glucose-6-phosphate isomerase,35700,95,0.97 [0.64-1.48],0.8956338216464991
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,35523,94,1.30 [0.96-1.76],0.0938026282560569
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,40064,101,2.29 [1.78-2.95],1.5319623528746227e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,39918,102,1.23 [0.66-2.27],0.5194577075329037
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPR101,Probable G-protein coupled receptor 101,34584,91,0.60 [0.37-0.98],0.0415773997373764
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPR158,Probable G-protein coupled receptor 158,35624,95,1.19 [0.72-1.98],0.5019544312110105
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPR15L,Protein GPR15L,35523,94,0.78 [0.57-1.07],0.1221449506639391
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPR37,Prosaposin receptor GPR37,40294,103,1.13 [0.86-1.48],0.387122169947703
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,35512,93,1.15 [0.83-1.59],0.398744314234182
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRAP2,GRB2-related adapter protein 2,41020,104,0.95 [0.83-1.09],0.4553773321406565
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,35674,93,1.18 [0.86-1.61],0.3080775509182696
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRIK2,"Glutamate receptor ionotropic, kainate 2",35624,95,1.01 [0.65-1.59],0.9534797765773088
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",34584,91,0.92 [0.62-1.37],0.6897525162602702
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRK5,G protein-coupled receptor kinase 5,40294,103,1.12 [0.81-1.54],0.4988560140677883
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,40830,102,9.21 [6.79-12.50],4.0386551346265976e-46
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRP,Gastrin-releasing peptide,34729,89,0.72 [0.50-1.03],0.0755828987059199
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",40826,102,1.34 [1.03-1.75],0.0284227551142475
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRSF1,G-rich sequence factor 1,34234,89,0.80 [0.61-1.05],0.1043457283479648
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GSAP,Gamma-secretase-activating protein,40089,100,0.92 [0.73-1.17],0.5076105716080966
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GSN,Gelsolin,35563,95,0.80 [0.29-2.18],0.6561617454731409
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GSR,"Glutathione reductase, mitochondrial",35495,93,1.60 [0.66-3.86],0.2994391675886672
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GSTA1,Glutathione S-transferase A1,40956,104,1.02 [0.83-1.25],0.8853989072676935
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GSTA3,Glutathione S-transferase A3,40089,100,0.99 [0.78-1.25],0.917254682174625
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GSTM4,Glutathione S-transferase Mu 4,34555,92,1.01 [0.77-1.33],0.9165375194397082
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GSTP1,Glutathione S-transferase P,39815,101,1.04 [0.81-1.34],0.768994166217838
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GSTT2B,Glutathione S-transferase theta-2B,35608,95,1.01 [0.93-1.09],0.8336021546821125
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,35020,92,0.89 [0.64-1.24],0.4902068624545415
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GTPBP2,GTP-binding protein 2,34720,90,0.97 [0.75-1.25],0.801941714357405
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GUCA2A,Guanylin,40817,103,0.88 [0.52-1.48],0.6219491768629813
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GUCY2C,Heat-stable enterotoxin receptor,35020,92,0.83 [0.62-1.12],0.2238219635542779
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GUK1,Guanylate kinase,34555,92,1.23 [0.81-1.87],0.3339084220545476
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,41207,106,0.80 [0.60-1.06],0.1206396332246551
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GYS1,"Glycogen [starch] synthase, muscle",40294,103,1.04 [0.86-1.25],0.7070941836479238
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,41488,104,2.67 [1.91-3.73],8.776376744378221e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GZMB,Granzyme B,40974,103,1.03 [0.80-1.34],0.8138720565906277
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,40294,103,1.38 [1.20-1.59],9.908314980978495e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",H2AP,Huntingtin-interacting protein M,34427,89,0.82 [0.50-1.34],0.42036633657284
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",34555,92,0.59 [0.36-0.95],0.0314114558126171
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",41272,103,1.09 [0.86-1.39],0.4586671186708864
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,41393,103,1.06 [0.92-1.21],0.4246480731356217
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HARS1,"Histidine--tRNA ligase, cytoplasmic",41027,103,0.97 [0.77-1.22],0.7927575954330552
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,41334,103,1.22 [0.93-1.61],0.1496606073655721
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,41027,103,3.01 [2.02-4.48],6.207594098195725e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,41272,103,0.64 [0.50-0.81],0.0002037899939056
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HBQ1,Hemoglobin subunit theta-1,41393,103,1.31 [1.01-1.69],0.0421344510538552
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HBZ,Hemoglobin subunit zeta,35674,93,1.08 [0.90-1.29],0.4141386270069281
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HCG22,Protein PBMUCL2,34555,92,0.89 [0.59-1.36],0.5995912286181524
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HCLS1,Hematopoietic lineage cell-specific protein,41488,104,1.34 [0.98-1.84],0.0679809726362513
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HDAC8,Histone deacetylase 8,34646,90,0.99 [0.70-1.39],0.9383170955783318
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HDAC9,Histone deacetylase 9,34584,91,0.97 [0.71-1.34],0.873034753325319
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HDDC2,5'-deoxynucleotidase HDDC2,35523,94,1.66 [1.12-2.47],0.0115092893809883
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HDGF,Hepatoma-derived growth factor,41329,103,1.14 [0.94-1.37],0.1735090299173216
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,35608,95,2.26 [1.89-2.72],1.7547636262632486e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HEBP1,Heme-binding protein 1,40294,103,0.78 [0.54-1.12],0.1768311912012156
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,34914,93,2.43 [1.17-5.04],0.0174953649611403
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HEPACAM2,HEPACAM family member 2,35608,95,1.15 [0.73-1.82],0.555339466242823
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HEPH,Hephaestin,35674,93,0.73 [0.40-1.33],0.3065781010920443
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HEXIM1,Protein HEXIM1,40974,103,1.13 [0.91-1.40],0.2808623825331953
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,41488,104,1.47 [0.91-2.39],0.1194324013848684
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,35365,93,0.68 [0.38-1.22],0.1932130474382407
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,40089,100,0.82 [0.64-1.05],0.1093164004191709
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,35608,95,1.34 [1.05-1.72],0.0200288402863986
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HIF1A,Hypoxia-inducible factor 1-alpha,34646,90,0.95 [0.68-1.34],0.7882370649475874
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HIP1,Huntingtin-interacting protein 1,34555,92,0.88 [0.47-1.65],0.685317701517792
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,35538,95,1.46 [1.11-1.93],0.0072953037072027
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HJV,Hemojuvelin,35624,95,0.86 [0.53-1.39],0.5340036576671128
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HK2,Hexokinase-2,40294,103,0.92 [0.49-1.74],0.8051796741615524
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",35624,95,3.10 [1.67-5.75],0.0003186553747181
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",40845,102,2.19 [1.45-3.33],0.0002224110868456
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",40974,103,3.18 [2.03-4.96],3.815792938487606e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMBS,Porphobilinogen deaminase,41393,103,1.42 [0.94-2.15],0.0951959147484828
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMCN2,Hemicentin-2,34848,93,0.82 [0.59-1.16],0.2643999511904364
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",34729,89,1.02 [0.67-1.55],0.9216863139165352
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",34555,92,0.60 [0.35-1.01],0.0544350309394689
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMMR,Hyaluronan mediated motility receptor,34361,89,0.49 [0.28-0.86],0.0131709382126587
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,40574,104,1.37 [0.97-1.94],0.0738810762551559
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,40064,101,1.89 [1.51-2.36],1.9214966574945536e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HNF1A,Hepatocyte nuclear factor 1-alpha,34720,90,1.06 [0.82-1.38],0.6576974998602607
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,40518,102,1.40 [0.97-2.01],0.0696729255280651
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,40163,102,1.37 [1.11-1.69],0.0030080590374281
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,35624,95,2.34 [1.99-2.74],2.120865951862516e-25
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HPCAL1,Hippocalcin-like protein 1,41488,104,0.87 [0.70-1.10],0.2484292619714381
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,40089,100,0.92 [0.57-1.48],0.7349935068127923
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HPSE,Heparanase,35205,90,0.92 [0.74-1.14],0.4249390094190324
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HRAS,GTPase Hras,34955,92,0.82 [0.62-1.08],0.1562879288972914
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,34729,89,1.38 [0.81-2.37],0.234258565494941
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HRG,Histidine-rich glycoprotein,35541,92,1.57 [0.86-2.89],0.1450868866759348
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HS1BP3,HCLS1-binding protein 3,34729,89,1.00 [0.79-1.26],0.998253169653654
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40826,102,0.74 [0.46-1.17],0.1966463170899207
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,41393,103,1.63 [1.14-2.34],0.0073797665697141
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,34646,90,1.42 [0.82-2.46],0.2107335152315378
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSBP1,Heat shock factor-binding protein 1,34729,89,0.98 [0.79-1.22],0.883175791971911
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40974,103,1.05 [0.68-1.63],0.8277662463301474
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,35608,95,1.09 [0.80-1.49],0.5868325140624879
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSD17B3,Testosterone 17-beta-dehydrogenase 3,34555,92,0.94 [0.61-1.44],0.7792487599080256
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,34729,89,1.34 [0.90-2.01],0.1541941526420146
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSP90B1,Endoplasmin,39878,100,0.76 [0.53-1.08],0.1228880153328313
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSPA1A,Heat shock 70 kDa protein 1A,41113,102,0.94 [0.73-1.21],0.653845703267866
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSPA2,Heat shock-related 70 kDa protein 2,35512,93,1.22 [0.72-2.05],0.4655291618221622
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSPB1,Heat shock protein beta-1,40364,103,0.91 [0.71-1.16],0.4416428356813103
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSPB6,Heat shock protein beta-6,41393,103,1.36 [0.89-2.08],0.1569530070146439
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40712,102,1.39 [0.72-2.66],0.3253943640742855
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,34584,91,0.68 [0.47-0.99],0.0467306052126466
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,34584,91,0.93 [0.58-1.50],0.7613299977807949
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HTRA2,"Serine protease HTRA2, mitochondrial",41133,105,1.04 [0.78-1.38],0.7882961581286884
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HYAL1,Hyaluronidase-1,40780,102,0.66 [0.31-1.44],0.3018490297895295
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,41521,106,3.45 [1.66-7.17],0.0009094909676572
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICA1,Islet cell autoantigen 1,40284,100,0.90 [0.71-1.13],0.3497387286967469
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,40846,102,3.56 [2.18-5.81],4.0377791769625044e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,41521,106,1.80 [1.04-3.09],0.0344938405962248
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,41521,106,26.36 [19.48-35.67],7.841323045594391e-100
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICAM4,Intercellular adhesion molecule 4,40974,103,0.75 [0.55-1.04],0.0863385610156446
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICAM5,Intercellular adhesion molecule 5,41020,104,0.80 [0.55-1.16],0.2325225080847913
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,40826,102,11.68 [5.09-26.79],6.6178830705591945e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ID4,DNA-binding protein inhibitor ID-4,35020,92,0.93 [0.58-1.51],0.7835253226462596
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IDI2,Isopentenyl-diphosphate delta-isomerase 2,40064,101,0.95 [0.65-1.38],0.784017845531315
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IDO1,"Indoleamine 2,3-dioxygenase 1",34729,89,1.01 [0.73-1.40],0.936096862415296
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IDS,Iduronate 2-sulfatase,41488,104,1.39 [0.19-10.16],0.7472801543914069
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IDUA,Alpha-L-iduronidase,41393,103,0.79 [0.55-1.13],0.1978349730440585
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,34680,94,3.86 [2.85-5.24],3.310688212780851e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,35020,92,0.75 [0.49-1.14],0.1831209855096915
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,35020,92,1.08 [0.64-1.81],0.7670482304111009
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,35523,94,2.22 [1.26-3.91],0.0059920186341087
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,40284,100,1.01 [0.86-1.18],0.9382117313370688
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,41181,102,3.27 [2.02-5.31],1.6466656598125751e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNGR2,Interferon gamma receptor 2,40720,102,0.78 [0.55-1.11],0.1638243080138025
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,40064,101,1.40 [0.98-2.00],0.0661397187956832
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNL2,Interferon lambda-2,34584,91,1.21 [0.93-1.57],0.1577546100802147
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,40974,103,2.68 [2.22-3.23],1.4256555094215388e-24
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNW1,Interferon omega-1,34555,92,0.79 [0.42-1.51],0.4813974043374049
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFT20,Intraflagellar transport protein 20 homolog,34720,90,1.28 [0.84-1.95],0.2499510491977021
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGBP1,Immunoglobulin-binding protein 1,35624,95,1.22 [0.89-1.68],0.2070661063869665
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,34584,91,1.11 [0.76-1.62],0.5791154517258614
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,35680,94,1.05 [0.50-2.21],0.8953705962078968
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGF1R,Insulin-like growth factor 1 receptor,40826,102,1.73 [0.88-3.41],0.1109137991513008
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,34555,92,0.90 [0.56-1.43],0.648414870605714
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,41027,103,5.10 [2.62-9.96],1.7748350212444355e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,41457,106,1.07 [0.93-1.23],0.3499925412779712
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,41451,105,1.43 [1.08-1.90],0.013973993715247
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,41170,103,0.92 [0.53-1.59],0.7542084956143573
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,40508,102,1.51 [1.04-2.18],0.0285281606887009
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFBP6,Insulin-like growth factor-binding protein 6,40839,102,1.25 [0.71-2.21],0.4402005720032191
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,41521,106,1.83 [1.20-2.79],0.0051203916322041
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,41020,104,1.55 [0.95-2.54],0.078426556247445
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFL4,Insulin growth factor-like family member 4,34646,90,0.87 [0.62-1.21],0.3940577022630707
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGHMBP2,DNA-binding protein SMUBP-2,34555,92,0.88 [0.60-1.28],0.5010154029613825
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGLC2,Immunoglobulin lambda constant 2,35667,94,1.23 [0.65-2.35],0.5244330906561934
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGLON5,IgLON family member 5,34427,89,0.93 [0.72-1.19],0.5535463524214032
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGSF21,Immunoglobulin superfamily member 21,34729,89,0.84 [0.49-1.46],0.5465722226651502
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,40826,102,4.79 [4.19-5.47],4.616319057193699e-118
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,41020,104,1.81 [1.10-2.96],0.0190876955343361
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,35674,93,0.91 [0.72-1.16],0.4578237971975986
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IKBKG,NF-kappa-B essential modulator,40974,103,1.21 [1.00-1.47],0.0561253650189737
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IKZF2,Zinc finger protein Helios,40089,100,1.02 [0.84-1.24],0.8130814499623844
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,40284,100,1.49 [1.30-1.70],5.172282336499535e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL10RA,Interleukin-10 receptor subunit alpha,40284,100,1.07 [0.80-1.42],0.6536892193699655
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,41181,102,2.62 [1.88-3.64],1.0479400529245513e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL11,Interleukin-11,40284,100,0.89 [0.65-1.22],0.4664787454805421
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,40826,102,1.93 [1.59-2.33],1.2800233997936056e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,41488,104,2.53 [1.88-3.41],9.000932253274944e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,40284,100,3.25 [2.33-4.52],2.6344304990095704e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,34646,90,1.84 [1.28-2.63],0.000954219500766
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL13,Interleukin-13,40284,100,0.76 [0.48-1.21],0.2520195435552857
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,40493,103,1.52 [0.71-3.25],0.2784294864542648
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL13RA2,Interleukin-13 receptor subunit alpha-2,34584,91,1.10 [0.55-2.20],0.7817547864007698
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,40974,103,0.60 [0.35-1.04],0.0704208157286322
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,40284,100,3.28 [2.05-5.24],6.827925152717e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,41488,104,2.59 [2.10-3.19],9.157218136208617e-19
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL17A,Interleukin-17A,40220,100,0.80 [0.50-1.26],0.3329697078042413
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL17C,Interleukin-17C,40284,100,1.21 [0.97-1.51],0.0878391772988358
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL17D,Interleukin-17D,40284,100,1.19 [0.75-1.87],0.4635537315076218
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL17F,Interleukin-17F,40284,100,0.88 [0.68-1.15],0.3617458196367782
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,41027,103,1.11 [0.75-1.64],0.5989576868946769
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,40457,102,1.46 [1.05-2.01],0.0231111582618552
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,40843,101,1.47 [1.03-2.11],0.0332682454395631
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,41170,103,4.73 [3.23-6.92],1.309019029194442e-15
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,41488,104,1.47 [0.88-2.46],0.1426078512358034
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL18RAP,Interleukin-18 receptor accessory protein,40461,102,0.86 [0.76-0.97],0.0116084065813474
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,39994,103,1.06 [0.84-1.36],0.610441787506905
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1A,Interleukin-1 alpha,40284,100,0.82 [0.57-1.16],0.261699547273677
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1B,Interleukin-1 beta,40097,99,1.03 [0.76-1.41],0.831542051232535
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,40961,102,2.68 [1.37-5.24],0.0039298719230431
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,40924,102,0.56 [0.24-1.33],0.1898884488118385
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,41027,103,1.28 [0.88-1.86],0.1998991329193695
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,41393,106,0.96 [0.67-1.40],0.8449520142435204
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1RL2,Interleukin-1 receptor-like 2,40284,100,1.10 [0.69-1.76],0.681848378489244
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,40917,102,1.21 [0.91-1.63],0.1950179872043661
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL2,Interleukin-2,40284,100,1.43 [0.81-2.50],0.2164133355044838
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL20,Interleukin-20,40284,100,1.17 [0.87-1.59],0.2936657231463874
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL20RA,Interleukin-20 receptor subunit alpha,40284,100,0.82 [0.52-1.30],0.3989273671090952
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL20RB,Interleukin-20 receptor subunit beta,34646,90,1.30 [0.82-2.04],0.2627193799601854
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL21R,Interleukin-21 receptor,34646,90,0.48 [0.27-0.86],0.013110182267856
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,35512,93,1.01 [0.76-1.36],0.9304482653002978
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL22RA1,Interleukin-22 receptor subunit alpha-1,40284,100,0.64 [0.39-1.06],0.0814186581353616
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL24,Interleukin-24,40284,100,0.88 [0.59-1.29],0.5036498271921312
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL25,Interleukin-25,34299,89,0.76 [0.42-1.37],0.3592278163404592
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,40734,104,4.64 [3.72-5.78],3.5657380167700057e-42
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL2RB,Interleukin-2 receptor subunit beta,40284,100,0.99 [0.62-1.60],0.975316373520133
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,35512,93,1.93 [1.49-2.48],4.561449495527759e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL3,Interleukin-3,34427,89,0.98 [0.70-1.35],0.8878320783164874
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL31,Interleukin-31,34646,90,0.63 [0.39-1.02],0.0620343140616711
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL31RA,Interleukin-31 receptor subunit alpha,34515,90,1.04 [0.61-1.76],0.8842660421067546
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,40974,103,1.27 [0.86-1.86],0.2296641140128278
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL33,Interleukin-33,40284,100,1.08 [0.69-1.70],0.7354809000334874
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL34,Interleukin-34,40004,101,0.87 [0.54-1.42],0.5877276225631383
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL36A,Interleukin-36 alpha,34646,90,0.91 [0.62-1.33],0.6246785860209733
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL36G,Interleukin-36 gamma,34517,88,0.92 [0.66-1.27],0.6061886719386547
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,40284,100,1.45 [0.85-2.47],0.1701920339436353
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL4,Interleukin-4,40284,100,0.83 [0.72-0.96],0.0122275909203621
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,40974,103,4.27 [3.32-5.50],2.4485066335030857e-29
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL5,Interleukin-5,40284,100,0.82 [0.71-0.96],0.0123803703438089
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,40974,103,0.43 [0.31-0.60],4.450387095017431e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,40826,102,1.19 [0.97-1.45],0.0890090390589564
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,40777,102,1.66 [1.00-2.76],0.0498471643109975
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,41020,104,0.94 [0.35-2.55],0.9013546211688672
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,40974,103,0.51 [0.38-0.67],3.2991172102025208e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,41027,103,0.74 [0.54-1.03],0.0745058517305686
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL9,Interleukin-9,35020,92,0.95 [0.65-1.39],0.7907125617727006
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,40007,100,1.68 [1.39-2.03],9.03909286728931e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,35512,93,1.52 [1.08-2.12],0.0157176046756142
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IMPA1,Inositol monophosphatase 1,40720,102,0.90 [0.67-1.21],0.4871565889866427
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,35608,95,1.23 [0.87-1.75],0.2495365146622026
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IMPG1,Interphotoreceptor matrix proteoglycan 1,34584,91,0.56 [0.26-1.22],0.1471208585858585
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,39988,101,2.14 [1.84-2.49],2.3478704613110865e-23
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INHBB,Inhibin beta B chain,34914,93,1.44 [1.00-2.09],0.0500580608810261
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INHBC,Inhibin beta C chain,41027,103,0.89 [0.58-1.37],0.6019239919405082
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INPP1,Inositol polyphosphate 1-phosphatase,40826,102,1.07 [0.77-1.48],0.6841181116491828
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",34729,89,2.97 [2.25-3.93],1.6316016084991102e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",35624,95,1.08 [0.69-1.69],0.7298430373632252
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40826,102,0.95 [0.79-1.14],0.5614312600010822
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,35608,95,0.87 [0.69-1.10],0.2505411805895231
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,35512,93,0.86 [0.55-1.35],0.5113542120389283
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INSL5,Insulin-like peptide INSL5,35523,94,0.94 [0.77-1.16],0.5804200179161043
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INSR,Insulin receptor,34646,90,5.12 [1.69-15.50],0.0038274157499939
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IPCEF1,Interactor protein for cytohesin exchange factors 1,40651,102,1.01 [0.83-1.23],0.9295494449416474
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IQGAP2,Ras GTPase-activating-like protein IQGAP2,40826,102,0.90 [0.65-1.26],0.5515739508712862
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40294,103,1.55 [1.33-1.79],6.893669883439345e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IRAK1,Interleukin-1 receptor-associated kinase 1,40284,100,1.01 [0.78-1.31],0.9311863414766056
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IRAK4,Interleukin-1 receptor-associated kinase 4,40974,103,0.94 [0.80-1.11],0.4570007492709743
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39480,99,0.76 [0.47-1.22],0.2507332709473799
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,40974,103,1.26 [0.82-1.95],0.2850642669794045
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ISM2,Isthmin-2,35680,94,0.92 [0.57-1.47],0.7146446069601653
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IST1,IST1 homolog,35257,94,0.95 [0.78-1.17],0.650055017856884
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,40974,103,0.62 [0.37-1.03],0.0659250427749227
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGA2,Integrin alpha-2,34914,93,0.64 [0.36-1.15],0.1358251518401045
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,41027,103,2.33 [1.19-4.57],0.0133660611624146
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,40974,103,0.54 [0.36-0.79],0.0016114622000751
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,34646,90,3.66 [2.28-5.87],7.165432002908782e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,41027,103,0.68 [0.39-1.19],0.178789295571646
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGAV,Integrin alpha-V,41393,103,0.42 [0.15-1.18],0.0997691015695871
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,35020,92,0.74 [0.50-1.11],0.147684788316847
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,40977,103,1.16 [0.52-2.61],0.7151708610512084
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGB1BP1,Integrin beta-1-binding protein 1,40089,100,0.83 [0.53-1.28],0.3964594417542956
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGB1BP2,Integrin beta-1-binding protein 2,40294,103,0.99 [0.84-1.16],0.8761230910179052
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,40784,105,1.94 [1.12-3.36],0.0180903272250592
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGB5,Integrin beta-5,41133,105,0.75 [0.47-1.20],0.2333514993548774
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGB6,Integrin beta-6,40284,100,1.01 [0.56-1.82],0.9661382822019826
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,41393,103,1.25 [0.87-1.79],0.2363051451450966
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,35680,94,2.03 [1.30-3.18],0.0018529654892604
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,35728,94,0.81 [0.28-2.34],0.7026524922568997
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,41170,103,1.93 [1.21-3.06],0.005447668422709
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,35728,94,1.15 [0.53-2.49],0.7178972553363024
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,35512,93,0.65 [0.39-1.08],0.0973467640557992
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,40974,103,1.30 [0.98-1.72],0.066616093090829
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITPA,Inosine triphosphate pyrophosphatase,34555,92,1.17 [0.88-1.57],0.2832313417307324
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",34729,89,0.63 [0.44-0.91],0.01293641073388
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",34584,91,0.63 [0.36-1.09],0.1012390745715324
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",40064,101,1.06 [0.75-1.49],0.7330900105380427
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IZUMO1,Izumo sperm-egg fusion protein 1,34427,89,0.93 [0.59-1.48],0.773813765282578
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,41382,103,2.16 [1.18-3.94],0.0120361607172693
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",JAM3,Junctional adhesion molecule C,34914,93,0.89 [0.59-1.34],0.5681629750017034
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,40284,100,0.97 [0.72-1.29],0.8284199126043037
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,34427,89,0.83 [0.56-1.23],0.3471805786930518
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",JPT2,Jupiter microtubule associated homolog 2,35523,94,0.99 [0.79-1.25],0.948540593802736
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,40284,100,1.46 [1.17-1.83],0.0009093119095249
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40826,102,2.07 [1.36-3.15],0.000676763439499
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KAZN,Kazrin,35523,94,0.99 [0.82-1.19],0.9002461271231419
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,34584,91,0.55 [0.33-0.93],0.0246525431633116
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,34720,90,0.59 [0.39-0.90],0.0151278022701078
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KCNIP4,Kv channel-interacting protein 4,40064,101,1.11 [0.81-1.51],0.5303785435183077
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,34929,92,2.26 [1.91-2.67],2.861590852272529e-21
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KDM3A,Lysine-specific demethylase 3A,34646,90,0.93 [0.73-1.20],0.5877073450428383
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,41133,105,1.00 [0.51-1.97],0.9999328394244386
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,40064,101,1.73 [1.07-2.82],0.0261257367597212
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KHDC3L,KH domain-containing protein 3,34427,89,0.83 [0.57-1.20],0.313970056440641
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KHK,Ketohexokinase,34729,89,1.03 [0.75-1.43],0.8483267050011285
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,35608,95,2.12 [1.41-3.18],0.000279350031238
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIAA1549,UPF0606 protein KIAA1549,35020,92,0.94 [0.71-1.25],0.6659217916186646
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIAA1549L,UPF0606 protein KIAA1549L,35020,92,1.04 [0.51-2.11],0.9129068909011964
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIAA2013,Uncharacterized protein KIAA2013,35512,93,0.95 [0.65-1.39],0.7801002728168679
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIF1C,Kinesin-like protein KIF1C,34555,92,1.42 [0.92-2.20],0.1170566738556445
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIF20B,Kinesin-like protein KIF20B,34584,91,1.19 [0.95-1.49],0.1394565957373284
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,34555,92,1.33 [1.12-1.59],0.0013810682077107
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIFBP,KIF-binding protein,40826,102,0.97 [0.79-1.20],0.7893740917310583
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,35512,93,1.43 [1.15-1.78],0.0011827074912099
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,40089,100,1.44 [1.16-1.79],0.0008952176129735
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,35523,94,0.96 [0.85-1.08],0.4782331217930782
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,40089,100,0.90 [0.78-1.04],0.141831260151088
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,34427,89,0.80 [0.58-1.10],0.1709534555139808
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIRREL1,Kin of IRRE-like protein 1,34584,91,0.93 [0.64-1.35],0.6945340960956239
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,40064,101,0.93 [0.59-1.45],0.7435026738536764
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,41111,103,0.45 [0.25-0.81],0.0078787754952159
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KITLG,Kit ligand,41020,104,1.28 [0.79-2.06],0.3092762621975583
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLB,Beta-klotho,40064,101,0.99 [0.78-1.25],0.9010110472840078
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,34584,91,1.78 [1.31-2.43],0.0002231515407221
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLHL41,Kelch-like protein 41,35624,95,0.88 [0.58-1.35],0.5667752006975737
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK1,Kallikrein-1,40607,103,1.02 [0.89-1.16],0.7907836768048806
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,41008,105,0.50 [0.32-0.78],0.0023096252790085
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK11,Kallikrein-11,40726,105,1.32 [0.81-2.14],0.2665048032866529
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK12,Kallikrein-12,40089,100,0.98 [0.86-1.12],0.7549228396236525
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK13,Kallikrein-13,40091,101,0.79 [0.53-1.17],0.2436501079634869
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK14,Kallikrein-14,41393,103,0.78 [0.53-1.13],0.1897596146132924
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK15,Kallikrein-15,35456,93,1.30 [0.89-1.90],0.1798634156190287
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,35680,94,0.98 [0.80-1.20],0.8126250649505073
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,41393,103,1.33 [1.04-1.70],0.0235197475508815
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK6,Kallikrein-6,41069,105,1.34 [0.76-2.35],0.3100870370758181
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,34010,89,0.52 [0.30-0.90],0.020291732757185
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK8,Kallikrein-8,39639,103,1.01 [0.62-1.65],0.9792482362629084
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,35013,92,1.09 [0.49-2.45],0.8318736069299484
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,41488,104,2.56 [1.69-3.88],1.0196904097613478e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,34584,91,1.02 [0.73-1.42],0.9236586059020936
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,41488,104,1.34 [0.92-1.93],0.122960327001472
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLRF1,Killer cell lectin-like receptor subfamily F member 1,34646,90,1.45 [1.08-1.95],0.014833835909664
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,35608,95,1.86 [1.37-2.52],6.170114272761152e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KRT14,"Keratin, type I cytoskeletal 14",38788,98,1.14 [0.64-2.04],0.6530325142807554
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KRT17,"Keratin, type I cytoskeletal 17",34555,92,1.33 [0.87-2.04],0.1935533989845709
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",40826,102,1.17 [0.96-1.44],0.1181532841670181
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",40910,103,1.15 [0.89-1.48],0.2852520044982277
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KRT5,"Keratin, type II cytoskeletal 5",40064,101,0.80 [0.56-1.16],0.2417782343087677
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KRT6C,"Keratin, type II cytoskeletal 6C",34555,92,0.67 [0.36-1.27],0.2227481832413766
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",34584,91,1.08 [0.85-1.36],0.5334631447097915
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,40950,104,1.55 [1.18-2.05],0.0019047926996043
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KYNU,Kynureninase,41488,104,1.54 [1.07-2.21],0.0206724958601344
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,41133,105,6.36 [3.79-10.68],2.437471310409696e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,35674,93,1.06 [0.85-1.32],0.6039044998718748
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LACRT,Extracellular glycoprotein lacritin,35441,93,0.98 [0.65-1.49],0.926933144760976
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LACTB2,Endoribonuclease LACTB2,41020,104,0.97 [0.75-1.27],0.8414926774058598
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,40826,102,2.80 [2.28-3.45],2.40805369112145e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40982,102,2.22 [1.60-3.07],1.5200993913910254e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40720,102,1.10 [0.93-1.31],0.2788191871769304
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAMA1,Laminin subunit alpha-1,34555,92,0.93 [0.62-1.40],0.7214056149000841
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,41181,102,0.57 [0.34-0.99],0.0444792020721265
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,34729,89,0.95 [0.48-1.84],0.8698399391550773
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAMP1,Lysosome-associated membrane glycoprotein 1,34697,90,0.66 [0.27-1.61],0.3637993247373617
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAMP2,Lysosome-associated membrane glycoprotein 2,39773,97,0.64 [0.27-1.53],0.3140417177664858
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,41415,104,1.34 [0.97-1.87],0.0777682911156938
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAMTOR5,Ragulator complex protein LAMTOR5,35512,93,0.97 [0.59-1.59],0.9067228868700448
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAP3,Cytosol aminopeptidase,40284,100,0.99 [0.68-1.44],0.9674342518757878
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LARP1,La-related protein 1,35512,93,1.19 [0.90-1.57],0.2175032533164652
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAT,Linker for activation of T-cells family member 1,41488,104,0.79 [0.64-0.98],0.034379831166419
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAT2,Linker for activation of T-cells family member 2,40826,102,0.92 [0.80-1.06],0.2699414845184034
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LATS1,Serine/threonine-protein kinase LATS1,34646,90,0.98 [0.77-1.25],0.8752310797088592
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,40644,102,2.52 [1.66-3.83],1.396031018383118e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,41170,103,1.27 [0.94-1.70],0.1157365196223862
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LBR,Delta(14)-sterol reductase LBR,41382,103,1.19 [0.95-1.48],0.1287370636186163
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LCAT,Phosphatidylcholine-sterol acyltransferase,35700,95,0.77 [0.32-1.82],0.5475453023255337
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LCN15,Lipocalin-15,35624,95,1.13 [0.85-1.51],0.4069021238224544
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LCN2,Neutrophil gelatinase-associated lipocalin,39791,102,0.88 [0.55-1.41],0.5996723334835071
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LCP1,Plastin-2,35680,94,1.26 [0.85-1.85],0.24910013709853
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,41130,106,0.89 [0.63-1.24],0.4803897416092912
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LDLRAP1,Low density lipoprotein receptor adapter protein 1,35624,95,0.88 [0.72-1.07],0.2039023813961688
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,35674,93,0.65 [0.48-0.89],0.0068786637101748
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,41331,103,0.71 [0.50-0.99],0.0440951314040004
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LEG1,Protein LEG1 homolog,33711,88,0.85 [0.62-1.16],0.297780473458028
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LELP1,Late cornified envelope-like proline-rich protein 1,34584,91,0.96 [0.72-1.29],0.8074664083370056
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LEO1,RNA polymerase-associated protein LEO1,35624,95,1.59 [1.14-2.22],0.0061846155197261
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LEP,Leptin,41020,104,0.70 [0.54-0.89],0.0039627378842142
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LEPR,Leptin receptor,41020,104,1.11 [0.64-1.91],0.7175165259128009
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LETM1,Mitochondrial proton/calcium exchanger protein,35624,95,1.35 [0.98-1.88],0.0692380002126089
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS1,Galectin-1,41020,104,1.47 [0.91-2.37],0.1175273574417685
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS3,Galectin-3,41128,104,1.26 [0.70-2.25],0.4380723837446579
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,35728,94,1.73 [1.03-2.89],0.0365385423397548
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,40982,102,1.12 [0.82-1.53],0.4576419632729657
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS7_LGALS7B,Galectin-7,40950,100,1.04 [0.68-1.58],0.8639684916581805
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS8,Galectin-8,41382,103,1.00 [0.75-1.34],0.9876284932650452
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,40995,102,3.14 [1.94-5.08],3.315056457087687e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGMN,Legumain,41181,102,0.66 [0.40-1.08],0.0969088308595838
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LHB,Lutropin subunit beta,40089,100,0.98 [0.80-1.20],0.8400679802232929
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,41043,102,1.34 [1.02-1.76],0.0359706627626583
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,40064,101,1.17 [0.87-1.58],0.3005143796402834
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,40974,103,1.15 [0.56-2.39],0.7021389144062505
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,41027,103,1.58 [0.95-2.63],0.075478525364846
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,35680,94,0.98 [0.86-1.12],0.7961325858582907
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,34555,92,0.78 [0.50-1.24],0.2933686273729001
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40966,104,1.18 [0.69-2.02],0.545588924421802
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,35674,93,0.95 [0.73-1.24],0.725772999190406
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,41521,106,10.58 [6.22-17.97],2.795853584059172e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,41323,105,3.16 [1.87-5.33],1.5836801949130833e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40284,100,2.39 [1.67-3.42],2.159449337864239e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,41521,106,1.19 [0.92-1.54],0.1821922690381351
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LIPF,Gastric triacylglycerol lipase,34729,89,1.00 [0.72-1.40],0.989411004423998
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,35453,94,1.50 [1.21-1.85],0.000188929918143
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,35608,95,3.05 [1.91-4.87],2.883889094442417e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LMOD1,Leiomodin-1,35624,95,1.47 [0.93-2.34],0.1022911242034703
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LMOD2,Leiomodin-2,34584,91,0.61 [0.41-0.91],0.0143574752179077
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LONP1,"Lon protease homolog, mitochondrial",34729,89,1.15 [0.91-1.44],0.2480088746093435
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LPA,Apolipoprotein(a),34882,92,1.06 [0.95-1.19],0.2781148549231264
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LPCAT2,Lysophosphatidylcholine acyltransferase 2,40826,102,1.08 [0.74-1.57],0.6964991291224689
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LPL,Lipoprotein lipase,41020,104,0.93 [0.65-1.34],0.707798231667219
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LPO,Lactoperoxidase,39677,100,0.89 [0.66-1.20],0.4345821071379969
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LPP,Lipoma-preferred partner,34555,92,0.88 [0.65-1.21],0.4384751089866047
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,34555,92,1.58 [1.24-2.01],0.0001777737775907
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,34720,90,0.61 [0.35-1.08],0.08791341787629
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,35728,94,3.98 [2.21-7.19],4.550987730754636e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,41272,103,1.32 [0.81-2.16],0.2672534886449487
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,34522,89,1.55 [0.87-2.75],0.1356826661843135
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,40826,102,1.01 [0.52-1.96],0.9690438213768768
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,41020,104,1.70 [1.07-2.69],0.0240273846580039
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRP2,Low-density lipoprotein receptor-related protein 2,34720,90,0.82 [0.45-1.49],0.5207088957535777
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRP2BP,LRP2-binding protein,34720,90,0.97 [0.76-1.26],0.8383963788745203
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,41382,103,0.68 [0.45-1.01],0.0532899430984049
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,40826,102,1.71 [1.26-2.32],0.0005654017295412
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,35523,94,6.32 [4.10-9.75],6.713283071708976e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRC38,Leucine-rich repeat-containing protein 38,34720,90,0.91 [0.59-1.41],0.6846358801090164
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRC59,Leucine-rich repeat-containing protein 59,35674,93,1.08 [0.72-1.61],0.7221792971134653
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,35512,93,1.38 [0.95-2.00],0.0917556699735579
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRN1,Leucine-rich repeat neuronal protein 1,40284,100,1.44 [0.91-2.27],0.1189509069398538
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,34720,90,1.00 [0.62-1.64],0.986187393960886
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,35624,95,1.68 [0.89-3.15],0.1092713295812099
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LSM1,U6 snRNA-associated Sm-like protein LSm1,40089,100,0.57 [0.38-0.85],0.0062501572959033
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LSM8,U6 snRNA-associated Sm-like protein LSm8,35020,92,0.88 [0.67-1.16],0.3612950866448399
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,40974,103,5.76 [4.36-7.60],5.350891873137634e-35
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,40974,103,3.06 [2.63-3.57],3.4575514192029926e-47
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTA4H,Leukotriene A-4 hydrolase,41393,103,1.06 [0.79-1.42],0.7177312917639629
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,35512,93,1.65 [1.19-2.29],0.0025599043658666
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,41521,106,2.04 [1.22-3.44],0.0069446311842633
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,40089,100,1.45 [1.14-1.85],0.0025559646171606
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,40788,102,2.29 [1.33-3.93],0.002655881114901
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTO1,Protein LTO1 homolog,40284,100,0.89 [0.56-1.41],0.6191616080314687
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LUZP2,Leucine zipper protein 2,35512,93,1.43 [1.01-2.03],0.0460377703382576
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LXN,Latexin,40534,102,1.10 [0.86-1.41],0.4341039344443079
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,40794,101,1.17 [0.74-1.84],0.5060464594592164
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,40974,103,5.30 [3.24-8.67],3.2486601765396694e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,40572,102,28.44 [21.04-38.44],3.9775944796746935e-105
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,40720,102,0.38 [0.22-0.63],0.0002382577738251
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,40089,100,1.73 [1.53-1.94],2.012253859128192e-19
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYN,Tyrosine-protein kinase Lyn,40826,102,0.96 [0.78-1.18],0.7089783908670412
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,40064,101,0.54 [0.33-0.86],0.0099982660855307
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,40806,105,1.93 [1.22-3.06],0.0048978120449128
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,40089,100,1.50 [1.24-1.81],2.093807415460797e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYPLA2,Acyl-protein thioesterase 2,34584,91,1.00 [0.83-1.21],0.9896973753266628
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,34720,90,1.00 [0.82-1.22],0.9977561210195616
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,35728,94,1.03 [0.38-2.83],0.9475519473602916
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,34427,89,0.63 [0.34-1.19],0.1550018096729875
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LZTFL1,Leucine zipper transcription factor-like protein 1,34914,93,1.05 [0.79-1.39],0.7341515537902602
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",M6PR,Cation-dependent mannose-6-phosphate receptor,34729,89,1.15 [0.72-1.84],0.5517973015625277
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40579,102,1.90 [1.63-2.21],1.5381932097635042e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAEA,E3 ubiquitin-protein transferase MAEA,40089,100,1.12 [0.72-1.73],0.6199844369892462
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAG,Myelin-associated glycoprotein,34720,90,1.02 [0.67-1.56],0.9163333911318836
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAGEA3,Melanoma-associated antigen 3,35020,92,0.92 [0.74-1.15],0.4592094450017955
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,40089,100,1.54 [1.13-2.08],0.0055748908616621
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,35674,93,1.77 [1.03-3.03],0.0377371005035689
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAMDC4,Apical endosomal glycoprotein,35512,93,1.03 [0.72-1.48],0.8572579198561181
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",34729,89,10.60 [5.04-22.29],4.800048808682332e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAN2B2,Epididymis-specific alpha-mannosidase,35674,93,0.89 [0.64-1.24],0.5031136173815094
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",34427,89,0.91 [0.60-1.37],0.654195347468296
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MANF,Mesencephalic astrocyte-derived neurotrophic factor,41181,102,0.91 [0.79-1.04],0.1602506270109161
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MANSC1,MANSC domain-containing protein 1,41133,105,0.79 [0.42-1.49],0.468425120693939
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MANSC4,MANSC domain-containing protein 4,34555,92,1.11 [0.83-1.48],0.4724592750125149
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,34584,91,0.94 [0.50-1.78],0.8595056082922105
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,34555,92,0.82 [0.56-1.21],0.3251483213663066
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,35608,95,2.73 [2.21-3.38],9.278902524494682e-21
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,35523,94,1.18 [0.87-1.60],0.2983574814335688
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40974,103,0.94 [0.79-1.12],0.4776308385310885
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,40089,100,1.16 [0.97-1.37],0.1009981143096516
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40644,102,0.95 [0.81-1.11],0.5448102207014411
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,34427,89,1.81 [1.40-2.33],4.7598424766418e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAPK9,Mitogen-activated protein kinase 9,40974,103,1.02 [0.68-1.53],0.9183533468582188
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAPKAPK2,MAP kinase-activated protein kinase 2,35020,92,0.99 [0.75-1.30],0.9352168141197836
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAPRE3,Microtubule-associated protein RP/EB family member 3,34427,89,0.96 [0.83-1.12],0.6108481211656711
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAPT,Microtubule-associated protein tau,40064,101,0.89 [0.64-1.22],0.4625817963198821
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,41020,104,4.43 [2.36-8.32],3.81183522843546e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MARS1,"Methionine--tRNA ligase, cytoplasmic",34844,93,1.05 [0.83-1.32],0.7046051976130188
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MASP1,Mannan-binding lectin serine protease 1,40644,102,0.77 [0.37-1.63],0.4987200288695123
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,41054,102,1.10 [0.60-1.99],0.7632756700604755
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MATN3,Matrilin-3,40651,102,0.53 [0.31-0.91],0.0206625154372425
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAVS,Mitochondrial antiviral-signaling protein,40089,100,0.98 [0.81-1.20],0.8563751803736342
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAX,Protein max,40064,101,0.91 [0.77-1.08],0.265043365716346
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,41521,106,1.19 [0.88-1.61],0.2521815511539315
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MBL2,Mannose-binding protein C,35225,92,1.02 [0.84-1.22],0.8714771033372981
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,41170,103,1.80 [1.10-2.94],0.0187771135552256
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",35624,95,0.85 [0.51-1.40],0.5226089576798133
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MCEMP1,Mast cell-expressed membrane protein 1,34646,90,0.90 [0.71-1.13],0.355849874369458
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MCFD2,Multiple coagulation factor deficiency protein 2,40826,104,0.89 [0.60-1.33],0.5733744239269727
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MCTS1,Malignant T-cell-amplified sequence 1,35523,94,0.83 [0.37-1.83],0.6382869962067612
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40720,102,1.07 [0.83-1.37],0.6212435893488986
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MDH1,"Malate dehydrogenase, cytoplasmic",35495,93,1.38 [0.87-2.19],0.1647203559862367
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MDK,Midkine,41011,105,0.77 [0.54-1.11],0.1610689035752284
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MDM1,Nuclear protein MDM1,34720,90,0.76 [0.39-1.48],0.4183751097004393
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",34729,89,1.12 [0.90-1.40],0.3041054684258681
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MED18,Mediator of RNA polymerase II transcription subunit 18,40089,100,0.91 [0.72-1.15],0.4371834909023868
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MED21,Mediator of RNA polymerase II transcription subunit 21,34555,92,0.88 [0.56-1.38],0.5907213659470597
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MEGF10,Multiple epidermal growth factor-like domains protein 10,40982,102,0.78 [0.50-1.22],0.2838813084484165
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MEGF11,Multiple epidermal growth factor-like domains protein 11,34555,92,1.08 [0.60-1.93],0.7987836478807743
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,41393,106,1.14 [0.48-2.70],0.7727632756666788
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,35674,93,0.81 [0.42-1.59],0.5457401922564278
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,34914,93,0.59 [0.25-1.38],0.2223640923748662
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MEP1A,Meprin A subunit alpha,35523,94,0.82 [0.62-1.09],0.1698195006245676
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MEP1B,Meprin A subunit beta,41020,104,0.93 [0.81-1.08],0.3456882748801413
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,40982,102,1.23 [0.60-2.55],0.570146729364635
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,41488,104,2.16 [1.11-4.21],0.0233407966596223
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MESD,LRP chaperone MESD,41027,103,0.93 [0.80-1.07],0.3082501643114485
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MET,Hepatocyte growth factor receptor,41124,105,1.09 [0.46-2.62],0.842969475930938
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",METAP1,Methionine aminopeptidase 1,40064,101,0.81 [0.43-1.51],0.5104685578236623
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40974,103,0.92 [0.74-1.14],0.4486138173161329
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",METAP2,Methionine aminopeptidase 2,41331,103,1.17 [0.86-1.61],0.3132043929367774
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MFAP3,Microfibril-associated glycoprotein 3,40294,103,0.93 [0.63-1.35],0.6909071857068407
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MFAP3L,Microfibrillar-associated protein 3-like,34720,90,0.85 [0.60-1.23],0.3925985719203315
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,34914,93,1.36 [0.73-2.52],0.329720179166579
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,41521,106,0.88 [0.57-1.34],0.5382300410346231
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MFGE8,Lactadherin,41027,103,0.79 [0.53-1.18],0.2436842881586279
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MGLL,Monoglyceride lipase,41121,102,0.84 [0.69-1.01],0.0661691769095689
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MGMT,Methylated-DNA--protein-cysteine methyltransferase,40974,103,1.04 [0.90-1.20],0.6383720906766106
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MIA,Melanoma-derived growth regulatory protein,41133,105,1.11 [0.70-1.76],0.6618727237181288
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MICALL2,MICAL-like protein 2,34720,90,0.96 [0.71-1.30],0.8063805393370067
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40974,103,0.99 [0.88-1.11],0.8579341028726604
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MIF,Macrophage migration inhibitory factor,40962,103,1.11 [0.85-1.44],0.443037679201389
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,40284,100,1.89 [1.38-2.59],7.374598615677932e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,35512,93,0.92 [0.76-1.10],0.3459958022633229
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MINK1,Misshapen-like kinase 1,35608,95,0.94 [0.76-1.16],0.5503363988002914
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MITD1,MIT domain-containing protein 1,40720,102,0.99 [0.83-1.19],0.9355726887574244
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MKI67,Proliferation marker protein Ki-67,34646,90,1.26 [0.83-1.91],0.2729622583916453
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MLLT1,Protein ENL,34427,89,1.11 [0.84-1.47],0.4499531611524794
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MLN,Promotilin,40974,103,1.01 [0.83-1.23],0.910007248463077
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,40826,102,1.01 [0.81-1.26],0.9159778221340928
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP1,Interstitial collagenase,39539,99,0.97 [0.80-1.18],0.7392338136336611
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP10,Stromelysin-2,40926,100,0.98 [0.72-1.33],0.8805770820084989
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,41082,102,1.28 [0.93-1.76],0.1247639124021884
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,40064,101,0.69 [0.40-1.19],0.1791173811850686
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,35674,93,1.02 [0.69-1.51],0.9205762205460862
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,41027,103,1.21 [0.86-1.71],0.2742779054675427
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,40229,103,1.27 [0.88-1.84],0.2025582830181441
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP8,Neutrophil collagenase,41312,103,1.18 [0.93-1.48],0.172532083362414
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP9,Matrix metalloproteinase-9,40964,101,1.26 [0.94-1.69],0.1197157261342251
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",34555,92,0.87 [0.57-1.32],0.5115290148374365
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MN1,Transcriptional activator MN1,34720,90,0.68 [0.44-1.04],0.0758383225557841
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MNAT1,CDK-activating kinase assembly factor MAT1,35020,92,1.42 [1.01-1.99],0.0428186803384121
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MNDA,Myeloid cell nuclear differentiation antigen,40956,104,1.01 [0.86-1.20],0.8662821915364416
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MOCS2,Molybdopterin synthase catalytic subunit,34914,93,1.19 [0.88-1.59],0.2581305800376891
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MOG,Myelin-oligodendrocyte glycoprotein,41393,103,1.46 [0.87-2.44],0.1564072592981174
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,35608,95,2.94 [2.21-3.91],1.1375539170895668e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MORF4L1,Mortality factor 4-like protein 1,35020,92,1.35 [0.93-1.95],0.1136584905261553
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MORF4L2,Mortality factor 4-like protein 2,34427,89,1.59 [1.06-2.40],0.0254326435979131
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MORN4,MORN repeat-containing protein 4,34427,89,1.09 [0.86-1.37],0.4891234568948679
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MPHOSPH8,M-phase phosphoprotein 8,40294,103,1.26 [1.01-1.56],0.0369053902601556
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MPI,Mannose-6-phosphate isomerase,40826,102,1.12 [0.92-1.37],0.2689960581534145
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,41121,102,0.85 [0.69-1.06],0.1440467619629522
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,41027,103,1.06 [0.74-1.54],0.7460013951042128
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MPRIP,Myosin phosphatase Rho-interacting protein,35442,93,0.77 [0.48-1.22],0.2609466127996251
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,35700,95,2.40 [1.26-4.58],0.0078902409773753
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MRI1,Methylthioribose-1-phosphate isomerase,34720,90,1.25 [0.92-1.71],0.1576437297759203
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MRPL24,"39S ribosomal protein L24, mitochondrial",34555,92,0.87 [0.49-1.53],0.6253521416624561
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MRPL28,"39S ribosomal protein L28, mitochondrial",35624,95,0.96 [0.55-1.66],0.8706914004230669
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",40064,101,0.66 [0.33-1.32],0.2407327581725238
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MRPL52,"39S ribosomal protein L52, mitochondrial",34361,89,0.82 [0.37-1.85],0.6360258566810563
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",35624,95,0.83 [0.60-1.14],0.2431010898008549
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MRPS16,"28S ribosomal protein S16, mitochondrial",34646,90,0.90 [0.43-1.88],0.7854061650095417
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MSLN,Mesothelin,40765,102,1.32 [0.99-1.76],0.0592834530156429
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MSLNL,Mesothelin-like protein,34720,90,0.89 [0.51-1.56],0.6782051592274572
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,40911,101,0.99 [0.77-1.27],0.934446030260771
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,41382,103,1.38 [0.94-2.02],0.0995918537971034
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MSRA,Mitochondrial peptide methionine sulfoxide reductase,41133,105,0.86 [0.68-1.10],0.2338020444285526
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MST1,Hepatocyte growth factor-like protein,35159,93,0.91 [0.71-1.17],0.4588458360520784
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MSTN,Growth/differentiation factor 8,40294,103,0.88 [0.63-1.23],0.4607662316388312
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,34646,90,1.30 [1.05-1.60],0.0163628341346142
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",35608,95,1.00 [0.46-2.17],0.994390800192152
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,35020,92,1.06 [0.89-1.26],0.5396121960111908
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTIF3,"Translation initiation factor IF-3, mitochondrial",35523,94,0.87 [0.69-1.10],0.2389136769148786
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTPN,Myotrophin,40294,103,1.03 [0.61-1.74],0.905861986610254
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTR,Methionine synthase,34555,92,1.06 [0.80-1.41],0.6826299752322591
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTSS1,Protein MTSS 1,35523,94,1.10 [0.93-1.32],0.2685624391244336
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTSS2,Protein MTSS 2,35512,93,0.92 [0.75-1.13],0.4312896726965225
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,35020,92,1.01 [0.71-1.45],0.9569290739394672
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,40064,101,1.00 [0.71-1.41],0.9973934454911108
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MUC16,Mucin-16,40826,102,1.01 [0.92-1.10],0.8913133564897331
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MUC2,Mucin-2,35680,94,0.85 [0.69-1.06],0.1494680391974186
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MUCL3,Mucin-like protein 3,34427,89,0.80 [0.46-1.40],0.4368595164280613
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MVK,Mevalonate kinase,40284,100,1.11 [0.89-1.37],0.3647180123483513
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MXRA8,Matrix remodeling-associated protein 8,34914,93,0.89 [0.47-1.71],0.7349756287344422
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYBPC1,"Myosin-binding protein C, slow-type",35674,93,1.11 [0.85-1.44],0.4376794518291884
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYBPC2,"Myosin-binding protein C, fast-type",34729,89,1.16 [0.95-1.43],0.150942554486926
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,35624,95,1.67 [1.38-2.03],2.2604028548509014e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYDGF,Myeloid-derived growth factor,35674,93,0.94 [0.77-1.15],0.5637515405174054
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYH4,Myosin-4,34555,92,0.82 [0.50-1.34],0.4293849547039571
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,34427,89,0.53 [0.29-0.97],0.0404790983743054
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYH9,Myosin-9,35680,94,1.05 [0.88-1.24],0.6086334466267725
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",34555,92,1.01 [0.61-1.68],0.9722096286268588
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYL3,Myosin light chain 3,34729,89,1.10 [0.84-1.44],0.5086812079305288
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYL4,Myosin light chain 4,34729,89,1.43 [1.05-1.94],0.0226243387315212
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYL6B,Myosin light chain 6B,34720,90,0.93 [0.74-1.18],0.5638990139746916
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",34720,90,0.81 [0.51-1.28],0.3611208394682944
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYO6,Unconventional myosin-VI,35624,95,1.12 [0.69-1.82],0.6365764991755347
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYO9B,Unconventional myosin-IXb,40284,100,1.09 [0.84-1.41],0.5164522687938684
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYOC,Myocilin,41027,103,0.76 [0.52-1.11],0.1506452142950154
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYOM1,Myomesin-1,34584,91,0.57 [0.32-1.01],0.0524827899415061
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYOM2,Myomesin-2,34555,92,0.78 [0.51-1.19],0.2536332481564168
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYOM3,Myomesin-3,34914,93,0.99 [0.80-1.23],0.9464794084635356
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,41114,102,0.60 [0.42-0.85],0.0046016836331246
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MZT1,Mitotic-spindle organizing protein 1,40089,100,0.92 [0.64-1.31],0.6388604991679308
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAA10,N-alpha-acetyltransferase 10,34555,92,0.92 [0.62-1.37],0.6811052881765447
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAA80,N-alpha-acetyltransferase 80,34720,90,0.96 [0.81-1.13],0.5960811463499014
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,40535,102,1.17 [0.88-1.56],0.2694096617627134
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,35512,93,1.77 [1.38-2.25],5.134649500862701e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NADK,NAD kinase,41020,104,1.07 [0.80-1.44],0.6423058620051885
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAGA,Alpha-N-acetylgalactosaminidase,34580,90,1.02 [0.72-1.44],0.9007312772525384
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,34664,89,1.98 [1.45-2.71],2.0199898950289283e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,34914,93,6.02 [2.88-12.59],1.8237015741183409e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAMPT,Nicotinamide phosphoribosyltransferase,40089,100,0.95 [0.67-1.34],0.7540662540474216
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAP1L4,Nucleosome assembly protein 1-like 4,35457,94,1.66 [1.00-2.75],0.0498765550633745
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAPRT,Nicotinate phosphoribosyltransferase,35608,95,1.49 [0.90-2.47],0.1174742903565564
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NARS1,"Asparagine--tRNA ligase, cytoplasmic",35624,95,1.27 [0.83-1.95],0.2623119743309197
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,41133,105,1.54 [0.82-2.92],0.1823730327625984
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,40284,100,2.03 [1.81-2.27],4.6959252365137265e-34
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCAM1,Neural cell adhesion molecule 1,41170,103,1.29 [0.74-2.23],0.3685024330016349
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCAM2,Neural cell adhesion molecule 2,41027,103,1.32 [0.70-2.49],0.399305416775267
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCAN,Neurocan core protein,41382,103,1.38 [0.87-2.20],0.1761534866254597
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCF2,Neutrophil cytosol factor 2,40907,103,1.03 [0.84-1.26],0.7861766803065614
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCK2,Cytoplasmic protein NCK2,41181,102,0.88 [0.75-1.04],0.1328662220647309
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCLN,Nicalin,40284,100,1.00 [0.71-1.42],0.9824436183963448
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,40915,102,1.05 [0.66-1.68],0.8373922096823923
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,35523,94,1.92 [1.12-3.28],0.0175869225819161
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,41393,103,1.00 [0.54-1.86],0.9958958667948352
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NDRG1,Protein NDRG1,40064,101,1.06 [0.82-1.36],0.6649516887515622
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,35512,93,0.84 [0.58-1.22],0.3657447930307311
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,34583,90,1.22 [0.70-2.13],0.483524531053779
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,35523,94,0.82 [0.66-1.03],0.0947830340710795
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",40089,100,0.84 [0.64-1.09],0.1834528171290849
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NEB,Nebulin,34555,92,1.02 [0.60-1.72],0.9521991135089906
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NECAP2,Adaptin ear-binding coat-associated protein 2,34555,92,0.75 [0.53-1.05],0.0973608857081785
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NECTIN1,Nectin-1,34646,90,1.58 [1.00-2.51],0.0487895198704077
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,40966,104,2.11 [1.25-3.57],0.0053602483612216
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,41133,105,1.31 [0.77-2.22],0.3236112207613868
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,34646,90,1.11 [0.72-1.70],0.6380915349693853
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,34646,90,1.47 [0.93-2.33],0.097734794556234
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,39933,101,1.31 [0.90-1.90],0.1541679294755172
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NEK7,Serine/threonine-protein kinase Nek7,35020,92,0.86 [0.64-1.17],0.3475238033136437
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,41133,105,0.57 [0.38-0.85],0.0061474840964825
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,41181,102,1.67 [0.93-2.97],0.083255538702738
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NENF,Neudesin,35512,93,0.97 [0.81-1.16],0.7265578190850277
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NEO1,Neogenin,35624,95,1.38 [0.64-2.99],0.4106897774281736
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NEXN,Nexilin,35700,95,0.85 [0.63-1.15],0.2894459807190001
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,41488,104,1.20 [0.65-2.20],0.5557449599825175
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFAT5,Nuclear factor of activated T-cells 5,34646,90,1.08 [0.85-1.35],0.5348941739161412
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40974,103,1.28 [1.07-1.52],0.0056146372990862
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40284,100,0.98 [0.72-1.32],0.8716823032781406
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFE2,Transcription factor NF-E2 45 kDa subunit,34729,89,0.98 [0.74-1.30],0.9051968175599526
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFIC,Nuclear factor 1 C-type,35624,95,1.11 [0.76-1.63],0.5730480848037911
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,34555,92,1.64 [1.26-2.13],0.0001998114629306
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFKB2,Nuclear factor NF-kappa-B p100 subunit,35020,92,0.97 [0.66-1.40],0.8561104722085116
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,40089,100,3.11 [2.53-3.83],3.811535056893583e-27
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",35523,94,0.99 [0.82-1.20],0.9111314154685256
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFX1,Transcriptional repressor NF-X1,34555,92,1.20 [0.91-1.59],0.2003195426975865
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,34555,92,1.53 [1.25-1.88],5.108860624671013e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NGF,Beta-nerve growth factor,40720,102,1.01 [0.25-4.15],0.9900735168302012
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NGFR,Tumor necrosis factor receptor superfamily member 16,35674,93,1.04 [0.53-2.02],0.9157897496120556
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,35608,95,2.49 [1.46-4.26],0.0007979879310712
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,34065,88,3.99 [2.05-7.77],4.8034855033260375e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NID1,Nidogen-1,41038,102,0.78 [0.49-1.26],0.3167860290622113
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NID2,Nidogen-2,41027,103,0.89 [0.71-1.13],0.3500058176112585
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NINJ1,Ninjurin-1,40089,100,1.09 [0.81-1.47],0.5703880261108474
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NIT1,Deaminated glutathione amidase,34729,89,1.32 [0.83-2.10],0.2432756678346746
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NIT2,Omega-amidase NIT2,35544,92,1.09 [0.83-1.43],0.5360252649425137
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NLGN1,Neuroligin-1,34720,90,0.69 [0.46-1.05],0.0814588902572569
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NLGN2,Neuroligin-2,34584,91,0.55 [0.31-0.98],0.0413363672290597
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NME1,Nucleoside diphosphate kinase A,34646,90,1.03 [0.40-2.64],0.9568296914117064
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NME3,Nucleoside diphosphate kinase 3,41054,102,0.70 [0.32-1.55],0.378555322945005
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,35375,93,1.10 [0.84-1.44],0.5009527998061597
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40720,102,1.82 [1.65-2.02],2.108734548497929e-31
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NMRK2,Nicotinamide riboside kinase 2,34427,89,1.29 [0.86-1.94],0.2117812622471353
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,35624,95,1.02 [0.77-1.37],0.8778432725217532
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,41027,103,1.80 [0.87-3.69],0.1113564357712443
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOP56,Nucleolar protein 56,34555,92,0.77 [0.60-0.99],0.0408854532019199
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",40064,101,1.04 [0.75-1.42],0.8307786880095712
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOS2,"Nitric oxide synthase, inducible",34555,92,0.68 [0.39-1.19],0.1746376443780036
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",40064,101,1.62 [1.30-2.01],1.273536288548213e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,41521,106,33.45 [17.38-64.37],7.95044603737717e-26
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOTCH2,Neurogenic locus notch homolog protein 2,35680,94,1.36 [0.56-3.31],0.4955016159916321
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,41521,106,1.33 [0.80-2.22],0.2684937470357074
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,35079,89,2.69 [1.82-3.96],6.073828159585229e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,41020,104,2.03 [1.28-3.20],0.0024044066367181
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPHS1,Nephrin,34646,90,0.67 [0.36-1.27],0.2203931865273616
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPHS2,Podocin,34646,90,0.92 [0.75-1.14],0.4615320555715567
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPL,N-acetylneuraminate lyase,35674,93,1.24 [0.81-1.90],0.3167584532081289
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,40294,103,1.09 [0.96-1.24],0.1827170937666218
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,40974,103,0.93 [0.65-1.33],0.6819571269276911
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPR1,Atrial natriuretic peptide receptor 1,34555,92,0.72 [0.40-1.27],0.2516119602857428
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPTN,Neuroplastin,40089,100,0.71 [0.52-0.97],0.0306214222003371
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,41027,103,0.86 [0.56-1.34],0.5075406672793192
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,35680,94,0.49 [0.28-0.88],0.0175582311729743
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPTXR,Neuronal pentraxin receptor,41020,104,0.92 [0.55-1.54],0.7624155770509419
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPY,Pro-neuropeptide Y,41393,103,0.81 [0.62-1.05],0.1086216807039041
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,41020,104,4.83 [2.93-7.96],6.30524632863716e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRGN,Neurogranin,35700,95,0.90 [0.73-1.12],0.3502986249909364
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRN1,Neuritin,35624,95,0.70 [0.36-1.37],0.29945802932511
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,41246,103,1.67 [0.90-3.10],0.1065985757547597
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,41027,103,2.33 [1.39-3.90],0.001300560423367
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRTN,Neurturin,40284,100,0.75 [0.51-1.09],0.1340971877036568
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRXN3,Neurexin-3,34720,90,0.62 [0.31-1.26],0.186740266987854
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NSFL1C,NSFL1 cofactor p47,41382,103,1.13 [0.86-1.47],0.3769266643097397
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",35674,93,1.20 [0.92-1.57],0.186871832042046
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,35608,95,1.74 [1.16-2.62],0.007864306701922
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NT5C3A,Cytosolic 5'-nucleotidase 3A,40906,102,0.95 [0.78-1.16],0.6160849643169672
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,41133,105,0.92 [0.67-1.27],0.6037439960399194
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NTF3,Neurotrophin-3,40974,103,0.81 [0.49-1.34],0.407692130173917
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NTF4,Neurotrophin-4,40089,100,0.63 [0.34-1.15],0.1308260962424433
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NTRK2,BDNF/NT-3 growth factors receptor,41020,104,0.80 [0.40-1.58],0.5165675763178394
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,41382,103,0.90 [0.40-2.01],0.7956060867444639
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,41020,104,1.15 [0.99-1.33],0.0693034036805633
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUB1,NEDD8 ultimate buster 1,40974,103,1.12 [0.91-1.37],0.2805885195135024
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,35512,93,1.04 [0.86-1.26],0.6872980610010355
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUCB2,Nucleobindin-2,41324,103,0.73 [0.45-1.19],0.2067885651855575
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUDC,Nuclear migration protein nudC,41488,104,1.04 [0.79-1.37],0.7622461518151484
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,34729,89,1.35 [0.71-2.59],0.3627137052210081
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,34555,92,0.96 [0.64-1.44],0.840667513259342
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUDT16,U8 snoRNA-decapping enzyme,35462,94,0.91 [0.72-1.15],0.4250086069668681
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40826,102,0.76 [0.55-1.05],0.0969843314949317
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUDT5,ADP-sugar pyrophosphatase,41027,103,1.21 [0.86-1.69],0.2757823565422153
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUMB,Protein numb homolog,34646,90,0.96 [0.75-1.22],0.7338475471041527
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,34555,92,1.38 [0.86-2.22],0.1776143544836912
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NXPE4,NXPE family member 4,34555,92,0.75 [0.38-1.49],0.40980972744148
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NXPH1,Neurexophilin-1,40064,101,0.79 [0.49-1.28],0.3395477350895098
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NXPH3,Neurexophilin-3,34646,90,0.68 [0.35-1.31],0.2427084721842556
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,40591,102,0.77 [0.58-1.02],0.0716941374585845
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,35624,95,1.96 [1.37-2.80],0.0002145911724108
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ODAM,Odontogenic ameloblast-associated protein,40004,101,1.01 [0.73-1.39],0.965216103568943
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,35020,92,1.08 [0.81-1.44],0.5897207560324511
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OGA,Protein O-GlcNAcase,35523,94,1.38 [1.05-1.81],0.0215586389518014
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,40826,102,3.79 [2.48-5.79],7.10562489097354e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,41027,103,1.19 [0.79-1.79],0.4171731528164246
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,35020,92,0.84 [0.58-1.20],0.3277010043797653
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OLFM4,Olfactomedin-4,33599,89,0.87 [0.74-1.02],0.0924046562903537
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OLR1,Oxidized low-density lipoprotein receptor 1,40620,104,1.01 [0.75-1.35],0.9567867221941916
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,41181,102,0.88 [0.58-1.33],0.5444742640778868
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,40826,102,0.96 [0.74-1.24],0.7574387486879717
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OMP,Olfactory marker protein,34584,91,0.87 [0.56-1.36],0.5427891396420441
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OPHN1,Oligophrenin-1,35608,95,0.95 [0.79-1.14],0.5769412133728642
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OPLAH,5-oxoprolinase,34729,89,1.16 [0.87-1.55],0.3248411921034356
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,40826,102,0.69 [0.45-1.05],0.0854572882125084
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,35599,94,2.67 [1.07-6.63],0.0344534105793858
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OSBPL2,Oxysterol-binding protein-related protein 2,35608,95,0.66 [0.34-1.26],0.2056025009232312
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,41054,102,1.36 [0.81-2.28],0.2414672119253707
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OSM,Oncostatin-M,40778,103,1.17 [0.91-1.50],0.2148118380036595
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,41246,103,1.84 [0.77-4.35],0.1678772274755478
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OSTN,Osteocrin,34720,90,0.75 [0.42-1.34],0.327608432138933
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OTOA,Otoancorin,34584,91,0.49 [0.28-0.85],0.0106611429060469
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OTUD6B,Deubiquitinase OTUD6B,35523,94,0.93 [0.66-1.31],0.6730755821978256
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OTUD7B,OTU domain-containing protein 7B,35624,95,0.99 [0.72-1.35],0.933892553132226
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",34729,89,1.08 [0.81-1.45],0.5966458542512386
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OXT,Oxytocin-neurophysin 1,41382,103,0.94 [0.83-1.06],0.292211612168514
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",P4HB,Protein disulfide-isomerase,40806,104,0.74 [0.47-1.16],0.1893974659102608
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PACS2,Phosphofurin acidic cluster sorting protein 2,34555,92,0.95 [0.68-1.32],0.7711425380833965
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PADI2,Protein-arginine deiminase type-2,40284,100,0.70 [0.47-1.05],0.0832454630290953
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PADI4,Protein-arginine deiminase type-4,40004,101,0.92 [0.72-1.19],0.5291484917809876
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,40720,102,1.14 [0.99-1.31],0.0666794985244332
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,35624,95,0.97 [0.82-1.15],0.7368032331670948
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",35020,92,0.93 [0.61-1.40],0.7186935177625258
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40294,103,1.29 [0.96-1.72],0.0871093154326359
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,34729,89,1.48 [1.01-2.18],0.0447631824186116
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,34362,89,1.30 [0.93-1.83],0.1271141115748492
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAK4,Serine/threonine-protein kinase PAK 4,40064,101,0.74 [0.54-1.02],0.0639307569228083
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PALLD,Palladin,34646,90,0.78 [0.43-1.42],0.4210057881890727
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,35323,94,1.68 [0.94-2.99],0.0778104034980071
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,35608,95,1.62 [1.02-2.58],0.0389933172794178
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PALM3,Paralemmin-3,34555,92,1.10 [0.88-1.38],0.4089374095725482
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,41310,105,1.43 [0.75-2.71],0.27318518535899
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,41027,103,0.46 [0.24-0.86],0.0159631294276998
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,40284,100,0.95 [0.65-1.39],0.8043314155042862
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PARD3,Partitioning defective 3 homolog,35020,92,0.84 [0.62-1.13],0.2542508976821188
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PARK7,Parkinson disease protein 7,41027,103,1.09 [0.78-1.53],0.6062768169385875
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,40974,103,1.86 [1.70-2.04],1.107790045021219e-38
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAXX,Protein PAXX,34914,93,1.30 [0.86-1.96],0.219109518678047
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PBK,Lymphokine-activated killer T-cell-originated protein kinase,34427,89,1.33 [0.69-2.54],0.3937802151157614
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PBLD,Phenazine biosynthesis-like domain-containing protein,40064,101,1.08 [0.76-1.52],0.6798234276092363
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,35523,94,1.81 [1.12-2.93],0.0154470829776541
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCARE,Photoreceptor cilium actin regulator,34584,91,0.80 [0.59-1.09],0.1511681296142012
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,34840,93,1.50 [1.03-2.19],0.0347463790478668
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCBP2,Poly(rC)-binding protein 2,35624,95,1.09 [0.83-1.43],0.5261213009803232
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCDH1,Protocadherin-1,41353,104,1.25 [0.57-2.72],0.5736501269680183
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,35624,95,1.72 [0.82-3.58],0.1510764164136291
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,41020,104,2.01 [1.28-3.14],0.0022992321700445
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCDH7,Protocadherin-7,35523,94,0.65 [0.34-1.26],0.2037617036610506
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,35523,94,5.95 [3.85-9.18],8.080914507012562e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCDHB15,Protocadherin beta-15,35512,93,1.41 [0.90-2.22],0.1348954082587095
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCNA,Proliferating cell nuclear antigen,34427,89,0.79 [0.53-1.17],0.2373192510412174
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCSK7,Proprotein convertase subtilisin/kexin type 7,35512,93,1.24 [0.87-1.78],0.2376657260813983
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCSK9,Proprotein convertase subtilisin/kexin type 9,41521,106,1.22 [0.80-1.88],0.3512367824033136
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCYT2,Ethanolamine-phosphate cytidylyltransferase,35523,94,1.04 [0.80-1.36],0.7449485413013011
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDAP1,28 kDa heat- and acid-stable phosphoprotein,35674,93,0.94 [0.76-1.15],0.5341293059614047
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,41329,103,4.12 [3.49-4.88],9.412012335252954e-62
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,40826,102,1.70 [1.00-2.89],0.048278888840104
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDCD5,Programmed cell death protein 5,41382,103,1.16 [0.87-1.56],0.3152505181383693
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDCD6,Programmed cell death protein 6,41020,104,1.06 [0.82-1.38],0.6591120995651352
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDCL2,Phosducin-like protein 2,34427,89,1.25 [0.91-1.70],0.1643943242323439
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",34427,89,0.62 [0.37-1.05],0.0744038404792949
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",34555,92,0.96 [0.68-1.36],0.8107998802159204
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",34914,93,0.93 [0.77-1.12],0.4467473561843078
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,41521,106,0.73 [0.58-0.92],0.0067585329189574
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,41181,102,0.74 [0.60-0.89],0.0021360835108718
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,40089,100,0.90 [0.47-1.71],0.7409584747534206
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,41020,104,1.53 [0.84-2.78],0.1650612969620183
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDGFRB,Platelet-derived growth factor receptor beta,41521,106,1.38 [0.84-2.28],0.2082430262726987
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDIA2,Protein disulfide-isomerase A2,34427,89,0.89 [0.52-1.51],0.6526221230745839
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,34914,93,0.81 [0.35-1.86],0.6219803340221282
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDIA4,Protein disulfide-isomerase A4,35680,94,0.99 [0.72-1.38],0.9738132654945476
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDIA5,Protein disulfide-isomerase A5,34427,89,0.87 [0.60-1.25],0.436826921702181
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDLIM5,PDZ and LIM domain protein 5,35624,95,1.05 [0.88-1.24],0.6008820642030497
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDLIM7,PDZ and LIM domain protein 7,41181,102,0.92 [0.80-1.06],0.2442334527414493
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",40089,100,0.94 [0.65-1.36],0.7464752573033911
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDRG1,p53 and DNA damage-regulated protein 1,34720,90,0.90 [0.60-1.37],0.6309810762164163
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,34427,89,1.03 [0.73-1.46],0.8551528516968139
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDZD2,PDZ domain-containing protein 2,34555,92,1.01 [0.72-1.42],0.9675671468929812
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,34646,90,1.42 [0.96-2.10],0.0811743036839611
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PEAR1,Platelet endothelial aggregation receptor 1,41521,106,1.38 [0.65-2.92],0.4054005330103221
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PEBP1,Phosphatidylethanolamine-binding protein 1,41027,103,1.35 [1.01-1.80],0.0439006390074017
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PECAM1,Platelet endothelial cell adhesion molecule,41027,103,1.23 [0.70-2.16],0.4772196972037823
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PECR,Peroxisomal trans-2-enoyl-CoA reductase,34729,89,1.17 [0.59-2.30],0.6543429421241878
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PENK,Proenkephalin-A,34914,93,0.71 [0.36-1.40],0.3159887059808992
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PEPD,Xaa-Pro dipeptidase,35700,95,1.21 [0.57-2.55],0.6260024819717888
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PER3,Period circadian protein homolog 3,34646,90,1.01 [0.86-1.20],0.8804381737033216
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PF4,Platelet factor 4,35463,93,0.87 [0.71-1.07],0.2021220875370659
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PFDN2,Prefoldin subunit 2,40064,101,1.05 [0.77-1.44],0.7577735719234454
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PFDN4,Prefoldin subunit 4,34427,89,0.81 [0.53-1.24],0.3360433276988492
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PFDN6,Prefoldin subunit 6,34720,90,0.94 [0.67-1.31],0.7038682551912891
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40760,102,1.43 [1.15-1.77],0.0010613484923203
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PGA4,Pepsin A-4,35700,95,0.91 [0.71-1.17],0.4592700925779749
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",35674,93,0.98 [0.68-1.43],0.9266006805961752
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,41488,104,1.77 [0.97-3.22],0.0634607568610546
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PGLYRP1,Peptidoglycan recognition protein 1,41323,105,0.94 [0.62-1.41],0.7520103941980398
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,35272,92,0.76 [0.39-1.46],0.4056916043314115
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PGLYRP4,Peptidoglycan recognition protein 4,34555,92,0.70 [0.46-1.08],0.1039468319406775
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,34720,90,0.91 [0.62-1.32],0.6126720458909976
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PGR,Progesterone receptor,34646,90,1.04 [0.86-1.25],0.7083484959304565
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PHACTR2,Phosphatase and actin regulator 2,35624,95,0.97 [0.82-1.16],0.7584603435119752
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PHLDB1,Pleckstrin homology-like domain family B member 1,35523,94,1.26 [0.87-1.82],0.2228222515239056
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PHLDB2,Pleckstrin homology-like domain family B member 2,34427,89,1.09 [0.89-1.32],0.4160994996696319
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,40720,102,0.93 [0.51-1.67],0.8026446605872201
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,34914,93,1.65 [1.03-2.65],0.0375838132552809
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PI16,Peptidase inhibitor 16,35700,95,0.83 [0.37-1.84],0.6416245387595423
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PI3,Elafin,40483,103,1.13 [0.83-1.53],0.450321551348193
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",35624,95,1.37 [1.08-1.73],0.0089222533800804
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,40510,99,0.88 [0.53-1.46],0.6294946636170855
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40974,103,2.64 [2.16-3.22],2.744280643881177e-21
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,41027,103,3.75 [2.37-5.92],1.5694855045246822e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,34646,90,1.33 [0.99-1.78],0.0562590561860267
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,41027,103,1.23 [0.81-1.86],0.3406689803986472
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,41020,104,1.12 [0.82-1.53],0.4683418071016059
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,34914,93,0.78 [0.60-1.03],0.0812162088311046
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PITHD1,PITH domain-containing protein 1,34362,89,0.98 [0.75-1.28],0.8806710869124279
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,35674,93,0.92 [0.43-1.94],0.8225486652805386
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PKD2,Polycystin-2,34555,92,1.21 [0.88-1.66],0.2340025614848829
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,41053,102,1.32 [1.03-1.69],0.027754522861258
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PKN3,Serine/threonine-protein kinase N3,35020,92,0.75 [0.56-1.00],0.0473814799127197
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLA2G10,Group 10 secretory phospholipase A2,40720,102,0.87 [0.64-1.17],0.3442401168760615
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,41133,105,2.90 [1.61-5.22],0.0003784821427265
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLA2G1B,Phospholipase A2,41456,104,0.80 [0.54-1.18],0.2685154102002308
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLA2G2A,"Phospholipase A2, membrane associated",40929,102,1.00 [0.73-1.39],0.9809390792356648
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLA2G4A,Cytosolic phospholipase A2,41181,102,0.85 [0.70-1.04],0.1183401743808536
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLA2G7,Platelet-activating factor acetylhydrolase,41027,103,1.28 [0.74-2.20],0.3790149851101784
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,41393,106,1.12 [0.80-1.58],0.4962384855633635
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,41027,103,1.54 [1.00-2.37],0.0494101238722909
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,40725,100,2.04 [1.10-3.78],0.023101312439077
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",35608,95,0.97 [0.70-1.35],0.8670941271803101
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",34646,90,0.98 [0.61-1.57],0.922601524358793
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",35608,95,0.97 [0.79-1.18],0.7448671559018571
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,35608,95,1.33 [1.02-1.75],0.0382520248113469
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLG,Plasminogen,34814,90,0.66 [0.26-1.67],0.3811690671566055
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLIN1,Perilipin-1,40064,101,0.75 [0.43-1.32],0.3199215790308322
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLIN3,Perilipin-3,41020,104,1.09 [0.73-1.63],0.6621739256408207
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLPBP,Pyridoxal phosphate homeostasis protein,41020,104,1.07 [0.83-1.39],0.5935663124824533
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLSCR3,Phospholipid scramblase 3,35550,95,1.04 [0.74-1.45],0.8369088697292975
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLTP,Phospholipid transfer protein,41375,105,1.09 [0.68-1.76],0.7263852625634253
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLXDC1,Plexin domain-containing protein 1,40089,100,0.91 [0.52-1.60],0.743661531034682
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLXDC2,Plexin domain-containing protein 2,35608,95,0.80 [0.38-1.68],0.557557152629379
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLXNA4,Plexin-A4,40974,103,0.87 [0.70-1.07],0.1906439506230021
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,41337,106,2.57 [1.34-4.93],0.0045999400858567
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLXNB3,Plexin-B3,40892,103,0.71 [0.49-1.04],0.075394547722658
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40839,104,0.96 [0.88-1.05],0.4191459820524794
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PMCH,Pro-MCH,34555,92,0.76 [0.53-1.08],0.1204416142379974
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PMM2,Phosphomannomutase 2,34555,92,0.81 [0.58-1.15],0.2467699518799464
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,34720,90,2.09 [1.74-2.52],9.5151972199108e-15
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PMVK,Phosphomevalonate kinase,39997,101,0.96 [0.82-1.12],0.6274750009652975
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PNLIP,Pancreatic triacylglycerol lipase,35700,95,0.92 [0.67-1.25],0.5743480284167555
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PNLIPRP1,Inactive pancreatic lipase-related protein 1,35608,95,1.03 [0.81-1.32],0.803981367244394
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PNLIPRP2,Pancreatic lipase-related protein 2,40982,102,1.02 [0.96-1.08],0.584354652634834
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PNMA1,Paraneoplastic antigen Ma1,34729,89,0.88 [0.60-1.27],0.4895571685596243
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,34584,91,1.95 [1.53-2.48],6.384013743652928e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40284,100,0.73 [0.59-0.90],0.0031633064055607
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PODXL,Podocalyxin,40826,102,1.15 [0.36-3.62],0.8161737442064831
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PODXL2,Podocalyxin-like protein 2,41133,105,1.27 [0.69-2.34],0.4488157722738024
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,34646,90,1.68 [1.23-2.29],0.0010719409783018
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",POLR2A,DNA-directed RNA polymerase II subunit RPB1,34646,90,1.11 [0.57-2.16],0.7523699313844089
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40826,102,2.75 [2.29-3.29],6.094101287991132e-28
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",POMC,Pro-opiomelanocortin,34729,89,1.02 [0.76-1.37],0.8814730767246335
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PON1,Serum paraoxonase/arylesterase 1,35700,95,0.66 [0.34-1.28],0.2175977032429271
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,40294,103,1.14 [0.70-1.88],0.5963255411305184
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,41181,102,0.83 [0.49-1.39],0.4801478237263172
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,35680,94,0.38 [0.22-0.65],0.0004052440614784
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,35458,93,0.71 [0.56-0.89],0.0032194243837395
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPCDC,Phosphopantothenoylcysteine decarboxylase,41382,103,1.13 [0.78-1.63],0.5164899996287684
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPIB,Peptidyl-prolyl cis-trans isomerase B,41038,102,0.93 [0.78-1.12],0.4484441076077957
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPIE,Peptidyl-prolyl cis-trans isomerase E,35020,92,1.15 [0.88-1.52],0.3050280971797249
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",35680,94,0.98 [0.72-1.34],0.902290127260604
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPL,Periplakin,34646,90,1.40 [0.82-2.37],0.2152161022025722
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPM1A,Protein phosphatase 1A,40089,100,0.83 [0.45-1.51],0.5362435099539371
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,34646,90,0.89 [0.61-1.28],0.5276969285715034
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPM1F,Protein phosphatase 1F,35674,93,0.88 [0.60-1.29],0.5142721879968993
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,40826,102,1.25 [0.93-1.67],0.134073096768121
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,35512,93,0.96 [0.75-1.22],0.7406646638395482
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,41133,105,0.98 [0.82-1.17],0.8166464058367856
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,35020,92,1.06 [0.81-1.38],0.6594983707564339
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,35624,95,0.84 [0.65-1.09],0.198466965850122
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,35624,95,0.91 [0.54-1.55],0.7408809224806948
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP1R2,Protein phosphatase inhibitor 2,41020,104,1.14 [0.92-1.42],0.2201097639616303
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP1R9B,Neurabin-2,41488,104,1.15 [0.96-1.38],0.1345649938020792
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,35523,94,1.01 [0.86-1.19],0.9056574244987016
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP3R1,Calcineurin subunit B type 1,40720,102,0.71 [0.46-1.10],0.1240749651369585
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPT1,Palmitoyl-protein thioesterase 1,34720,90,0.93 [0.70-1.24],0.6332988057971262
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPY,Pancreatic prohormone,40942,105,0.92 [0.78-1.09],0.3254240124316332
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,40089,100,1.91 [1.69-2.16],5.105765826717676e-25
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRAME,Melanoma antigen preferentially expressed in tumors,34427,89,1.44 [0.70-2.93],0.32167182619654
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,35680,94,1.22 [0.74-2.02],0.4390614549130319
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRC1,Protein regulator of cytokinesis 1,35512,93,0.58 [0.30-1.15],0.1181484646890352
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,41270,104,1.74 [1.06-2.85],0.0274450479423567
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,39881,100,1.08 [0.89-1.31],0.4651958635556232
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRDX2,Peroxiredoxin-2,35101,95,1.28 [0.95-1.72],0.1021298046009328
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40284,100,1.02 [0.79-1.30],0.893398414003797
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRDX5,"Peroxiredoxin-5, mitochondrial",41488,104,0.90 [0.70-1.16],0.4185081649599856
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRDX6,Peroxiredoxin-6,41393,103,0.94 [0.71-1.26],0.6987028840034969
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PREB,Prolactin regulatory element-binding protein,40284,100,0.88 [0.47-1.66],0.7040794173215454
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRELP,Prolargin,40982,102,1.42 [0.66-3.08],0.372406223357952
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRG2,Bone marrow proteoglycan,35680,94,1.02 [0.70-1.50],0.9176175006913412
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,35680,94,0.49 [0.34-0.71],0.0001709045471603
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40284,100,1.16 [0.85-1.59],0.3536841989478244
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,34720,90,0.89 [0.46-1.73],0.7325216389665834
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,41020,104,0.88 [0.71-1.08],0.2173798397563121
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,35537,94,1.19 [0.93-1.52],0.1674552407411948
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKCQ,Protein kinase C theta type,40284,100,0.89 [0.58-1.38],0.6108650319048892
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKD2,Serine/threonine-protein kinase D2,34555,92,1.00 [0.64-1.57],0.9922433471632266
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKG1,cGMP-dependent protein kinase 1,34914,93,0.94 [0.81-1.11],0.4835459866340099
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,40089,100,1.94 [1.55-2.42],5.121097569888052e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,41382,103,1.03 [0.82-1.30],0.7900941411111195
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,35608,95,1.34 [0.92-1.95],0.1272220446238576
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,41111,103,0.55 [0.28-1.09],0.0850423533007606
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PROCR,Endothelial protein C receptor,34555,92,1.21 [0.75-1.96],0.4410238894943827
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,40974,103,0.72 [0.52-1.01],0.0596591040210256
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,35728,94,0.37 [0.18-0.77],0.0081768133791879
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRR4,Proline-rich protein 4,34666,93,0.99 [0.74-1.31],0.9212787310663416
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRR5,Proline-rich protein 5,34646,90,0.93 [0.59-1.47],0.7571209815720807
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,34729,89,3.29 [2.11-5.12],1.47928948807835e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRSS2,Trypsin-2,41170,103,0.92 [0.66-1.27],0.6064265877727089
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,34646,90,0.57 [0.29-1.12],0.1024047623239221
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRSS27,Serine protease 27,40893,104,0.82 [0.53-1.27],0.3773641694748838
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRSS53,Serine protease 53,35608,95,1.06 [0.64-1.75],0.8268145636302305
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,40853,100,1.50 [0.99-2.28],0.0549144606821587
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,40064,101,0.89 [0.76-1.03],0.1224611703964774
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,41393,103,1.19 [0.59-2.40],0.6350273883398668
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,39978,102,0.87 [0.59-1.27],0.4685681889493828
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRUNE2,Protein prune homolog 2,35020,92,0.99 [0.50-1.97],0.9838422563612153
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,35348,90,1.89 [1.06-3.37],0.0300001472009317
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSAPL1,Proactivator polypeptide-like 1,35523,94,1.12 [0.76-1.66],0.5641342916991017
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSCA,Prostate stem cell antigen,35523,94,1.08 [0.99-1.17],0.0780545796509861
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSG1,Pregnancy-specific beta-1-glycoprotein 1,40720,102,1.00 [0.86-1.16],0.9737558384790664
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,40974,103,1.90 [1.69-2.15],4.245864040997869e-26
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSMA1,Proteasome subunit alpha type-1,40089,100,0.92 [0.62-1.39],0.704205298581299
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSMC3,26S proteasome regulatory subunit 6A,34427,89,1.28 [0.68-2.39],0.4411411977711486
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSMD1,26S proteasome non-ATPase regulatory subunit 1,35624,95,1.32 [0.93-1.86],0.1224785189111797
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSMD5,26S proteasome non-ATPase regulatory subunit 5,34720,90,0.76 [0.49-1.20],0.237986698948881
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSMD9,26S proteasome non-ATPase regulatory subunit 9,40826,102,1.17 [0.87-1.57],0.3087010394405718
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSME1,Proteasome activator complex subunit 1,40658,100,1.53 [0.96-2.43],0.0722530288943343
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,40533,102,1.67 [1.05-2.67],0.0304577186678983
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,40974,103,1.49 [1.08-2.06],0.0142939130005673
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,34646,90,1.49 [1.12-1.99],0.0065347096514996
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,40974,103,0.75 [0.62-0.90],0.0023309259323085
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSRC1,Proline/serine-rich coiled-coil protein 1,40089,100,0.70 [0.50-0.99],0.0426964548086301
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,33671,91,0.92 [0.76-1.10],0.3463753994600779
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",40064,101,0.66 [0.37-1.20],0.1717720519236557
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,40714,102,3.04 [2.05-4.51],3.080514790051431e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTGES2,Prostaglandin E synthase 2,34383,90,1.02 [0.70-1.48],0.9244046931853692
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTGR1,Prostaglandin reductase 1,35674,93,0.85 [0.66-1.08],0.1840663551030593
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTH,Parathyroid hormone,34720,90,0.93 [0.72-1.19],0.5554586329557183
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40974,103,0.90 [0.55-1.48],0.678160026698222
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,40064,101,0.56 [0.37-0.85],0.0069788332079943
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,40294,103,1.24 [0.88-1.75],0.2253447015514746
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTP4A3,Protein tyrosine phosphatase type IVA 3,34646,90,1.10 [0.76-1.59],0.6163976274204424
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40720,102,1.57 [1.29-1.92],6.779306506584318e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,41121,102,0.96 [0.79-1.16],0.6832690392816401
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,34581,89,0.83 [0.47-1.47],0.5208861540872403
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,35674,93,0.47 [0.24-0.93],0.0301864744265872
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,35680,94,14.58 [10.40-20.43],1.2882538679829278e-54
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRF,Receptor-type tyrosine-protein phosphatase F,41521,106,1.55 [0.86-2.81],0.147468678492635
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,35523,94,1.60 [1.11-2.32],0.0123482857391005
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,35523,94,1.58 [0.73-3.41],0.2407512065186139
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,40905,103,1.55 [0.76-3.14],0.2286182922065423
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40580,102,1.80 [1.08-3.02],0.0244744874806717
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRR,Receptor-type tyrosine-protein phosphatase R,35608,95,1.29 [0.78-2.15],0.3201131267777011
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,41521,106,4.64 [2.41-8.91],4.259929036627869e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,35674,93,0.64 [0.34-1.20],0.166587032894094
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,34914,93,0.90 [0.64-1.26],0.5264250214746773
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,39880,100,1.63 [1.24-2.13],0.0003821807572454
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTTG1,Securin,35020,92,1.06 [0.67-1.69],0.7994118232431094
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,40974,103,1.92 [1.26-2.94],0.0025842011019586
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PVALB,Parvalbumin alpha,41206,103,0.87 [0.75-1.00],0.056588928620907
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,41382,103,0.97 [0.60-1.55],0.888672457299999
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PXDNL,Peroxidasin-like protein,35512,93,0.93 [0.64-1.36],0.7219086719122423
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PXN,Paxillin,40064,101,1.16 [0.85-1.59],0.3512133437601806
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PYDC1,Pyrin domain-containing protein 1,34729,89,1.27 [0.81-1.97],0.2975560370102449
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PYY,Peptide YY,34555,92,1.01 [0.83-1.24],0.8918789771135819
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,35728,94,0.85 [0.55-1.33],0.4767905100603939
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",QDPR,Dihydropteridine reductase,40829,104,1.18 [0.79-1.76],0.4281075949600131
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,41075,104,1.61 [0.85-3.07],0.1434379855136086
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,35002,91,1.38 [1.03-1.85],0.0333920895192123
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB10,Ras-related protein Rab-10,35674,93,0.90 [0.62-1.32],0.6004670548810153
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB11FIP3,Rab11 family-interacting protein 3,35674,93,0.95 [0.79-1.14],0.583368053804359
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB27B,Ras-related protein Rab-27B,35674,93,0.92 [0.72-1.16],0.4626806427327651
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB2B,Ras-related protein Rab-2B,35512,93,0.89 [0.64-1.24],0.5001709661324092
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB33A,Ras-related protein Rab-33A,34555,92,0.87 [0.64-1.19],0.3931365485593767
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,40284,100,0.59 [0.44-0.79],0.0004297014884065
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB39B,Ras-related protein Rab-39B,34555,92,0.89 [0.68-1.16],0.3921906242148769
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,34584,91,0.78 [0.51-1.19],0.2443104842730345
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB44,Ras-related protein Rab-44,35512,93,0.88 [0.54-1.43],0.6014033045191365
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB6A,Ras-related protein Rab-6A,40974,103,0.83 [0.56-1.22],0.3423076248968977
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,40064,101,0.91 [0.62-1.34],0.6419196331102326
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RABEP1,Rab GTPase-binding effector protein 1,34914,93,1.22 [0.94-1.57],0.1324907765510143
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RABEPK,Rab9 effector protein with kelch motifs,40089,100,0.75 [0.52-1.06],0.1044687032848811
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,40284,100,1.46 [1.12-1.91],0.0054587466574838
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAC3,Ras-related C3 botulinum toxin substrate 3,34720,90,0.69 [0.45-1.05],0.0793492956873392
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAD23B,UV excision repair protein RAD23 homolog B,40089,100,0.86 [0.58-1.28],0.4522734389230932
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAD51,DNA repair protein RAD51 homolog 1,35020,92,1.11 [0.81-1.54],0.5171457152177168
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RALB,Ras-related protein Ral-B,34646,90,0.96 [0.49-1.89],0.9091496305981676
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,35512,93,1.87 [1.52-2.30],2.281268204174369e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RANBP1,Ran-specific GTPase-activating protein,34729,89,1.22 [0.84-1.78],0.3021507571158727
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RANBP2,E3 SUMO-protein ligase RanBP2,34584,91,1.25 [0.70-2.23],0.4539945904679806
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RANGAP1,Ran GTPase-activating protein 1,40089,100,0.98 [0.67-1.43],0.9090328646164452
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAP1A,Ras-related protein Rap-1A,34646,90,0.96 [0.71-1.31],0.7960224052302913
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAPGEF2,Rap guanine nucleotide exchange factor 2,35020,92,0.86 [0.57-1.28],0.4498575208964231
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RARRES1,Retinoic acid receptor responder protein 1,40089,100,0.56 [0.29-1.08],0.0831177378783378
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,41246,103,0.78 [0.54-1.14],0.1965975862771557
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RASA1,Ras GTPase-activating protein 1,40064,101,0.74 [0.42-1.28],0.2804102668059989
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,34427,89,1.01 [0.63-1.61],0.9798851022842784
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,40089,100,1.80 [1.57-2.06],1.0501386508120149e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,35624,95,1.68 [1.15-2.44],0.0070671458525711
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,40061,102,1.73 [1.25-2.39],0.0010122456233833
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBM17,Splicing factor 45,35624,95,0.93 [0.72-1.21],0.5813202149697255
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,34555,92,1.88 [1.52-2.32],4.36501620851861e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBM25,RNA-binding protein 25,34427,89,0.74 [0.46-1.18],0.2037120163854789
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBP1,Retinol-binding protein 1,34720,90,1.05 [0.80-1.37],0.7442777325183769
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBP2,Retinol-binding protein 2,40826,102,1.10 [0.88-1.38],0.4107322955967242
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,40826,102,1.58 [1.19-2.10],0.0015053922813961
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBP7,Retinoid-binding protein 7,35523,94,1.04 [0.76-1.42],0.7983325219224827
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,34646,90,0.99 [0.72-1.35],0.9248948210417088
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBPMS2,RNA-binding protein with multiple splicing 2,34729,89,1.01 [0.83-1.23],0.9371855926833916
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,35512,93,1.42 [1.09-1.86],0.0094254895937365
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,40294,103,1.39 [1.06-1.82],0.0177630213726764
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,34729,89,1.55 [0.59-4.10],0.3728231960214284
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REEP4,Receptor expression-enhancing protein 4,35624,95,1.20 [0.89-1.60],0.2346549103037394
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,40774,102,1.37 [1.00-1.89],0.0502667577481932
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,41521,106,1.29 [0.98-1.69],0.065014529170209
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,41521,106,1.08 [0.83-1.42],0.5669206645279607
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REG3G,Regenerating islet-derived protein 3-gamma,35512,93,0.95 [0.57-1.57],0.8307167985519116
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,41054,102,1.05 [0.74-1.48],0.7978483416475195
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RELB,Transcription factor RelB,34646,90,0.56 [0.33-0.96],0.0358572248692601
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,41027,103,3.72 [2.32-5.96],4.48965776303848e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REN,Renin,41020,104,0.80 [0.63-1.01],0.0595488929442277
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REPS1,RalBP1-associated Eps domain-containing protein 1,34646,90,0.96 [0.56-1.63],0.8731016263094731
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REST,RE1-silencing transcription factor,34427,89,1.13 [0.65-1.97],0.6531052193569298
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40826,102,0.74 [0.47-1.16],0.1880211501736114
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RETN,Resistin,40921,105,1.12 [0.75-1.67],0.5709337246614978
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",34555,92,0.55 [0.31-0.97],0.0397390169145614
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RFC4,Replication factor C subunit 4,35512,93,2.01 [0.94-4.31],0.0735616182580521
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RGCC,Regulator of cell cycle RGCC,35624,95,0.88 [0.68-1.14],0.3265285754340251
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,35020,92,0.85 [0.59-1.22],0.379161890673663
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,41382,103,1.53 [0.89-2.64],0.1263981661276725
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,41382,103,2.18 [1.19-3.98],0.0114431741402607
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RGS10,Regulator of G-protein signaling 10,35624,95,0.93 [0.67-1.30],0.6877086779953299
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RGS8,Regulator of G-protein signaling 8,40284,100,0.84 [0.61-1.15],0.2752669629970125
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RHOC,Rho-related GTP-binding protein RhoC,40469,102,0.95 [0.82-1.10],0.4782123423745198
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RICTOR,Rapamycin-insensitive companion of mTOR,34646,90,0.64 [0.36-1.13],0.1241842214234956
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,34914,93,1.54 [1.07-2.20],0.0186636478001854
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RILP,Rab-interacting lysosomal protein,41272,103,1.05 [0.79-1.41],0.7192583722490005
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RILPL2,RILP-like protein 2,35674,93,0.92 [0.75-1.12],0.419923034290337
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,34555,92,0.61 [0.40-0.93],0.0219162973742306
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RLN1,Prorelaxin H1,35624,95,1.04 [0.73-1.46],0.8399110394001916
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,34853,92,1.00 [0.77-1.30],0.997593668897826
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASE1,Ribonuclease pancreatic,35700,95,1.39 [0.68-2.85],0.3689869334335312
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASE10,Inactive ribonuclease-like protein 10,34729,89,1.08 [0.71-1.63],0.7329285045268528
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASE3,Eosinophil cationic protein,40829,104,0.92 [0.78-1.08],0.3137422910632578
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASE4,Ribonuclease 4,34525,90,1.32 [0.65-2.68],0.4404678734958024
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,35434,91,2.04 [1.55-2.70],4.786718564890325e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASEH2A,Ribonuclease H2 subunit A,35624,95,1.11 [0.77-1.60],0.5777651325270154
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,41334,104,3.06 [1.99-4.70],3.363714016018e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,34729,89,2.81 [1.89-4.19],3.590774116726308e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,34646,90,1.72 [1.24-2.37],0.0010173573992013
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF31,E3 ubiquitin-protein ligase RNF31,34646,90,1.03 [0.60-1.77],0.91934502594128
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF4,E3 ubiquitin-protein ligase RNF4,35020,92,0.84 [0.60-1.18],0.3245828739796026
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF41,E3 ubiquitin-protein ligase NRDP1,40089,100,1.18 [0.91-1.52],0.2188262458162063
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF43,E3 ubiquitin-protein ligase RNF43,35020,92,0.70 [0.43-1.11],0.1295827698211069
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF5,E3 ubiquitin-protein ligase RNF5,34729,89,0.92 [0.70-1.22],0.5727013594450254
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,41054,102,4.27 [2.40-7.61],8.310029177990859e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,41382,103,1.82 [0.87-3.81],0.1128499748193619
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ROBO4,Roundabout homolog 4,34729,89,1.84 [0.59-5.73],0.2922164530546363
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,41020,104,6.77 [4.11-11.16],6.48940602362094e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RP2,Protein XRP2,40826,102,0.88 [0.58-1.35],0.5690489013520712
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RPA2,Replication protein A 32 kDa subunit,34646,90,1.65 [1.04-2.62],0.0321087232713217
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RPE,Ribulose-phosphate 3-epimerase,35020,92,1.02 [0.77-1.35],0.8810329847776417
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RPGR,X-linked retinitis pigmentosa GTPase regulator,34720,90,1.10 [0.69-1.75],0.6932882493147945
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,34729,89,2.67 [2.21-3.23],6.559886608467569e-24
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RPS10,40S ribosomal protein S10,34555,92,0.63 [0.35-1.13],0.1205564714151842
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RRAS,Ras-related protein R-Ras,34720,90,0.95 [0.81-1.11],0.5190546444666873
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,40089,100,1.57 [1.28-1.93],1.7467698031629396e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,40089,100,1.42 [1.10-1.83],0.0074766945562935
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RRP15,RRP15-like protein,34584,91,1.06 [0.85-1.32],0.5903841365258546
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RSPO1,R-spondin-1,40720,102,1.05 [0.63-1.75],0.8569886480309418
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RSPO3,R-spondin-3,41393,103,1.45 [0.78-2.67],0.2379082747839926
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RTBDN,Retbindin,40826,102,0.62 [0.33-1.15],0.1286383090190149
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RTKN2,Rhotekin-2,34555,92,0.69 [0.42-1.14],0.1470625187025204
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",35624,95,1.07 [0.86-1.32],0.5600088002186812
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,41393,103,1.71 [1.12-2.62],0.0137808391802412
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RUVBL1,RuvB-like 1,40089,100,0.95 [0.79-1.14],0.5803041350979055
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RWDD1,RWD domain-containing protein 1,41382,103,1.00 [0.76-1.32],0.981300682755164
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RYR1,Ryanodine receptor 1,34555,92,0.64 [0.32-1.28],0.2034363007796869
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100A11,Protein S100-A11,40705,104,1.00 [0.69-1.44],0.9791218083529674
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100A12,Protein S100-A12,40446,102,1.11 [0.88-1.41],0.3635255583563319
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,34646,90,1.84 [1.18-2.86],0.0070977022011088
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100A14,Protein S100-A14,35624,95,0.77 [0.52-1.15],0.2048511089211605
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100A16,Protein S100-A16,40004,101,0.90 [0.67-1.22],0.4972039646714767
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,35512,93,1.40 [1.08-1.82],0.0100047091362898
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100A4,Protein S100-A4,41133,105,0.84 [0.62-1.14],0.2567214789533493
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100G,Protein S100-G,35624,95,0.85 [0.55-1.31],0.4634448259197438
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100P,Protein S100-P,40294,103,0.78 [0.55-1.11],0.1680855615950907
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAA4,Serum amyloid A-4 protein,35728,94,1.22 [0.76-1.98],0.4133878408247937
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,35624,95,2.16 [1.61-2.90],2.4775253691692885e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAG,S-arrestin,34584,91,0.92 [0.62-1.38],0.6890260060011851
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAMD9L,Sterile alpha motif domain-containing protein 9-like,40974,103,1.10 [0.87-1.39],0.4282974966126038
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAP18,Histone deacetylase complex subunit SAP18,35020,92,0.96 [0.72-1.27],0.7748189185005352
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SARG,Specifically androgen-regulated gene protein,35548,91,0.90 [0.75-1.08],0.2656906099908125
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,34555,92,2.36 [2.05-2.71],3.7247173071249792e-34
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAT1,Diamine acetyltransferase 1,34555,92,0.70 [0.43-1.15],0.160972951268486
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAT2,Thialysine N-epsilon-acetyltransferase,35020,92,1.11 [0.85-1.46],0.4298156490018665
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SATB1,DNA-binding protein SATB1,35624,95,0.84 [0.42-1.72],0.6411594467546013
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SBSN,Suprabasin,35612,94,0.98 [0.56-1.72],0.9396420725236858
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,40826,102,1.50 [1.23-1.82],5.081594260638228e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCARA5,Scavenger receptor class A member 5,41382,103,0.84 [0.46-1.50],0.5489746587482387
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCARB1,Scavenger receptor class B member 1,40064,101,0.87 [0.61-1.24],0.4398477878656578
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,39945,99,2.26 [1.40-3.64],0.0007772711646444
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCARF1,Scavenger receptor class F member 1,41521,106,0.96 [0.64-1.45],0.8599812696140312
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,41382,103,2.38 [1.35-4.19],0.0027485678813406
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCG2,Secretogranin-2,41203,103,1.11 [0.65-1.90],0.6951577733179743
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCG3,Secretogranin-3,41054,102,0.86 [0.51-1.46],0.5850768972572316
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCGB1A1,Uteroglobin,41053,100,1.31 [0.93-1.84],0.1175838991406258
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCGB2A2,Mammaglobin-A,34555,92,0.65 [0.30-1.37],0.2540091536336159
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,34914,93,1.29 [0.59-2.80],0.521938888025528
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCGB3A2,Secretoglobin family 3A member 2,41121,102,0.86 [0.68-1.08],0.1979897049799306
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCGN,Secretagogin,40284,100,1.33 [0.90-1.95],0.151272750065204
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCIN,Adseverin,34584,91,0.91 [0.68-1.21],0.5045008400361364
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,41272,103,1.56 [1.10-2.20],0.0117015471712899
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCN2A,Sodium channel protein type 2 subunit alpha,34584,91,1.01 [0.67-1.53],0.9454617577399724
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCN2B,Sodium channel subunit beta-2,34720,90,0.61 [0.28-1.35],0.22276736971007
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCN3A,Sodium channel protein type 3 subunit alpha,34720,90,0.92 [0.52-1.64],0.7786113203931241
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCN3B,Sodium channel subunit beta-3,34584,91,1.09 [0.72-1.63],0.6921198311719616
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCN4B,Sodium channel subunit beta-4,34729,89,1.10 [0.68-1.78],0.6960658538089931
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCP2,Non-specific lipid-transfer protein,40089,100,0.81 [0.61-1.08],0.1511348844513101
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCPEP1,Retinoid-inducible serine carboxypeptidase,34604,89,1.04 [0.69-1.56],0.8603576154547623
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,35674,93,1.01 [0.49-2.10],0.9739808116178468
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCRIB,Protein scribble homolog,34729,89,1.26 [1.05-1.51],0.0109727247402102
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,40974,103,1.38 [1.04-1.83],0.0235914149065554
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCT,Secretin,34720,90,0.95 [0.62-1.47],0.8242580317026964
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,41020,104,1.59 [1.07-2.38],0.0222566933932815
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,41020,104,0.63 [0.51-0.78],2.202870300825136e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDCCAG8,Serologically defined colon cancer antigen 8,35512,93,1.17 [0.98-1.39],0.0865405123087167
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,35523,94,1.21 [0.93-1.58],0.1606851269603347
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,34914,93,4.25 [3.68-4.90],5.709897035075591e-88
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEC31A,Protein transport protein Sec31A,34729,89,1.06 [0.81-1.39],0.6571386578559728
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,34729,89,1.36 [0.85-2.19],0.1966213465570513
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,41521,106,1.22 [0.86-1.71],0.2620957842921587
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SELENOP,Selenoprotein P,35728,94,0.64 [0.26-1.55],0.3185867652485028
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,35728,94,10.06 [7.50-13.48],9.269396713906935e-54
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SELP,P-selectin,41170,103,0.81 [0.59-1.11],0.1908115669682343
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,40974,103,2.13 [1.14-3.96],0.0173311705825969
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,41020,104,1.51 [0.79-2.90],0.2158158343404998
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,34914,93,2.27 [1.61-3.20],3.134734418176892e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,40826,102,1.64 [1.07-2.51],0.0224069046863719
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,41382,103,2.24 [1.25-4.02],0.0070150076268772
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA6C,Semaphorin-6C,34646,90,0.77 [0.33-1.76],0.5314881058805316
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,41393,106,7.67 [6.41-9.18],2.0812052568451372e-109
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,35624,95,0.76 [0.57-1.01],0.0544510372266412
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,35020,92,0.78 [0.49-1.23],0.2846119004712485
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,35535,95,2.23 [1.44-3.45],0.0003275983059443
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,40826,102,2.79 [1.97-3.94],6.509001923169719e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA1,Alpha-1-antitrypsin,35046,92,4.82 [0.89-26.05],0.06751828076841
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,41521,106,0.95 [0.62-1.43],0.7901378547845713
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA12,Serpin A12,39860,102,0.82 [0.67-1.00],0.0543972347961626
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,35603,92,1.45 [0.41-5.13],0.5613973917283781
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA4,Kallistatin,35059,90,0.58 [0.25-1.35],0.2058707172209365
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,35187,92,0.66 [0.32-1.34],0.2456435558768892
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,35728,94,2.28 [0.69-7.50],0.1739299322502205
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,35728,94,2.21 [0.79-6.18],0.1295515135716393
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,40617,102,0.68 [0.53-0.87],0.0020972083641429
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINB1,Leukocyte elastase inhibitor,40899,101,0.92 [0.76-1.13],0.4357495744431507
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINB5,Serpin B5,40294,103,1.09 [0.76-1.57],0.632919815295689
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINB6,Serpin B6,41249,103,0.87 [0.64-1.18],0.3666661956445766
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,41488,104,1.58 [1.34-1.87],1.0295319889585173e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINB9,Serpin B9,40720,102,1.15 [0.68-1.97],0.6012093934379628
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,35659,94,0.77 [0.20-2.93],0.7069520230361205
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,35659,94,0.90 [0.45-1.81],0.7732668575636605
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINE1,Plasminogen activator inhibitor 1,41521,106,0.74 [0.58-0.94],0.0158448506458378
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,35674,93,0.63 [0.45-0.86],0.0045218822606667
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,35190,94,1.02 [0.48-2.16],0.9569075050029624
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,35047,94,0.45 [0.11-1.92],0.2819370607287141
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,35659,94,1.07 [0.37-3.09],0.9070070940419024
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINH1,Serpin H1,35020,92,0.99 [0.84-1.15],0.8703736857791519
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINI1,Neuroserpin,34844,93,1.02 [0.52-2.00],0.9528605514554302
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINI2,Serpin I2,35523,94,1.11 [0.79-1.55],0.5640193316754819
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,40064,101,0.91 [0.69-1.21],0.5228903976866779
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,40590,101,3.17 [2.15-4.68],5.3271469825667195e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEZ6,Seizure protein 6 homolog,34720,90,1.50 [0.84-2.69],0.1709339092098573
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEZ6L,Seizure 6-like protein,41133,105,1.44 [0.77-2.68],0.2514203594098687
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,40826,102,1.38 [0.67-2.82],0.3829209860290575
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SF3B4,Splicing factor 3B subunit 4,40826,102,1.02 [0.80-1.29],0.8905405380012236
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,40587,102,0.55 [0.36-0.86],0.0081078750986344
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SFRP4,Secreted frizzled-related protein 4,34914,93,1.28 [0.78-2.10],0.3358443799134343
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SFTPA1,Pulmonary surfactant-associated protein A1,40089,100,0.98 [0.71-1.35],0.9068151749371036
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,40089,100,1.47 [1.07-2.01],0.0175131897621217
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,41020,104,0.96 [0.74-1.24],0.7568109280543099
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SGSH,N-sulphoglucosamine sulphohydrolase,35071,90,0.87 [0.60-1.27],0.4649818264017118
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SH2B3,SH2B adapter protein 3,40089,100,0.86 [0.72-1.03],0.1061095622079193
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,40974,103,1.10 [0.83-1.46],0.489729673607812
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,34584,91,0.74 [0.49-1.13],0.1637776028997302
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SH3BP1,SH3 domain-binding protein 1,35523,94,1.18 [0.83-1.67],0.3509342204168718
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SH3GL3,Endophilin-A3,34820,92,0.98 [0.77-1.24],0.8436238846635398
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SH3GLB2,Endophilin-B2,35608,95,1.19 [0.89-1.59],0.2284601232598627
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SHBG,Sex hormone-binding globulin,35700,95,1.05 [0.70-1.56],0.816575683744685
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SHC1,SHC-transforming protein 1,34427,89,0.77 [0.62-0.94],0.0125828182055241
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SHD,SH2 domain-containing adapter protein D,34488,92,0.79 [0.58-1.08],0.141501632605702
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SHH,Sonic hedgehog protein,34646,90,1.03 [0.64-1.64],0.9118474425521712
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,35680,94,2.42 [1.48-3.97],0.0004411150959477
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SHMT1,"Serine hydroxymethyltransferase, cytosolic",41121,102,0.93 [0.76-1.15],0.5089189116040418
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SHPK,Sedoheptulokinase,35020,92,0.69 [0.39-1.24],0.2177551335220369
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIAE,Sialate O-acetylesterase,41068,105,0.80 [0.55-1.17],0.2471804946230065
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,41181,102,2.45 [1.72-3.51],8.568002695023731e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,40974,103,10.60 [8.66-12.96],1.6842502654485411e-116
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC15,Sialic acid-binding Ig-like lectin 15,40064,101,0.89 [0.68-1.15],0.3692704693192206
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,41027,103,1.55 [1.25-1.92],5.907591657802535e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,41393,103,6.18 [5.03-7.59],2.142187306349973e-67
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,41020,104,1.37 [0.74-2.53],0.3094970641103645
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,34729,89,3.08 [2.06-4.61],4.048756178173697e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC9,Sialic acid-binding Ig-like lectin 9,41334,103,0.77 [0.43-1.36],0.3629037074679476
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIL1,Nucleotide exchange factor SIL1,34729,89,0.94 [0.48-1.81],0.8442185635150641
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,41119,104,1.27 [0.92-1.75],0.14971396316541
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,40914,102,1.30 [0.90-1.89],0.1671687491077373
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,34646,90,1.31 [1.12-1.53],0.0005287133757117
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIRT2,NAD-dependent protein deacetylase sirtuin-2,40826,102,0.96 [0.79-1.18],0.7196665496267729
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",40064,101,0.57 [0.38-0.87],0.0083687577042097
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,40284,100,2.25 [1.67-3.03],9.876122404825496e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,40644,102,1.05 [0.83-1.34],0.684856093276589
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SKAP2,Src kinase-associated phosphoprotein 2,41181,102,0.87 [0.74-1.03],0.1152240694855176
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SKIV2L,Helicase SKI2W,34555,92,0.62 [0.33-1.14],0.1220894742703959
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLA2,Src-like-adapter 2,35624,95,0.86 [0.71-1.04],0.1133377642798126
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,40284,100,1.26 [0.92-1.71],0.1440296669960559
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,40089,100,5.18 [4.43-6.05],9.147039570156188e-96
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,40974,103,0.83 [0.61-1.12],0.2272226673821578
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,40089,100,2.51 [1.88-3.34],3.3635706926226325e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC12A2,Solute carrier family 12 member 2,34555,92,0.95 [0.45-2.01],0.8877360620008757
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC13A1,Solute carrier family 13 member 1,35512,93,0.54 [0.31-0.92],0.0234055623034829
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC16A1,Monocarboxylate transporter 1,40064,101,1.13 [0.85-1.51],0.3855908195104857
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC1A4,Neutral amino acid transporter A,34720,90,0.78 [0.50-1.24],0.2997596774370378
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC27A4,Long-chain fatty acid transport protein 4,40064,101,1.08 [0.84-1.38],0.5467831515752668
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC28A1,Sodium/nucleoside cotransporter 1,34427,89,0.99 [0.70-1.40],0.9680330587835824
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC34A3,Sodium-dependent phosphate transport protein 2C,34427,89,0.94 [0.60-1.48],0.8015081274294427
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC39A14,Zinc transporter ZIP14,40064,101,1.29 [0.82-2.05],0.2756025281222635
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC39A5,Zinc transporter ZIP5,40974,103,1.22 [0.91-1.63],0.1876079822890854
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC44A4,Choline transporter-like protein 4,34720,90,0.74 [0.51-1.09],0.1319504777956709
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC4A1,Band 3 anion transport protein,35680,94,1.54 [1.05-2.26],0.0278578740711586
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC51B,Organic solute transporter subunit beta,34555,92,0.87 [0.65-1.17],0.3587808273801861
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,34914,93,0.92 [0.73-1.17],0.511525627241422
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,35523,94,1.17 [0.84-1.62],0.3584087546249301
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",34427,89,0.87 [0.59-1.29],0.4978643518845937
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLIT2,Slit homolog 2 protein,40064,101,0.90 [0.63-1.28],0.5431666527300604
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLITRK1,SLIT and NTRK-like protein 1,34646,90,1.60 [0.87-2.95],0.1287691758153966
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,41393,103,2.17 [1.44-3.28],0.0002277383355023
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,40294,103,1.39 [0.86-2.24],0.1814253347675684
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLK,STE20-like serine/threonine-protein kinase,35020,92,0.83 [0.61-1.14],0.2543552911035526
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLMAP,Sarcolemmal membrane-associated protein,35523,94,1.09 [0.86-1.38],0.462408357554699
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLURP1,Secreted Ly-6/uPAR-related protein 1,35413,94,0.92 [0.52-1.61],0.765525734792013
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMAD1,Mothers against decapentaplegic homolog 1,40089,100,0.84 [0.68-1.05],0.133590519764754
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMAD2,Mothers against decapentaplegic homolog 2,35512,93,0.90 [0.67-1.20],0.4676390941942185
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMAD3,Mothers against decapentaplegic homolog 3,35512,93,1.07 [0.73-1.56],0.7216276290223624
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,40826,102,0.47 [0.21-1.06],0.0673359774430516
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMARCA2,Probable global transcription activator SNF2L2,40064,101,0.80 [0.61-1.04],0.0940134933319841
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMC3,Structural maintenance of chromosomes protein 3,34427,89,1.18 [0.85-1.65],0.3200628770567755
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,35523,94,2.13 [1.91-2.38],4.6087354213245414e-42
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,41393,103,1.82 [1.11-2.99],0.0172677837649904
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMOC2,SPARC-related modular calcium-binding protein 2,41181,102,1.18 [0.75-1.85],0.4771395608214849
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,41176,103,0.79 [0.55-1.14],0.2041497839170721
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMPD3,Sphingomyelin phosphodiesterase 3,34646,90,0.96 [0.67-1.39],0.8442517467622277
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,41113,102,0.91 [0.70-1.19],0.5026568089488849
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,35512,93,0.68 [0.47-0.99],0.0415904179732367
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMS,Spermine synthase,34584,91,1.07 [0.79-1.44],0.6589026597722372
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMTN,Smoothelin,35544,95,0.98 [0.79-1.21],0.8437587540772039
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNAP23,Synaptosomal-associated protein 23,41020,104,0.89 [0.73-1.08],0.2330809093603528
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNAP25,Synaptosomal-associated protein 25,34584,91,1.32 [0.88-1.98],0.1861677184331543
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNAP29,Synaptosomal-associated protein 29,41133,105,0.89 [0.74-1.07],0.2233054404338081
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNAPIN,SNARE-associated protein Snapin,35624,95,1.41 [1.02-1.93],0.0359703534430787
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNCA,Alpha-synuclein,34914,93,0.89 [0.75-1.06],0.1901811027660191
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNCG,Gamma-synuclein,40720,102,1.13 [0.86-1.47],0.3824090255656882
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",34729,89,0.51 [0.26-1.02],0.0579824641665934
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',35608,95,1.11 [0.76-1.61],0.5908782981349123
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,34555,92,1.69 [1.42-2.00],1.591712912708078e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNX15,Sorting nexin-15,34914,93,1.26 [0.88-1.80],0.2051681672753907
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,35523,94,1.40 [0.97-2.03],0.0698840002911498
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNX2,Sorting nexin-2,35512,93,1.20 [0.97-1.47],0.0905977892093207
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNX5,Sorting nexin-5,34729,89,1.55 [0.84-2.86],0.1629117165997296
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNX9,Sorting nexin-9,41020,104,1.22 [0.95-1.56],0.1207517198410193
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SOD1,Superoxide dismutase [Cu-Zn],40196,101,1.12 [0.78-1.61],0.5300780449318552
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",41027,103,1.38 [0.90-2.12],0.1342853871002692
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SOD3,Extracellular superoxide dismutase,35700,95,0.83 [0.55-1.25],0.3714895601104946
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SORBS1,Sorbin and SH3 domain-containing protein 1,35624,95,1.01 [0.62-1.64],0.9811999372896586
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,40089,100,1.91 [1.18-3.10],0.0089395373918124
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SORD,Sorbitol dehydrogenase,41202,103,1.08 [0.83-1.39],0.5752944573039819
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SORT1,Sortilin,40966,104,0.99 [0.62-1.58],0.974242463452294
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SOST,Sclerostin,40966,104,0.94 [0.60-1.47],0.7832000590499536
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,34720,90,1.12 [0.77-1.61],0.5504429236990268
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SOX2,Transcription factor SOX-2,35559,95,1.30 [0.60-2.80],0.5063311252729515
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SOX9,Transcription factor SOX-9,34720,90,1.62 [0.76-3.43],0.2082453543111841
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,35624,95,1.75 [1.10-2.78],0.0189673534793635
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPAG1,Sperm-associated antigen 1,35624,95,0.97 [0.69-1.37],0.8742984265895357
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPARC,SPARC,41133,105,0.79 [0.63-0.99],0.0430776419236851
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,41033,103,1.38 [0.80-2.37],0.2463276907451006
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPART,Spartin,34914,93,0.86 [0.66-1.12],0.2674240630861301
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,35674,93,2.36 [1.39-4.04],0.0016093916492516
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,41027,103,1.18 [0.78-1.78],0.4331640378610846
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,34914,93,0.69 [0.39-1.22],0.1987434685596887
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,40974,103,1.11 [0.85-1.44],0.4416291834503073
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINK5,Serine protease inhibitor Kazal-type 5,41027,103,0.55 [0.32-0.93],0.0271494392168393
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINK6,Serine protease inhibitor Kazal-type 6,41393,103,1.17 [0.84-1.63],0.3492423924283946
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINK8,Serine protease inhibitor Kazal-type 8,34555,92,1.03 [0.60-1.75],0.9192622733963692
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,40896,102,4.92 [3.36-7.20],2.568849498554329e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINT2,Kunitz-type protease inhibitor 2,41181,102,0.75 [0.49-1.16],0.1947684616513916
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,35523,94,0.88 [0.78-0.99],0.0350434457069149
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,40720,102,0.38 [0.19-0.76],0.0058461631642194
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,41054,102,0.78 [0.45-1.36],0.3807544499691596
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,40838,103,1.47 [0.89-2.42],0.1322468459947414
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,41451,105,1.16 [0.79-1.71],0.4401735754300675
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",34646,90,1.12 [0.72-1.76],0.6072271083845657
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,34427,89,1.37 [1.09-1.73],0.0069147739919632
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPRR1B,Cornifin-B,35020,92,0.95 [0.73-1.22],0.6696879307575635
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPRR3,Small proline-rich protein 3,35608,95,0.87 [0.64-1.17],0.3487392950057232
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPRY2,Protein sprouty homolog 2,40284,100,0.90 [0.74-1.10],0.3128209727610739
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",34584,91,2.72 [2.09-3.53],6.481247980775182e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPTLC1,Serine palmitoyltransferase 1,35608,95,0.69 [0.37-1.29],0.2433750925361423
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SRC,Proto-oncogene tyrosine-protein kinase Src,41064,105,0.89 [0.77-1.03],0.1106740774918936
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,40826,102,2.64 [2.24-3.11],2.8565621267111203e-31
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,40974,103,1.37 [1.14-1.64],0.0006949978956512
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,35674,93,0.74 [0.44-1.25],0.2624106113594752
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SSB,Lupus La protein,40064,101,1.09 [0.84-1.42],0.5033441639194325
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",34646,90,0.77 [0.41-1.47],0.4349511429477166
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40966,104,0.99 [0.86-1.15],0.9390036908746782
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,41170,103,0.91 [0.60-1.37],0.6564200798819203
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SSH3,Protein phosphatase Slingshot homolog 3,34427,89,0.70 [0.33-1.50],0.3590319873825556
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SSNA1,Sjoegren syndrome nuclear autoantigen 1,35523,94,1.22 [0.84-1.76],0.290186132122013
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ST13,Hsc70-interacting protein,34914,93,1.10 [0.77-1.57],0.6122087943620638
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40826,102,1.69 [1.26-2.28],0.0005202654543587
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",41521,106,1.10 [0.62-1.94],0.7449150443114985
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",34646,90,0.74 [0.44-1.26],0.2722170708957785
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STAB2,Stabilin-2,35680,94,1.12 [0.56-2.27],0.7461189257235102
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STAM,Signal transducing adapter molecule 1,35512,93,0.73 [0.40-1.31],0.2897860509916447
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STAMBP,STAM-binding protein,40644,102,1.04 [0.79-1.37],0.7746177298048755
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,34646,90,1.38 [1.08-1.78],0.0109290419150114
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STAT5B,Signal transducer and activator of transcription 5B,40826,102,0.94 [0.83-1.07],0.3441104185045085
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,34427,89,0.90 [0.65-1.25],0.5348119849067314
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,41382,103,2.40 [2.05-2.81],1.0680116101659971e-27
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,40972,103,4.24 [2.08-8.66],7.155772580721841e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STEAP4,Metalloreductase STEAP4,34584,91,0.59 [0.39-0.87],0.0087664328520422
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STIP1,Stress-induced-phosphoprotein 1,40962,103,1.13 [0.87-1.47],0.3725076625418171
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STK11,Serine/threonine-protein kinase STK11,40294,103,0.91 [0.72-1.17],0.4707700476053855
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STK24,Serine/threonine-protein kinase 24,40064,101,0.87 [0.65-1.17],0.3595969324937162
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STK4,Serine/threonine-protein kinase 4,41020,104,0.89 [0.73-1.09],0.2567983286487476
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STOML2,"Stomatin-like protein 2, mitochondrial",34427,89,1.09 [0.89-1.33],0.4035114911208571
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX16,Syntaxin-16,40089,100,0.85 [0.61-1.19],0.3485341378109337
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX1B,Syntaxin-1B,34720,90,0.79 [0.44-1.41],0.4245296763536583
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX3,Syntaxin-3,35608,95,0.70 [0.38-1.30],0.2569293926183527
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX4,Syntaxin-4,40826,102,1.08 [0.82-1.42],0.5791617434454241
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX5,Syntaxin-5,34646,90,1.05 [0.64-1.71],0.8561767758278367
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX6,Syntaxin-6,40089,100,0.98 [0.75-1.29],0.8816997367159334
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,34646,90,2.44 [1.65-3.61],7.686922979722589e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX8,Syntaxin-8,40974,103,1.05 [0.73-1.50],0.8051380817828421
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STXBP1,Syntaxin-binding protein 1,35624,95,0.87 [0.68-1.12],0.2952905629725518
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STXBP3,Syntaxin-binding protein 3,40089,100,0.94 [0.62-1.43],0.7674129945018204
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,35523,94,1.85 [1.25-2.74],0.0021568759140279
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUGT1,Protein SGT1 homolog,40089,100,1.02 [0.82-1.28],0.8544267882894905
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SULT1A1,Sulfotransferase 1A1,41382,103,0.90 [0.79-1.03],0.112032072234876
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,40974,103,1.22 [0.93-1.60],0.1454334475160612
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUMF1,Formylglycine-generating enzyme,34646,90,0.84 [0.57-1.23],0.3588776145862472
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,41382,103,0.93 [0.67-1.29],0.6592289996566616
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",35624,95,1.25 [0.94-1.66],0.1207827836737265
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUSD1,Sushi domain-containing protein 1,40294,103,0.75 [0.53-1.07],0.112351625257239
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUSD2,Sushi domain-containing protein 2,41027,103,1.14 [0.62-2.08],0.6746281158073653
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,35512,93,1.42 [0.94-2.15],0.0997619059918057
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,34724,90,1.79 [0.98-3.25],0.0562366168293073
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SV2A,Synaptic vesicle glycoprotein 2A,34720,90,0.87 [0.61-1.23],0.4299947411532815
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,35523,94,2.76 [2.37-3.22],8.604059492955685e-38
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SYAP1,Synapse-associated protein 1,34914,93,0.72 [0.49-1.04],0.0831083694507837
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,34584,91,0.76 [0.50-1.15],0.195468869777325
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SYT1,Synaptotagmin-1,35608,95,1.07 [0.67-1.70],0.7738521740759924
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SYTL4,Synaptotagmin-like protein 4,35674,93,0.94 [0.72-1.25],0.6854469479208092
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,35020,92,1.00 [0.83-1.21],0.9784164192548644
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TACC3,Transforming acidic coiled-coil-containing protein 3,40826,102,0.93 [0.80-1.08],0.3371755165335833
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,36393,89,0.80 [0.41-1.55],0.50479925467099
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TADA3,Transcriptional adapter 3,35512,93,1.03 [0.63-1.69],0.9080064544041038
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TAFA5,Chemokine-like protein TAFA-5,40826,102,0.79 [0.48-1.30],0.3554375239339888
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TAGLN3,Transgelin-3,34427,89,1.02 [0.73-1.42],0.9124717030239629
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TALDO1,Transaldolase,35547,92,1.24 [0.81-1.92],0.322232944282088
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TANK,TRAF family member-associated NF-kappa-B activator,40284,100,1.19 [0.93-1.52],0.1696870891579944
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,35020,92,0.43 [0.26-0.72],0.0012390421194307
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TARBP2,RISC-loading complex subunit TARBP2,40064,101,1.01 [0.81-1.27],0.9110446874727576
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",34720,90,0.80 [0.58-1.10],0.1746580002840586
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",35512,93,1.32 [0.82-2.14],0.253035961503721
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,35608,95,2.14 [1.69-2.70],1.9393583851153006e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,40064,101,1.33 [0.95-1.87],0.0950999931867272
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TBC1D23,TBC1 domain family member 23,40826,102,0.92 [0.75-1.11],0.38203327752266
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TBC1D5,TBC1 domain family member 5,40974,103,1.08 [0.88-1.34],0.456447929197623
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TBCA,Tubulin-specific chaperone A,34914,93,1.02 [0.80-1.29],0.8824256711616489
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TBCB,Tubulin-folding cofactor B,40720,102,0.96 [0.81-1.14],0.6444956780602755
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TBCC,Tubulin-specific chaperone C,40720,102,0.88 [0.71-1.10],0.2613180426774798
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TBL1X,F-box-like/WD repeat-containing protein TBL1X,40089,100,0.89 [0.72-1.10],0.2807965892894825
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TBR1,T-box brain protein 1,34720,90,0.72 [0.42-1.23],0.2251867060169506
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,40658,102,2.90 [2.59-3.25],1.7387356742979262e-74
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCL1B,T-cell leukemia/lymphoma protein 1B,40294,103,0.90 [0.70-1.15],0.394757930987495
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCN1,Transcobalamin-1,34971,91,0.89 [0.49-1.63],0.7172411560041553
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,41451,105,1.74 [1.06-2.85],0.0279020587753196
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,35674,93,2.48 [1.99-3.08],3.706436379368485e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCP11,T-complex protein 11 homolog,35020,92,0.93 [0.63-1.36],0.7048637386193165
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCTN3,Tectonic-3,35674,93,1.48 [0.77-2.86],0.242746841897317
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TDGF1,Teratocarcinoma-derived growth factor 1,40064,101,1.04 [0.93-1.17],0.5001072655987135
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TDO2,"Tryptophan 2,3-dioxygenase",34720,90,1.13 [0.70-1.84],0.6135970962117501
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,35512,93,1.71 [1.47-1.98],1.9492881479946095e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TDRKH,Tudor and KH domain-containing protein,40064,101,1.21 [0.99-1.47],0.056521268203862
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TEF,Thyrotroph embryonic factor,34555,92,0.96 [0.59-1.54],0.8512961753230643
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,41133,105,2.71 [1.27-5.76],0.0096820082710513
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TERF1,Telomeric repeat-binding factor 1,34646,90,1.69 [0.94-3.05],0.0780305984255458
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TET2,Methylcytosine dioxygenase TET2,34955,92,0.93 [0.74-1.16],0.5181817590853979
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,34720,90,1.12 [0.78-1.61],0.5480364301908871
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TEX33,Testis-expressed protein 33,35020,92,1.20 [0.78-1.85],0.4029690226405996
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TF,Serotransferrin,35728,94,0.40 [0.16-0.98],0.0459395720122115
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TFAP2A,Transcription factor AP-2-alpha,34584,91,0.95 [0.67-1.34],0.7630945711918364
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TFF1,Trefoil factor 1,40838,100,0.94 [0.75-1.19],0.6093208478809596
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,41121,102,0.92 [0.67-1.26],0.6092341652045536
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,40984,103,1.18 [0.80-1.76],0.4019073422257497
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TFPI,Tissue factor pathway inhibitor,40911,102,0.71 [0.40-1.27],0.2466767172049584
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,41007,105,1.42 [1.04-1.94],0.0266207534237325
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,41183,103,2.15 [1.44-3.20],0.0001634587636783
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,35512,93,0.89 [0.73-1.07],0.2151635858108806
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,40974,103,1.54 [1.09-2.17],0.013603259392603
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,41415,104,1.01 [0.65-1.58],0.9556216544790844
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGFB2,Transforming growth factor beta-2 proprotein,35512,93,1.28 [0.92-1.78],0.1502842622681386
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,40777,102,1.51 [0.80-2.87],0.2054228223567696
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGFBR1,TGF-beta receptor type-1,34646,90,1.73 [0.93-3.23],0.0820040613711657
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,41133,105,1.94 [1.23-3.06],0.0042633536327448
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGFBR3,Transforming growth factor beta receptor type 3,41521,106,1.56 [0.89-2.74],0.120993792901151
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,40957,103,1.32 [1.05-1.66],0.0158714583559445
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,35700,95,4.34 [2.36-7.98],2.261285305045893e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THAP12,52 kDa repressor of the inhibitor of the protein kinase,34362,89,1.23 [1.03-1.47],0.0240294937423306
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,41020,104,3.20 [2.39-4.29],7.345072834026585e-15
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,41027,103,1.02 [0.64-1.63],0.9241473850138998
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,41038,102,0.76 [0.52-1.13],0.1727462250760782
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,40834,104,2.40 [1.54-3.73],0.0001089996379251
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,40294,103,1.08 [0.69-1.69],0.7460546888973997
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THRAP3,Thyroid hormone receptor-associated protein 3,34555,92,1.04 [0.88-1.24],0.6173120456438259
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THSD1,Thrombospondin type-1 domain-containing protein 1,34384,90,1.28 [0.73-2.24],0.3829099602602074
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THTPA,Thiamine-triphosphatase,35446,93,0.98 [0.78-1.23],0.858523424678728
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,41382,103,2.63 [1.49-4.65],0.0008748500395712
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIA1,Nucleolysin TIA-1 isoform p40,39849,102,1.00 [0.86-1.15],0.9683713840342276
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,41521,106,2.42 [1.38-4.22],0.0019548460017393
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39988,101,1.99 [1.53-2.58],2.336469712783109e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,35020,92,1.84 [1.49-2.26],9.836063115851732e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,41170,103,2.88 [2.03-4.08],2.523709893737433e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,35674,93,0.99 [0.60-1.62],0.9532468274912248
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,35608,95,1.19 [0.95-1.49],0.1324723041985924
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,40578,102,0.97 [0.52-1.81],0.9157108201669604
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIMP2,Metalloproteinase inhibitor 2,35674,93,0.75 [0.31-1.79],0.5147177330902661
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIMP3,Metalloproteinase inhibitor 3,41181,102,0.87 [0.76-1.00],0.0506141695641336
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,41027,103,0.52 [0.33-0.84],0.0068289163841596
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,40896,104,2.91 [1.36-6.22],0.0057940619145354
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TJAP1,Tight junction-associated protein 1,41133,105,1.03 [0.83-1.27],0.7937678136588582
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TJP3,Tight junction protein ZO-3,34584,91,0.97 [0.59-1.57],0.8887544959245356
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",35020,92,1.50 [1.09-2.08],0.0131654373419247
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,34646,90,2.82 [1.58-5.06],0.0004787605403276
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TLR2,Toll-like receptor 2,35020,92,1.50 [0.64-3.53],0.3495028251973618
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TLR3,Toll-like receptor 3,41488,104,0.98 [0.74-1.29],0.8676933119752838
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TLR4,Toll-like receptor 4,34646,90,1.14 [0.56-2.32],0.7162808629420135
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,34720,90,1.10 [0.77-1.57],0.6042764292163161
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMED1,Transmembrane emp24 domain-containing protein 1,35020,92,0.81 [0.54-1.22],0.3100565232034595
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMED10,Transmembrane emp24 domain-containing protein 10,34555,92,0.31 [0.14-0.69],0.0041484294867747
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMED4,Transmembrane emp24 domain-containing protein 4,34555,92,0.72 [0.46-1.13],0.1586380425952291
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMED8,Protein TMED8,35523,94,0.97 [0.80-1.18],0.7901651939608549
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMEM106A,Transmembrane protein 106A,35512,93,0.98 [0.74-1.30],0.8956941149307001
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMEM132A,Transmembrane protein 132A,34729,89,0.84 [0.60-1.16],0.2830411741796765
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMEM25,Transmembrane protein 25,35624,95,1.24 [0.86-1.78],0.2504895144305072
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMOD4,Tropomodulin-4,34427,89,1.07 [0.65-1.76],0.7982606650377186
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMPRSS11B,Transmembrane protease serine 11B,34584,91,0.63 [0.44-0.91],0.0143935198942705
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMPRSS11D,Transmembrane protease serine 11D,35535,95,0.62 [0.37-1.04],0.0712830818814754
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,40826,102,0.80 [0.65-0.97],0.0254128931335504
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,40524,102,1.08 [0.68-1.72],0.742496639886804
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,41027,103,1.50 [1.20-1.88],0.0003488881418751
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,41170,103,1.56 [1.10-2.21],0.0122253486372892
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,40228,103,1.94 [1.59-2.36],5.5804423239393525e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,35523,94,1.09 [0.73-1.62],0.6695476232055483
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40284,100,1.17 [0.73-1.86],0.5131787703096795
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,34914,93,0.76 [0.54-1.07],0.1115214913928328
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40720,102,2.91 [2.29-3.70],2.926895983343607e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40720,102,1.56 [1.35-1.79],1.0864915912479946e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,41096,104,0.97 [0.68-1.38],0.8686356228230583
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,41488,104,1.55 [1.02-2.37],0.0423345087213017
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40982,102,1.48 [0.83-2.65],0.1854981797931137
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,41133,105,1.59 [1.00-2.51],0.0497640547382456
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,41054,102,3.13 [2.56-3.84],1.874468340580644e-28
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40284,100,4.50 [3.96-5.11],7.850606868124709e-118
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,41054,102,2.30 [1.38-3.82],0.0013876344891979
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,34914,93,4.72 [3.09-7.21],6.528694791826166e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,41393,103,2.12 [1.32-3.40],0.0019050757129293
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,41027,103,2.75 [1.71-4.45],3.438868235450628e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,41027,103,1.95 [1.62-2.35],1.3516367607780905e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,41382,103,2.37 [1.31-4.29],0.0044045597391816
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,41415,104,5.80 [4.33-7.79],1.0483117841238502e-31
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40720,102,1.40 [1.06-1.84],0.0169386923263036
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,41382,103,2.76 [2.12-3.59],3.9659652534104894e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40720,102,5.77 [5.12-6.51],3.325546784236715e-179
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,41488,104,0.90 [0.45-1.76],0.7494269817929196
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,40974,103,1.28 [0.96-1.70],0.0892467359752691
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF12,Tumor necrosis factor ligand superfamily member 12,41488,104,0.54 [0.29-0.99],0.0474549511016495
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,41181,102,0.67 [0.47-0.97],0.0312309462890887
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,41451,106,0.38 [0.27-0.55],1.3208499326419385e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF14,Tumor necrosis factor ligand superfamily member 14,40720,102,0.90 [0.66-1.22],0.4989449864591514
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,35680,94,3.71 [2.66-5.18],1.1293987047699548e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,35608,95,1.45 [1.18-1.78],0.0003343754634505
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNN,Tenascin-N,35680,94,0.76 [0.48-1.19],0.2298941648646387
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNNI3,"Troponin I, cardiac muscle",40294,103,1.00 [0.81-1.23],0.9889523683868804
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNPO1,Transportin-1,35020,92,1.28 [0.76-2.17],0.3555317657188496
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,40720,102,0.72 [0.47-1.09],0.1202697182261272
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNXB,Tenascin-X,41027,103,0.68 [0.34-1.33],0.2554594553851617
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,35674,93,1.03 [0.80-1.33],0.8023272124498027
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TOP1,DNA topoisomerase 1,35523,94,0.93 [0.79-1.11],0.4247372239422906
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TOP1MT,"DNA topoisomerase I, mitochondrial",34427,89,0.92 [0.59-1.43],0.7046152854226475
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,34646,90,1.74 [1.41-2.15],2.251193909485865e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,34729,89,1.41 [1.06-1.87],0.0192181123792052
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,40089,100,2.20 [1.76-2.75],3.1380823282555398e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,34646,90,1.83 [1.50-2.24],4.2343836409559024e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TP53I3,Quinone oxidoreductase PIG3,34149,90,1.06 [0.72-1.56],0.7625246967724826
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TP53INP1,Tumor protein p53-inducible nuclear protein 1,40294,103,1.10 [0.64-1.87],0.7379360521500189
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TP73,Tumor protein p73,34720,90,1.57 [0.88-2.81],0.1245552738242425
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPBGL,Trophoblast glycoprotein-like,34720,90,0.59 [0.32-1.07],0.0803686011625838
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPD52L2,Tumor protein D54,34914,93,0.88 [0.74-1.06],0.1856530063018346
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,35674,93,4.47 [2.34-8.52],5.64115083221388e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPM3,Tropomyosin alpha-3 chain,34555,92,0.74 [0.45-1.21],0.2319003277035525
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPMT,Thiopurine S-methyltransferase,40089,100,0.90 [0.70-1.16],0.414491228317048
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,40721,100,0.86 [0.57-1.29],0.4738820140515273
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPPP2,Tubulin polymerization-promoting protein family member 2,35020,92,0.75 [0.56-1.02],0.0649626575010218
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPPP3,Tubulin polymerization-promoting protein family member 3,40064,101,0.62 [0.36-1.06],0.081944416566169
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,34555,92,1.81 [1.54-2.13],4.19818512495685e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPRKB,EKC/KEOPS complex subunit TPRKB,34427,89,1.10 [0.84-1.45],0.4934621802649731
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPSAB1,Tryptase alpha/beta-1,41425,104,1.10 [0.79-1.54],0.5573681708597307
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPSD1,Tryptase delta,35624,95,1.12 [0.70-1.81],0.6333332875938729
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPSG1,Tryptase gamma,34646,90,1.03 [0.49-2.18],0.9328644213283857
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPT1,Translationally-controlled tumor protein,40284,100,0.78 [0.56-1.10],0.1543255722286417
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRAF2,TNF receptor-associated factor 2,40974,103,1.23 [0.97-1.57],0.0923394154551832
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",34646,90,1.86 [1.40-2.47],2.2284770170591025e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,34555,92,0.73 [0.44-1.22],0.2322230754228601
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,35020,92,1.03 [0.82-1.30],0.799271657142054
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TREH,Trehalase,35680,94,1.18 [0.90-1.55],0.2267736059680344
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,40982,102,1.61 [1.18-2.19],0.0029561479835605
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TREML1,Trem-like transcript 1 protein,35700,95,0.75 [0.51-1.11],0.1476227134665295
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,41027,103,8.88 [6.61-11.93],1.4468804305188775e-47
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIAP1,TP53-regulated inhibitor of apoptosis 1,41393,103,1.24 [0.95-1.63],0.1200124760725045
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIM21,E3 ubiquitin-protein ligase TRIM21,40974,103,0.90 [0.72-1.13],0.3597455042272892
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIM24,Transcription intermediary factor 1-alpha,34950,92,1.32 [1.01-1.73],0.0436197461781477
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,35523,94,1.13 [0.94-1.35],0.2076300221811523
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIM26,Tripartite motif-containing protein 26,34427,89,1.15 [0.84-1.58],0.3914323230647877
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIM40,E3 ubiquitin ligase TRIM40,34720,90,0.75 [0.56-1.00],0.0519001916714881
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIM5,Tripartite motif-containing protein 5,40974,103,1.01 [0.82-1.23],0.9433101752114056
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIM58,E3 ubiquitin-protein ligase TRIM58,35512,93,1.05 [0.84-1.32],0.6649432528719017
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRPV3,Transient receptor potential cation channel subfamily V member 3,34555,92,0.58 [0.35-0.95],0.0317932161340507
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSC1,Hamartin,34646,90,1.06 [0.82-1.37],0.6379122107086053
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSC22D1,TSC22 domain family protein 1,35624,95,1.03 [0.76-1.38],0.8614372268862786
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSHB,Thyrotropin subunit beta,41020,104,1.08 [0.86-1.35],0.504789342376992
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSLP,Thymic stromal lymphopoietin,40294,103,0.92 [0.67-1.25],0.5819674591577755
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSNAX,Translin-associated protein X,34555,92,1.10 [0.67-1.81],0.7087499314833884
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,40294,103,0.86 [0.65-1.14],0.2872908667535402
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSPAN15,Tetraspanin-15,34555,92,0.74 [0.46-1.19],0.2114126196094181
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSPAN7,Tetraspanin-7,34584,91,0.74 [0.56-0.98],0.0376408149436027
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,35523,94,0.93 [0.76-1.14],0.4845968885985603
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSPYL1,Testis-specific Y-encoded-like protein 1,34646,90,1.07 [0.65-1.76],0.7801729099926691
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TST,Thiosulfate sulfurtransferase,39997,101,1.04 [0.82-1.31],0.7546291030082737
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TTF2,Transcription termination factor 2,34720,90,1.26 [0.86-1.86],0.2342829177784213
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TTN,Titin,34555,92,1.10 [0.84-1.44],0.4718269291966301
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,35338,92,0.37 [0.17-0.79],0.0101515041114617
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TUBB3,Tubulin beta-3 chain,34584,91,1.27 [0.64-2.49],0.4932899303017729
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TWF2,Twinfilin-2,35680,94,0.99 [0.79-1.26],0.963356381953038
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXK,Tyrosine-protein kinase TXK,35020,92,0.84 [0.62-1.15],0.2839273921698967
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXLNA,Alpha-taxilin,40720,102,1.29 [1.06-1.58],0.0125141170963787
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXN,Thioredoxin,35100,91,1.39 [0.96-2.03],0.0848485000704825
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXNDC15,Thioredoxin domain-containing protein 15,41133,105,0.54 [0.29-1.02],0.0558620849702419
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXNDC5,Thioredoxin domain-containing protein 5,41382,103,0.95 [0.74-1.24],0.7220672380962777
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXNDC9,Thioredoxin domain-containing protein 9,35608,95,0.93 [0.64-1.37],0.7212830506575484
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXNL1,Thioredoxin-like protein 1,34521,91,0.89 [0.71-1.12],0.3218189645165924
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",41027,103,0.90 [0.61-1.32],0.5862927424731661
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TYMP,Thymidine phosphorylase,40760,103,1.02 [0.79-1.33],0.8582090130220652
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TYRO3,Tyrosine-protein kinase receptor TYRO3,41020,104,1.27 [0.69-2.35],0.4382302817707266
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",34646,90,1.38 [0.99-1.92],0.0593335860618049
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,40826,102,1.69 [1.02-2.80],0.0402049728289831
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UBE2B,Ubiquitin-conjugating enzyme E2 B,35512,93,1.46 [0.80-2.68],0.2205075214195284
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,35674,93,1.27 [0.93-1.74],0.1356756552913168
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,34646,90,0.84 [0.57-1.23],0.3737943416735099
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UBQLN3,Ubiquilin-3,34555,92,0.88 [0.57-1.34],0.5366142143722252
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UBXN1,UBX domain-containing protein 1,34914,93,1.04 [0.78-1.39],0.8025712035036036
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,35523,94,0.94 [0.81-1.08],0.353577418072832
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UGDH,UDP-glucose 6-dehydrogenase,34555,92,0.92 [0.73-1.15],0.4760023297564231
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UHRF2,E3 ubiquitin-protein ligase UHRF2,34555,92,1.20 [0.73-1.98],0.4780041575968292
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,40720,102,2.31 [1.56-3.43],2.976249493824568e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UMOD,Uromodulin,41393,106,0.76 [0.56-1.02],0.0687782510117893
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UNC5D,Netrin receptor UNC5D,34646,90,1.00 [0.46-2.18],0.9993813420273768
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UNC79,Protein unc-79 homolog,34427,89,1.10 [0.78-1.57],0.5837819847607024
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UNG,Uracil-DNA glycosylase,35512,93,1.42 [0.90-2.22],0.1297467468547382
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UPB1,Beta-ureidopropionase,35674,93,1.07 [0.87-1.33],0.5203718555631925
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UPK3A,Uroplakin-3a,34584,91,1.30 [0.90-1.86],0.1565117860508594
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UPK3BL1,Uroplakin-3b-like protein 1,34954,92,0.74 [0.45-1.21],0.2277036701823632
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UROD,Uroporphyrinogen decarboxylase,34914,93,0.86 [0.64-1.16],0.3248143001739482
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UROS,Uroporphyrinogen-III synthase,34720,90,1.17 [0.89-1.53],0.2553023257634237
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",USO1,General vesicular transport factor p115,40826,102,0.97 [0.80-1.18],0.7685236640243038
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",USP25,Ubiquitin carboxyl-terminal hydrolase 25,35512,93,1.27 [0.97-1.67],0.0824779433342941
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,35608,95,2.78 [2.31-3.34],2.5229090504061118e-27
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",USP47,Ubiquitin carboxyl-terminal hydrolase 47,34555,92,1.03 [0.82-1.29],0.8036266793665636
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",USP8,Ubiquitin carboxyl-terminal hydrolase 8,40294,103,1.17 [0.97-1.40],0.0930622536098231
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UXS1,UDP-glucuronic acid decarboxylase 1,40089,100,1.13 [0.83-1.56],0.434831471513913
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,40294,103,1.04 [0.76-1.43],0.7943908580438896
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VAMP8,Vesicle-associated membrane protein 8,34646,90,1.10 [0.87-1.38],0.4318413688724253
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VASH1,Tubulinyl-Tyr carboxypeptidase 1,40974,103,0.87 [0.70-1.08],0.2180398543187215
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,40364,101,1.22 [0.64-2.33],0.5425377638472647
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VASP,Vasodilator-stimulated phosphoprotein,35700,95,0.89 [0.67-1.17],0.3939371360356154
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40826,102,1.06 [0.43-2.59],0.8966238333816297
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VAV3,Guanine nucleotide exchange factor VAV3,34584,91,1.02 [0.83-1.25],0.8782580980153964
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,41111,103,6.04 [3.73-9.78],2.697884074947799e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VCAN,Versican core protein,41382,103,1.43 [0.81-2.52],0.2214472426360095
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VCPKMT,Protein-lysine methyltransferase METTL21D,34427,89,0.95 [0.74-1.23],0.7047099345499483
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VEGFA,Vascular endothelial growth factor A,41364,104,0.97 [0.71-1.31],0.8373769058008222
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,34646,90,0.37 [0.19-0.75],0.0053437065257514
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VEGFC,Vascular endothelial growth factor C,41133,105,0.62 [0.46-0.84],0.0022098128696181
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VEGFD,Vascular endothelial growth factor D,41421,104,0.77 [0.50-1.19],0.2466736255957046
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VGF,Neurosecretory protein VGF,35624,95,1.42 [0.76-2.65],0.2747868059760984
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VIM,Vimentin,40294,103,0.91 [0.80-1.04],0.1836425209359231
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VIPR1,Vasoactive intestinal polypeptide receptor 1,34729,89,0.81 [0.33-1.94],0.6325048856035118
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VIT,Vitrin,35674,93,0.90 [0.53-1.52],0.6944408635470828
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VMO1,Vitelline membrane outer layer protein 1 homolog,40826,102,1.14 [0.87-1.49],0.3536420293289709
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VNN1,Pantetheinase,35700,95,1.09 [0.83-1.44],0.5194102319515262
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VNN2,Vascular non-inflammatory molecule 2,40826,102,1.25 [0.85-1.85],0.2617872050663971
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VPS28,Vacuolar protein sorting-associated protein 28 homolog,35020,92,0.80 [0.58-1.11],0.1782339496498772
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VPS37A,Vacuolar protein sorting-associated protein 37A,40826,102,0.98 [0.79-1.22],0.8648441329924601
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VPS4B,Vacuolar protein sorting-associated protein 4B,35512,93,0.92 [0.74-1.14],0.4458409986866702
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VPS53,Vacuolar protein sorting-associated protein 53 homolog,40826,102,0.96 [0.77-1.21],0.7426240212595647
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSIG10,V-set and immunoglobulin domain-containing protein 10,35512,93,1.05 [0.60-1.84],0.8579446381228766
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,34555,92,0.93 [0.50-1.71],0.8117408642941174
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,35512,93,1.05 [0.77-1.44],0.7439879950466328
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,40972,103,1.88 [1.27-2.77],0.001576843700111
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40956,104,0.88 [0.65-1.18],0.3783989648503516
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSNL1,Visinin-like protein 1,35608,95,1.51 [0.96-2.38],0.0713520550141763
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSTM1,V-set and transmembrane domain-containing protein 1,40064,101,0.96 [0.67-1.36],0.8012765655964199
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSTM2B,V-set and transmembrane domain-containing protein 2B,35020,92,1.04 [0.66-1.65],0.8670157152570793
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40294,103,0.76 [0.55-1.07],0.1133237999278556
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,41382,103,0.88 [0.69-1.13],0.3247674026203789
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,40089,100,0.86 [0.48-1.54],0.6192967445611615
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,34914,93,1.02 [0.72-1.45],0.8964394150973283
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,41331,103,1.32 [0.88-1.99],0.1850066548325152
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,34427,89,0.84 [0.61-1.16],0.2871423433016642
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,40575,102,0.99 [0.63-1.54],0.9525786479906182
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VWC2L,von Willebrand factor C domain-containing protein 2-like,35624,95,0.84 [0.52-1.37],0.492445854685777
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,41521,106,1.39 [1.10-1.74],0.004837414400496
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",41027,103,2.02 [1.30-3.13],0.0016924484196646
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WAS,Wiskott-Aldrich syndrome protein,40284,100,0.99 [0.75-1.29],0.9326271179017817
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WASF1,Wiskott-Aldrich syndrome protein family member 1,40294,103,1.02 [0.84-1.23],0.8644778259672004
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WASF3,Wiskott-Aldrich syndrome protein family member 3,40064,101,0.91 [0.74-1.12],0.3933343113276552
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WASHC3,WASH complex subunit 3,35608,95,1.16 [0.91-1.48],0.2234729157876065
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WASL,Neural Wiskott-Aldrich syndrome protein,34646,90,0.71 [0.48-1.06],0.0956832352917897
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,35512,93,3.19 [2.76-3.69],4.7944007936006745e-55
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WFDC1,WAP four-disulfide core domain protein 1,34791,92,0.92 [0.62-1.36],0.6706466744368123
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,41330,103,0.93 [0.71-1.23],0.6277616582878142
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,38924,100,1.94 [1.32-2.84],0.0007144522628172
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40590,101,1.83 [1.23-2.74],0.0031355458208918
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",41054,102,1.04 [0.62-1.75],0.8702645123573558
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WIF1,Wnt inhibitory factor 1,41393,103,0.96 [0.57-1.59],0.8615892347682834
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,40284,100,1.27 [0.70-2.30],0.4261469396463261
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,40720,102,1.17 [0.84-1.62],0.3490647663484831
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,41393,103,1.58 [1.27-1.97],4.519496716661101e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",XG,Glycoprotein Xg,41317,104,1.59 [0.95-2.67],0.0785014003088168
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",XIAP,E3 ubiquitin-protein ligase XIAP,34646,90,1.39 [1.00-1.93],0.0509736752492421
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",XPNPEP2,Xaa-Pro aminopeptidase 2,41133,105,0.96 [0.81-1.13],0.6300355641464224
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",XRCC4,DNA repair protein XRCC4,40064,101,1.51 [1.01-2.27],0.044548928455478
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,35608,95,2.35 [1.34-4.11],0.0028207996484892
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",35523,94,0.95 [0.84-1.09],0.4925964289479306
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YES1,Tyrosine-protein kinase Yes,40826,102,0.94 [0.80-1.09],0.3990636837973417
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,35512,93,2.64 [1.80-3.87],6.952978157892552e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YOD1,Ubiquitin thioesterase OTU1,34555,92,1.31 [0.96-1.78],0.0930068284912703
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YTHDF3,YTH domain-containing family protein 3,40284,100,0.95 [0.77-1.18],0.6649981531927402
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YWHAQ,14-3-3 protein theta,34914,93,0.99 [0.75-1.30],0.9362984401055272
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YY1,Transcriptional repressor protein YY1,34646,90,1.60 [0.83-3.08],0.1575423008562908
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,34646,90,2.59 [2.10-3.19],5.021034102681463e-19
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZBTB16,Zinc finger and BTB domain-containing protein 16,40089,100,0.96 [0.74-1.23],0.7322354317854918
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,40294,103,2.43 [2.08-2.84],6.646177362571314e-29
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,34555,92,1.32 [1.03-1.68],0.0270544756667297
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZFYVE19,Abscission/NoCut checkpoint regulator,35523,94,0.99 [0.80-1.24],0.9512138127589204
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,35608,95,3.05 [2.67-3.49],3.4631792896948014e-61
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZNF174,Zinc finger protein 174,34646,90,1.40 [0.95-2.06],0.0897153181054278
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZNF75D,Zinc finger protein 75D,35020,92,1.01 [0.73-1.40],0.945653151436668
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZNF830,Zinc finger protein 830,35512,93,0.85 [0.63-1.13],0.2598088692338081
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,35523,94,1.58 [1.24-2.03],0.000270370003964
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,35512,93,0.83 [0.57-1.23],0.3570944382543392
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZP3,Zona pellucida sperm-binding protein 3,34729,89,0.94 [0.87-1.01],0.0956813607537676
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,34427,89,0.50 [0.21-1.15],0.101186136933515
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZPR1,Zinc finger protein ZPR1,34584,91,0.74 [0.56-0.99],0.0413066267901016
